data_2m5z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m5z _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.3 mm . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.805 0.336 . . . . 72.409999999999997 111.113 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.53 35.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 63.43 111.096 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.7 -26.53 68.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 72.230000000000004 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.22 -24.63 19.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 72.439999999999998 110.935 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -70.39 -64.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 70.239999999999995 111.136 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.25 -25.74 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 111.045 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -82.43 -66.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 74.129999999999995 110.902 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -85.15 -75.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 110.844 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.57 153.74 8.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 72.019999999999996 112.462 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.525 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -53.33 -58.11 14.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 74.540000000000006 110.918 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.2 Cg_endo -69.73 -6.98 19.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.695 2.263 . . . . 73.129999999999995 112.343 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.88 -21.91 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 73.150000000000006 111.176 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -95.49 -25.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.340000000000003 111.12 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -25.05 66.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 110.896 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -79.88 -30.38 40.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.150000000000006 110.943 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -110.18 25.42 11.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 75.109999999999999 110.92 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -25.18 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 73.329999999999998 110.891 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -76.04 -5.72 47.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 73.310000000000002 110.919 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -115.92 -56.35 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 65.219999999999999 110.888 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 mt -51.18 -69.45 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 72.239999999999995 111.115 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -23.94 50.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 52.43 110.858 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -77.12 -21.49 54.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 74.25 110.898 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -89.57 -48.77 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 74.349999999999994 110.866 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.7 pt -51.5 -29.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.097 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -21.26 39.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 65.340000000000003 112.488 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -93.08 -74.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 73.010000000000005 110.889 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.91 44.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 75.120000000000005 112.504 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -69.47 -179.96 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 74.209999999999994 110.915 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.6 -175.83 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 63.100000000000001 111.098 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tt -88.45 -19.85 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 70.049999999999997 111.142 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -101.84 22.02 13.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 110.827 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -112.1 -64.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 63.240000000000002 110.916 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 pt -50.87 -35.31 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 72.040000000000006 111.149 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.3 -64.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 75.299999999999997 111.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.93 -21.96 61.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.853 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -71.51 -56.39 6.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 75.439999999999998 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.9 mt -56.22 -58.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 75.450000000000003 111.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -35.01 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.875 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.58 -36.31 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 75.140000000000001 110.877 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -72.47 -62.51 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 74.109999999999999 110.869 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 pt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 111.152 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.1 mm . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.86 0.362 . . . . 74.430000000000007 111.141 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.67 -27.54 28.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 61.240000000000002 111.085 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.45 -32.06 71.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 75.019999999999996 110.929 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.38 -24.71 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.549999999999997 110.968 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.1 t -69.6 -59.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 75.109999999999999 111.11 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 64.239999999999995 111.09 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -81.11 -46.0 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.400000000000006 110.893 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.29 -74.83 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.150000000000006 110.862 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.31 150.77 7.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 74.310000000000002 112.476 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.514 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.71 -58.05 12.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 72.120000000000005 110.936 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.9 Cg_endo -69.79 -6.75 19.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 74.109999999999999 112.32 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.1 mm -94.49 -22.68 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 73.140000000000001 111.127 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.5 m -94.72 -27.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 63.130000000000003 111.097 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.85 -25.5 67.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.901 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.83 -30.67 40.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.877 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -109.8 28.04 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 75.109999999999999 110.948 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.59 -6.14 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 73.540000000000006 110.922 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -91.36 -11.26 38.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -109.77 -55.94 2.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 62.229999999999997 110.89 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.2 mt -51.62 -68.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 73.200000000000003 111.11 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 tpt -56.64 -24.94 51.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 74.400000000000006 110.848 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.76 -23.15 52.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 74.230000000000004 110.915 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -86.12 -49.42 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 73.219999999999999 110.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.5 pt -52.07 -28.37 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 71.530000000000001 111.091 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.46 -18.5 44.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.75 . . . . 62.119999999999997 112.532 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -97.7 -74.99 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 72.5 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.34 49.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 71.450000000000003 112.513 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -69.73 -179.76 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.322 . . . . 74.319999999999993 110.922 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.75 -169.47 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 71.129999999999995 111.125 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -101.58 -21.45 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 111.172 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -116.78 23.22 12.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 73.239999999999995 110.883 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -55.37 3.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 110.945 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.5 pt -50.76 -35.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 111.109 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mp -65.26 -53.46 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 111.128 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -66.48 -25.13 66.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 61.119999999999997 110.884 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -65.41 -57.33 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 73.349999999999994 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.4 mt -60.32 -46.51 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 111.14 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -52.28 -32.25 36.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.878 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -75.55 -46.91 29.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.340000000000003 110.888 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.25 -62.91 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.847 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 pt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.209999999999994 111.177 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.805 0.336 . . . . 74.200000000000003 111.061 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.99 -24.62 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 72.239999999999995 111.154 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.28 -35.55 81.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 110.845 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.08 -26.2 56.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 74.120000000000005 110.882 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.44 -58.78 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 64.109999999999999 111.16 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.9 -24.96 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 62.439999999999998 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -79.9 -44.47 20.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 64.010000000000005 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -111.99 -74.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.120000000000005 110.914 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.63 150.79 6.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 74.299999999999997 112.479 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.2 11.47 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.571 0.7 . . . . 75.420000000000002 110.905 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.76 -6.77 19.39 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.655 2.237 . . . . 73.200000000000003 112.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.4 mm -95.02 -22.9 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 74.450000000000003 111.138 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.6 m -94.07 -27.25 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 75.25 111.119 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -66.32 -25.43 66.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.439999999999998 110.958 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -78.89 -28.35 44.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 72.530000000000001 110.867 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -113.66 25.59 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 72.430000000000007 110.908 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -17.39 61.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.914 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -84.5 3.44 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 73.530000000000001 110.903 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -126.01 -56.34 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 110.938 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mt -51.2 -68.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 111.119 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.8 ttp -57.41 -23.56 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 74.400000000000006 110.867 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -78.27 -20.68 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 74.209999999999994 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.73 -49.23 6.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 71.120000000000005 110.893 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -51.17 -29.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 75.109999999999999 111.123 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.42 -22.06 36.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 64.319999999999993 112.542 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.72 -68.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 75.400000000000006 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.42 35.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 70.329999999999998 112.484 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -57.77 -179.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.804 0.335 . . . . 74.099999999999994 110.897 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.15 -169.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 75.219999999999999 111.057 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 tt -98.62 -10.01 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 111.124 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -111.09 -24.77 10.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 73.030000000000001 110.865 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -63.24 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.907 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.5 pt -50.51 -35.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 111.159 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.49 -60.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.349999999999994 111.112 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.69 -17.91 63.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 70.329999999999998 110.868 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -76.28 -58.62 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.905 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.0 mt -54.09 -55.0 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 75.510000000000005 111.167 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -34.53 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 70.099999999999994 110.931 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -53.2 -46.19 68.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.200000000000003 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.56 -72.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 72.510000000000005 110.904 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.157 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.895 0.379 . . . . 71.049999999999997 111.133 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.48 -25.4 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 72.219999999999999 111.07 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -58.27 -37.91 75.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.109999999999999 110.923 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.3 -23.11 40.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 53.539999999999999 110.952 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.86 -67.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 75.129999999999995 111.148 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.96 -27.22 29.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 111.108 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -78.5 -70.0 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 110.895 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -82.61 -74.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 74.319999999999993 110.837 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.67 150.84 7.01 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 75.209999999999994 112.498 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.17 -58.27 11.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.587 0.708 . . . . 71.319999999999993 110.89 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.74 -6.92 19.74 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 63.25 112.325 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.4 mm -94.87 -22.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 111.086 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.2 m -94.5 -27.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 74.540000000000006 111.148 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -61.6 -25.44 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 75.209999999999994 110.914 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -81.36 -42.23 20.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 110.896 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -100.77 27.32 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 62.439999999999998 110.894 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.13 -34.57 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 73.120000000000005 110.905 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -71.9 -9.04 57.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.922 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -103.64 -52.38 3.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 110.92 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.0 mt -54.5 -65.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 111.113 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.6 ttt -56.74 -25.81 55.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.884 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -73.71 -20.75 60.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 110.94 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.67 -51.53 5.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 70.519999999999996 110.871 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.85 -29.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 111.172 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.39 -23.58 34.91 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.209999999999994 112.49 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 -75.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 63.310000000000002 110.875 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.44 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 64.340000000000003 112.512 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.04 -179.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 75.409999999999997 110.955 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.54 -169.35 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 74.109999999999999 111.099 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 tt -102.86 -13.31 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 72.25 111.107 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -122.42 20.46 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.893 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.36 -54.36 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 70.140000000000001 110.899 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.0 pt -50.11 -35.73 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.150000000000006 111.169 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mp -64.82 -56.66 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.010000000000005 111.146 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.92 -25.53 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 70.420000000000002 110.867 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -66.44 -48.72 69.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 70.519999999999996 110.912 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.99 -36.35 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 75.120000000000005 111.141 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -38.91 92.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.908 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -73.87 -26.9 60.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 110.939 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.5 -61.84 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 110.859 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 111.09 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 mm . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.86 0.362 . . . . 75.450000000000003 111.113 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.05 -24.72 41.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 111.115 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.99 -41.92 84.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.895 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.2 -24.58 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 73.340000000000003 110.925 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.71 -43.54 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 74.120000000000005 111.129 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.41 37.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 111.11 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.34 -30.29 33.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 75.030000000000001 110.87 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -126.29 -75.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 63.240000000000002 110.872 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.88 151.98 7.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 75.049999999999997 112.5 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.518 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.7 -58.17 11.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.53 0.681 . . . . 74.349999999999994 110.908 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.76 -6.62 19.03 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 73.409999999999997 112.335 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.5 mm -95.06 -22.7 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 73.129999999999995 111.145 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 m -94.3 -27.18 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 111.119 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.48 -29.73 70.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 75.129999999999995 110.909 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -75.53 -32.82 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 75.25 110.921 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -104.87 24.76 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.299999999999997 110.904 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -11.44 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.503 . . . . 75.430000000000007 110.951 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -90.89 13.55 16.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 71.319999999999993 110.931 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -139.3 -51.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 72.010000000000005 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.68 -65.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 73.439999999999998 111.136 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -21.33 54.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 110.908 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -82.11 -21.99 36.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -86.96 -43.55 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 65.120000000000005 110.883 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -55.57 -25.5 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 73.319999999999993 111.099 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.07 -6.93 69.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.783 -0.722 . . . . 61.520000000000003 112.505 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.0 -71.48 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 65.129999999999995 110.908 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.87 49.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 74.319999999999993 112.473 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -82.52 -178.24 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 71.400000000000006 110.944 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.57 -175.6 2.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 63.310000000000002 111.116 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -86.38 -21.05 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.310000000000002 111.143 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -99.28 20.02 14.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.871 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -110.28 -68.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 pt -49.84 -31.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 72.439999999999998 111.152 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mm -61.38 -67.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 111.113 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -61.38 -31.02 70.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.833 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -55.56 -37.69 68.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 75.519999999999996 110.891 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.9 mt -86.43 -37.63 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 75.319999999999993 111.081 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -61.02 -28.75 69.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 75.310000000000002 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -89.37 -26.73 20.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.299999999999997 110.888 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.22 -26.53 52.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.109999999999999 110.846 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 111.107 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.827 0.346 . . . . 74.230000000000004 111.112 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.11 -24.86 43.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 61.340000000000003 111.147 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -35.08 70.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.319999999999993 110.92 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.53 -25.57 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 74.329999999999998 110.95 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.53 -35.31 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 71.299999999999997 111.15 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.01 17.14 11.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 62.539999999999999 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -130.49 -39.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 74.019999999999996 110.902 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -112.39 -75.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.129999999999995 110.931 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 149.09 5.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 31.309999999999999 112.5 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.516 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -50.79 -58.01 11.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.598 0.713 . . . . 74.200000000000003 110.922 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.82 -5.29 15.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 73.239999999999995 112.355 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.21 -22.28 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 75.400000000000006 111.139 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 m -92.99 -29.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 111.091 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -26.22 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 72.540000000000006 110.895 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -73.4 -21.12 60.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.030000000000001 110.88 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.91 21.51 11.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 73.209999999999994 110.909 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.86 -28.25 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 75.109999999999999 110.897 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.9 -9.35 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 75.439999999999998 110.936 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -109.02 -60.76 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.917 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.5 mt -51.37 -65.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 111.099 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 44.0 ttp -56.42 -28.48 59.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 110.859 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -75.22 -21.57 58.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 110.959 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -87.76 -50.35 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 75.299999999999997 110.908 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -51.95 -28.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 63.020000000000003 111.168 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -18.73 41.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.473 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -94.91 -69.18 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 75.230000000000004 110.906 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.66 36.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.757 . . . . 61.43 112.463 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -57.04 -179.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.793 0.33 . . . . 75.530000000000001 110.889 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.19 -169.33 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 74.129999999999995 111.107 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -101.54 -21.7 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 75.420000000000002 111.092 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -114.82 21.04 14.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 65.25 110.901 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 -58.02 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.879 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.5 pt -50.37 -31.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 74.549999999999997 111.138 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.71 -62.89 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 64.409999999999997 111.146 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -28.9 69.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 72.510000000000005 110.849 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -58.48 -53.79 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 73.420000000000002 110.951 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.8 mt -69.04 -40.08 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 111.14 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -52.01 -67.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 75.040000000000006 110.873 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -28.27 57.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 75.239999999999995 110.903 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -68.81 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 74.010000000000005 110.83 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.428 . . . . 75.209999999999994 111.132 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.1 mm . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.859 0.362 . . . . 74.5 111.145 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.5 -24.32 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 64.420000000000002 111.083 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -63.03 -25.03 68.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 110.883 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -92.02 -25.35 18.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 64.329999999999998 110.918 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.3 -68.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.150000000000006 111.125 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.59 -28.73 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.25 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -61.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.903 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.45 -74.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 71.340000000000003 110.907 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.92 151.64 7.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 74.530000000000001 112.508 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.517 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.44 -58.2 11.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 75.140000000000001 110.952 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.59 18.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 63.509999999999998 112.364 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.93 -22.44 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.114 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -94.81 -27.16 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 72.310000000000002 111.157 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -65.96 -25.42 67.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.872 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -25.74 39.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 74.209999999999994 110.924 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -114.49 24.94 11.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 73.230000000000004 110.913 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -27.84 64.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 73.400000000000006 110.945 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -7.84 53.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 74.530000000000001 110.863 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -109.98 -60.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 74.030000000000001 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.3 mt -52.74 -65.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 111.143 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -56.64 -25.79 54.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 110.881 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.68 -22.27 50.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 63.210000000000001 110.895 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -85.34 -47.95 9.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.420000000000002 110.912 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.8 pt -53.32 -27.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 75.340000000000003 111.171 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.56 -14.68 55.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 75.439999999999998 112.454 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.54 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 73.129999999999995 110.864 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.88 48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 54.530000000000001 112.481 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -72.82 -179.23 3.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.765 0.317 . . . . 75.450000000000003 110.92 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.92 -169.55 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 70.310000000000002 111.058 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tt -101.54 -11.11 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 111.096 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -122.96 4.29 9.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 75.430000000000007 110.85 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -78.6 -56.72 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.93 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.5 pt -49.42 -37.48 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.030000000000001 111.089 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mp -65.37 -44.37 94.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 75.400000000000006 111.125 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -74.48 -20.84 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.891 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -71.24 -53.88 12.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 71.530000000000001 110.891 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.7 mt -62.4 -47.87 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 75.299999999999997 111.139 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -43.39 63.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.912 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -68.23 -39.58 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 110.924 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -64.75 -62.04 1.82 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 110.86 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 74.439999999999998 111.081 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.3 mm . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.834 0.35 . . . . 73.019999999999996 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -21.15 58.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 63.32 111.114 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -64.52 -29.64 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 110.889 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.1 -25.08 24.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 73.329999999999998 110.931 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.61 -32.42 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 72.549999999999997 111.176 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.88 17.18 10.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 61.539999999999999 111.093 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -129.36 -45.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 110.909 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.77 -75.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.65 152.8 8.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.801 -0.714 . . . . 62.229999999999997 112.537 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.517 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.07 -58.14 12.46 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 75.430000000000007 110.957 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.78 -7.13 20.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 63.219999999999999 112.327 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.3 mm -95.28 -22.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 65.219999999999999 111.166 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.6 -26.22 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.239999999999995 111.144 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -65.37 -24.57 67.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 110.912 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -78.16 -47.97 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.9 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.26 22.22 8.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.931 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.53 -41.07 93.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 75.299999999999997 110.936 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.9 -56.47 21.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 74.510000000000005 110.854 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -56.24 -55.65 30.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.9 mt -50.97 -62.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 111.111 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -29.15 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 72.140000000000001 110.871 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -72.77 -23.63 60.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.319999999999993 110.905 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -86.8 -52.52 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.878 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.31 -29.84 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 75.409999999999997 111.059 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.5 38.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 74.129999999999995 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.0 -74.96 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 72.030000000000001 110.856 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.83 47.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 75.049999999999997 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -67.02 -179.65 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.782 0.325 . . . . 75.510000000000005 110.883 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.33 -169.45 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 111.091 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.39 -10.04 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.530000000000001 111.127 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -124.09 19.65 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.209999999999994 110.901 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -96.13 -56.17 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.150000000000006 110.893 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 pt -50.05 -31.29 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 72.239999999999995 111.145 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.1 mp -69.24 -50.74 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 71.549999999999997 111.126 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -69.53 -26.03 64.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 65.519999999999996 110.831 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -68.31 -44.08 76.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 110.955 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.72 -45.2 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 65.299999999999997 111.129 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -55.95 -38.65 70.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 73.420000000000002 110.935 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -72.95 -26.28 61.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 72.299999999999997 110.916 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -77.86 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 110.865 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 111.082 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.862 0.363 . . . . 75.439999999999998 111.107 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.57 67.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 65.329999999999998 111.067 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.59 -37.62 50.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 75.329999999999998 110.907 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.27 -34.16 74.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 73.420000000000002 110.939 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.39 -66.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 75.150000000000006 111.184 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.3 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.051 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -77.29 -41.72 39.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -118.84 -75.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 75.530000000000001 110.882 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.1 149.11 6.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 71.439999999999998 112.496 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.516 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.67 -58.22 11.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.519 0.676 . . . . 64.439999999999998 110.918 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.67 -6.94 19.76 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.248 . . . . 73.140000000000001 112.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.31 -23.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.519999999999996 111.132 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -93.63 -27.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.161 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -66.23 -28.2 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 75.219999999999999 110.902 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.45 -24.57 53.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 71.530000000000001 110.898 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -117.59 25.4 10.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 74.510000000000005 110.898 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -24.6 63.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 110.918 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -77.91 -3.82 43.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.914 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -114.27 -58.83 2.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.841 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mt -51.4 -69.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 111.113 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -23.79 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 72.040000000000006 110.868 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -77.01 -21.82 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 110.916 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -89.65 -48.43 7.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.875 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.7 pt -51.95 -28.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 64.140000000000001 111.132 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.39 -18.41 43.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 74.25 112.478 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -97.7 -75.03 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 64.150000000000006 110.874 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.85 48.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.753 . . . . 61.5 112.48 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -68.05 -179.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 73.219999999999999 110.885 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.21 -169.34 2.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 62.43 111.078 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -103.33 -7.94 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 111.18 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -118.63 14.63 13.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -95.81 -61.01 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.937 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 pt -50.04 -30.82 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 74.420000000000002 111.169 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -67.26 -72.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 111.144 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.25 -35.06 59.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 65.150000000000006 110.878 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -52.68 -45.9 67.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 74.25 110.912 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.9 mt -77.37 -47.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 75.430000000000007 111.09 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -52.81 -32.54 44.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 73.400000000000006 110.89 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -79.41 -43.59 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 64.519999999999996 110.865 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.25 -63.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.239999999999995 110.864 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 111.148 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.848 0.356 . . . . 75.230000000000004 111.118 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.46 47.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.030000000000001 111.071 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -61.3 -33.47 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 75.129999999999995 110.921 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -83.94 -21.23 31.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 65.340000000000003 110.923 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.28 -64.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.510000000000005 111.122 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.71 -24.95 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 70.5 111.086 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -79.81 -58.29 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 75.420000000000002 110.891 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -96.95 -75.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 75.230000000000004 110.892 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.85 151.78 7.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 63.439999999999998 112.479 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.518 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.58 -58.09 12.16 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.599 0.714 . . . . 72.25 110.933 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.83 19.54 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.692 2.262 . . . . 74.109999999999999 112.333 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.8 mm -94.6 -23.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.049999999999997 111.085 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 m -93.81 -27.36 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 64.219999999999999 111.124 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -62.61 -29.21 70.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.219999999999999 110.904 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -75.62 -36.36 60.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 74.349999999999994 110.913 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.07 26.21 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 73.319999999999993 110.933 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.45 -6.76 57.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 70.450000000000003 110.93 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -94.97 16.58 15.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 73.120000000000005 110.886 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -145.01 -50.17 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 72.120000000000005 110.943 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.7 mt -51.56 -67.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 111.133 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -57.51 -23.64 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.510000000000005 110.892 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.12 -19.55 50.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 74.099999999999994 110.905 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.35 -46.19 8.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 75.099999999999994 110.888 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.42 -23.46 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 65.340000000000003 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.28 9.46 70.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 74.439999999999998 112.454 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.37 -63.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 74.519999999999996 110.931 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.06 46.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 64.310000000000002 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -85.0 -178.66 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 75.239999999999995 110.945 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.33 -169.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 71.040000000000006 111.107 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.6 tt -101.19 -10.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.540000000000006 111.12 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -121.72 19.5 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.872 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -95.36 -58.34 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 74.230000000000004 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 pt -49.48 -33.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.453 . . . . 73.420000000000002 111.117 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.7 mt -60.58 -60.97 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 75.319999999999993 111.15 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -26.48 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 54.109999999999999 110.85 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -65.46 -30.03 70.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.510000000000005 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.3 mt -93.26 -30.98 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 72.299999999999997 111.084 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -38.78 78.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 74.319999999999993 110.909 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -70.21 -41.42 73.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 72.400000000000006 110.93 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.69 -64.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 73.400000000000006 110.859 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.510000000000005 111.134 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.1 mm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.837 0.351 . . . . 74.549999999999997 111.127 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -25.31 36.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 65.129999999999995 111.143 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -62.69 -32.67 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.889 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.67 -23.93 33.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 75.010000000000005 110.947 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.98 -56.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 53.43 111.153 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -26.17 66.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 111.094 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -79.97 -45.12 19.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 110.894 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -109.43 -74.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 73.409999999999997 110.87 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 150.9 6.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 60.399999999999999 112.492 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.52 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.26 11.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.572 0.701 . . . . 74.409999999999997 110.908 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.74 -6.59 18.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 64.420000000000002 112.36 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -95.13 -22.55 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.319999999999993 111.138 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.5 -27.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 75.450000000000003 111.113 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -64.44 -25.32 67.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 73.5 110.901 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -80.06 -32.48 39.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 75.030000000000001 110.884 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -106.52 24.44 12.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 64.420000000000002 110.902 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.82 -11.72 60.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 75.430000000000007 110.898 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -89.29 10.26 22.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 75.25 110.931 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -135.95 -54.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 73.329999999999998 110.897 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.6 mt -51.51 -68.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.108 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -23.78 51.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.239999999999995 110.859 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -78.18 -20.37 52.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 64.349999999999994 110.915 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -89.7 -47.5 7.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.897 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.2 -27.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 75.019999999999996 111.135 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.32 -21.97 35.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 62.109999999999999 112.502 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -93.45 -74.93 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 73.519999999999996 110.892 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.65 43.86 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 74.340000000000003 112.5 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -71.17 161.07 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.801 0.334 . . . . 74.140000000000001 110.924 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.86 -169.05 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 111.113 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.04 -0.07 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 73.099999999999994 111.136 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -115.84 -25.88 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 75.409999999999997 110.893 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -57.48 -62.8 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.913 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 pt -50.38 -35.37 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 64.340000000000003 111.111 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.88 -50.11 76.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.176 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.19 -3.79 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 75.150000000000006 110.868 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -90.43 -42.0 11.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 110.943 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.3 mt -72.29 -52.62 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 73.400000000000006 111.146 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -52.74 -30.59 33.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 72.530000000000001 110.87 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -67.25 -41.25 85.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 73.439999999999998 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -70.38 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.310000000000002 110.868 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 pt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.105 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.4 mm . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.843 0.354 . . . . 73.209999999999994 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.25 -20.95 58.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 75.439999999999998 111.059 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -68.25 -34.88 77.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 73.319999999999993 110.883 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.93 -22.73 49.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 74.299999999999997 110.903 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.59 -66.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 74.040000000000006 111.154 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.1 48.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 54.200000000000003 111.093 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -80.36 -56.74 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 110.902 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -98.47 -74.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 75.340000000000003 110.898 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.93 150.78 7.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 72.420000000000002 112.492 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.52 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.34 -58.32 11.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.568 0.699 . . . . 74.299999999999997 110.908 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.73 -6.65 19.09 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.687 2.258 . . . . 75.420000000000002 112.332 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.58 -22.54 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 63.409999999999997 111.124 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 m -94.95 -27.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.019999999999996 111.102 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.74 -25.07 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.922 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -80.16 -40.69 26.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 71.099999999999994 110.865 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -103.75 26.49 8.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 70.540000000000006 110.918 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.56 -35.01 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 110.953 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -71.86 -9.33 58.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 75.040000000000006 110.9 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.37 -51.8 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.329999999999998 110.951 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mt -56.44 -63.61 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 111.151 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ttt -57.17 -26.06 59.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.903 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.51 -18.64 60.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.239999999999995 110.871 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -91.9 -50.68 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.868 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.8 pt -51.09 -28.9 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 74.329999999999998 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.13 -23.57 32.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 73.230000000000004 112.51 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -92.06 -74.88 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 74.010000000000005 110.896 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.19 44.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 72.040000000000006 112.489 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.62 -179.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.78 0.324 . . . . 75.400000000000006 110.946 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.07 -169.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 73.230000000000004 111.134 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 tt -99.14 -10.03 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.239999999999995 111.146 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -111.04 -20.28 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.329999999999998 110.897 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -61.52 -59.2 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 73.430000000000007 110.921 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 pt -50.36 -31.35 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 111.182 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.82 -60.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 64.450000000000003 111.134 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.39 -25.06 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.852 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -67.21 -57.22 7.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.915 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.7 mt -62.7 -36.93 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 111.124 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -61.75 -61.36 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.540000000000006 110.924 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -52.7 -29.41 26.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.010000000000005 110.897 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -72.07 -68.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 73.409999999999997 110.859 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.150000000000006 111.129 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.823 0.344 . . . . 73.400000000000006 111.126 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.19 -19.95 56.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 111.114 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -67.62 -30.54 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 75.340000000000003 110.904 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.25 -26.06 28.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.933 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -61.04 -69.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 63.219999999999999 111.13 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -22.16 61.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.340000000000003 111.079 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -77.1 -37.48 54.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 72.209999999999994 110.909 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.04 -74.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.349999999999994 110.894 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.31 149.65 7.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.736 -0.745 . . . . 54.530000000000001 112.501 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.512 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.02 -58.11 12.55 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.554 0.693 . . . . 73.329999999999998 110.927 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.77 -6.41 18.55 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.669 2.246 . . . . 74.430000000000007 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mm -93.64 -23.29 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 73.140000000000001 111.127 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.0 m -94.37 -28.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 73.340000000000003 111.119 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.84 -35.66 81.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.869 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -73.25 -30.73 63.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 70.030000000000001 110.872 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -103.3 22.13 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 72.510000000000005 110.914 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -26.17 63.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 74.510000000000005 110.958 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -75.59 -6.07 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 73.310000000000002 110.885 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -112.09 -60.84 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 71.549999999999997 110.903 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mt -51.19 -67.98 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.329999999999998 111.124 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -26.51 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.853 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -74.64 -23.27 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.209999999999994 110.885 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -87.36 -51.33 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 72.230000000000004 110.843 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -51.29 -29.5 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 75.129999999999995 111.118 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.24 -21.03 38.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.742 . . . . 73.010000000000005 112.465 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -93.35 -68.99 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 75.510000000000005 110.861 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.48 36.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.704 -0.76 . . . . 63.240000000000002 112.468 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -56.64 179.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.754 0.311 . . . . 75.329999999999998 110.966 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.05 -169.32 2.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 73.400000000000006 111.09 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -102.13 -21.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.178 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -116.65 22.09 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 74.409999999999997 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -94.63 -54.71 3.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.219999999999999 110.839 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 pt -50.23 -36.04 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 75.510000000000005 111.129 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mp -65.18 -48.89 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.549999999999997 111.113 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 -24.01 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.540000000000006 110.886 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -69.18 -49.94 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.26 -45.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 75.140000000000001 111.115 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -57.74 -29.07 64.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 75.120000000000005 110.855 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.53 23.48 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 75.400000000000006 110.917 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -126.69 -38.84 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.837 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.140000000000001 111.133 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.798 0.332 . . . . 73.439999999999998 111.106 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.59 -21.79 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 60.109999999999999 111.073 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -67.62 -29.75 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 110.912 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.75 -27.65 28.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 75.530000000000001 110.885 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.68 -69.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.125 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.71 19.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 61.329999999999998 111.142 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -74.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 73.450000000000003 110.918 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -77.85 -74.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.835 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.07 150.89 7.11 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 63.409999999999997 112.462 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.33 11.02 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 75.209999999999994 110.928 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.85 19.58 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 60.119999999999997 112.324 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.0 mm -94.37 -23.21 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 111.134 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.8 m -94.12 -27.92 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.430000000000007 111.125 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -32.06 70.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 73.129999999999995 110.895 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.99 -42.29 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.88 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -99.58 27.72 5.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.95 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.85 -1.25 42.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.159 -0.473 . . . . 70.319999999999993 110.904 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 -11.79 22.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.91 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -109.74 -50.65 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 72.530000000000001 110.905 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mt -51.16 -69.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 111.122 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -24.72 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 75.230000000000004 110.885 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -75.65 -23.72 56.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 75.530000000000001 110.926 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -87.87 -50.2 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 72.25 110.865 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.4 pt -51.29 -29.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.52 -21.95 36.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 64.310000000000002 112.466 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -92.28 -74.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 65.329999999999998 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.0 41.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 52.310000000000002 112.491 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -68.43 -179.8 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.786 0.327 . . . . 72.409999999999997 110.892 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.42 -169.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 61.119999999999997 111.076 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -96.29 -21.93 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.128 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -99.7 -20.07 16.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.140000000000001 110.875 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.23 -63.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 73.239999999999995 110.865 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 pt -51.06 -35.26 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 74.5 111.101 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.87 -58.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 64.549999999999997 111.128 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.96 -25.29 67.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 75.340000000000003 110.861 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -66.88 -55.91 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 71.140000000000001 110.938 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.3 mt -63.58 -42.45 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 73.209999999999994 111.126 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -58.35 -38.49 77.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 71.349999999999994 110.909 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -69.07 -46.86 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.897 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -56.95 -61.3 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 75.340000000000003 110.86 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 70.450000000000003 111.139 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.3 mm . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.856 0.36 . . . . 72.329999999999998 111.125 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.47 -28.95 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 62.130000000000003 111.123 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -54.98 -40.71 70.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 65.439999999999998 110.894 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.6 -28.43 51.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 110.91 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.35 -58.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 61.350000000000001 111.139 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.25 65.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -75.86 -38.98 57.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.934 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.74 -74.63 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 73.430000000000007 110.913 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.98 151.83 8.55 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 65.109999999999999 112.508 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.48 -58.21 11.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 75.450000000000003 110.912 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.56 18.91 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.693 2.262 . . . . 73.200000000000003 112.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.2 mm -93.93 -23.46 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 70.319999999999993 111.134 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.8 m -94.09 -28.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 74.030000000000001 111.134 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -60.29 -29.66 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.030000000000001 110.902 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -76.17 -43.07 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.885 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -98.17 26.46 5.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.897 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.31 -1.53 41.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 74.219999999999999 110.938 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -98.09 -8.55 27.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 75.349999999999994 110.922 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -113.62 -50.95 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 73.439999999999998 110.902 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mt -51.32 -69.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 75.400000000000006 111.085 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -56.78 -24.57 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 73.299999999999997 110.885 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -76.32 -22.93 54.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 71.25 110.932 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -87.72 -49.74 6.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 75.140000000000001 110.881 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 pt -51.53 -29.12 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 72.540000000000006 111.206 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.96 39.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.545 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 -69.0 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 74.239999999999995 110.879 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.33 36.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.69 -0.767 . . . . 62.409999999999997 112.446 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -56.89 179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.310000000000002 110.891 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.25 -169.33 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.349999999999994 111.13 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.8 tp -100.97 -21.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 74.200000000000003 111.116 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -116.21 22.66 12.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.030000000000001 110.886 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -95.41 -55.4 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 75.099999999999994 110.873 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.1 pt -50.19 -36.22 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 72.140000000000001 111.157 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mp -64.54 -55.96 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 73.010000000000005 111.113 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -64.84 -22.26 66.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -72.31 -53.11 13.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 72.040000000000006 110.963 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.55 -59.11 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 75.219999999999999 111.159 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -52.16 -34.82 46.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.319999999999993 110.923 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -65.91 -35.35 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 75.129999999999995 110.882 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.36 -61.89 1.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.869 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 111.157 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.5 mm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.851 0.358 . . . . 72.230000000000004 111.136 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.94 53.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 111.118 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.53 -35.85 72.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.439999999999998 110.875 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.67 -22.02 29.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 75.200000000000003 110.884 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.19 -69.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 111.09 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.22 -29.48 22.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 75.430000000000007 111.154 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -76.5 -65.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 110.884 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -87.49 -75.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 73.329999999999998 110.872 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.77 152.41 7.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 63.229999999999997 112.477 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.69 -57.9 14.09 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 74.340000000000003 110.927 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.75 -7.12 20.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.684 2.256 . . . . 54.32 112.341 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.7 mm -94.57 -23.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 74.310000000000002 111.154 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 m -93.65 -26.6 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 75.230000000000004 111.128 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -62.2 -23.38 66.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.140000000000001 110.892 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -81.58 -47.5 12.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.861 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.83 24.99 5.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 110.881 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -50.59 64.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 72.230000000000004 110.951 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -50.98 -52.89 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 73.230000000000004 110.893 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -57.03 -58.83 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 73.239999999999995 110.894 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mt -50.75 -59.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 75.540000000000006 111.134 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -28.94 61.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.854 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -19.9 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 70.120000000000005 110.925 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.13 -48.61 6.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 71.209999999999994 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.47 -23.71 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 72.510000000000005 111.186 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.0 8.77 71.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 64.340000000000003 112.505 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.81 -65.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 70.299999999999997 110.849 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.96 48.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 72.239999999999995 112.491 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -85.94 -177.85 6.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 73.219999999999999 110.893 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.27 -168.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 75.319999999999993 111.13 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -100.57 -14.67 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.422 . . . . 64.420000000000002 111.117 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -119.28 19.6 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.902 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -95.24 -57.05 2.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.884 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 pt -48.01 -33.53 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.140000000000001 111.146 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -67.12 -49.45 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 74.129999999999995 111.105 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.01 -25.81 63.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 110.856 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -69.2 -42.9 75.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 75.310000000000002 110.904 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.2 mt -73.3 -41.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 75.5 111.097 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -56.94 -47.41 80.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.882 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -62.7 -44.51 96.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 110.88 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.24 -64.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 72.5 110.823 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.540000000000006 111.142 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.5 mm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.786 0.327 . . . . 75.209999999999994 111.13 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.71 -26.51 34.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 75.230000000000004 111.077 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.94 -34.5 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 110.893 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.7 -25.1 23.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 75.439999999999998 110.935 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.6 -70.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 74.299999999999997 111.131 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.08 -29.83 23.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 73.209999999999994 111.098 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -74.24 -71.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.92 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -81.27 -74.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.010000000000005 110.857 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.01 150.13 6.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 75.219999999999999 112.444 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.519 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.33 -58.3 11.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.523 0.678 . . . . 74.230000000000004 110.896 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.72 -6.74 19.29 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 2.264 . . . . 73.239999999999995 112.358 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.66 -22.94 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.299999999999997 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 m -94.28 -28.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 72.450000000000003 111.105 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -60.85 -30.61 70.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.877 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -75.73 -38.76 58.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 73.439999999999998 110.906 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.2 27.91 6.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 74.400000000000006 110.916 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -82.8 -0.82 49.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 73.400000000000006 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.87 32.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 75.329999999999998 110.902 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -116.01 -47.09 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.912 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mt -51.78 -67.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 74.450000000000003 111.11 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.1 ptm -57.12 -25.67 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.239999999999995 110.904 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.02 -19.46 60.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 74.540000000000006 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -94.5 -51.56 4.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 75.219999999999999 110.861 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.29 -29.49 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 111.116 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.77 -21.66 37.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 71.120000000000005 112.491 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -93.05 -74.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 73.409999999999997 110.884 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.79 41.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 53.32 112.476 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -64.77 177.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.737 0.303 . . . . 73.099999999999994 110.946 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.74 -171.55 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 111.122 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -102.73 0.71 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 62.409999999999997 111.101 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -129.08 5.82 5.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 75.140000000000001 110.893 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -86.35 -55.08 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.913 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 pt -50.21 -35.94 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 75.219999999999999 111.143 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -66.12 -62.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 72.120000000000005 111.171 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -57.79 -24.68 58.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 72.209999999999994 110.88 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -67.72 -60.97 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.908 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.54 -42.64 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 74.150000000000006 111.128 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -42.38 98.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 64.109999999999999 110.92 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.06 -26.01 67.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 75.040000000000006 110.932 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -80.2 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 110.848 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 111.137 -179.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 mm . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.853 0.358 . . . . 63.43 111.14 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.73 -25.09 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 72.540000000000006 111.089 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -59.64 -33.2 71.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 75.120000000000005 110.841 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -84.85 -25.83 27.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 74.409999999999997 110.934 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -61.38 -64.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 70.099999999999994 111.123 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.59 -23.96 44.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 71.099999999999994 111.129 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -77.67 -66.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 75.340000000000003 110.901 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -91.91 -75.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 110.843 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.15 155.19 11.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.699 -0.762 . . . . 73.140000000000001 112.47 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.526 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.77 -57.92 14.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.589 0.709 . . . . 74.200000000000003 110.889 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.78 -6.7 19.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.695 2.263 . . . . 73.120000000000005 112.332 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.8 mm -94.75 -23.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.310000000000002 111.124 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 m -93.71 -26.97 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.349999999999994 111.142 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.76 -20.75 66.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 75.120000000000005 110.885 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 -49.71 9.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 75.120000000000005 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -94.94 22.09 6.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 74.310000000000002 110.915 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -65.79 -40.67 92.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 70.140000000000001 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -55.48 34.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 70.239999999999995 110.906 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -56.77 -55.6 32.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 54.350000000000001 110.908 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.3 mt -50.52 -62.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 111.149 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.6 ttt -56.63 -29.78 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 110.872 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -72.86 -18.84 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 72.129999999999995 110.933 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.92 -51.79 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.450000000000003 110.886 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -51.31 -29.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 75.129999999999995 111.158 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.15 -21.33 38.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 71.409999999999997 112.478 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -95.29 -75.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 74.329999999999998 110.856 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.07 49.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 54.539999999999999 112.522 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -68.49 -179.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 75.0 110.906 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.97 -169.4 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 111.109 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.63 -21.26 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 75.310000000000002 111.121 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -115.49 17.05 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 75.540000000000006 110.88 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -89.38 -57.74 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 75.340000000000003 110.918 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.2 pt -49.58 -32.11 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.019999999999996 111.113 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.68 -58.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 71.150000000000006 111.112 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.78 -32.26 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 70.019999999999996 110.857 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.43 -47.63 85.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.929 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.2 mt -69.06 -42.66 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.158 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.49 -25.89 52.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 110.92 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -96.32 31.02 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 63.200000000000003 110.884 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -137.72 -49.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 73.340000000000003 110.815 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 111.126 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.5 mm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.821 0.343 . . . . 72.129999999999995 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.31 -26.18 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 54.43 111.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -61.31 -25.59 67.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 72.430000000000007 110.918 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.41 -22.97 20.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.239999999999995 110.897 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.57 -57.39 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.106 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.48 -24.07 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 65.530000000000001 111.084 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -78.37 -46.6 19.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 110.912 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -111.86 -74.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 110.896 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.7 151.65 7.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 75.150000000000006 112.435 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.518 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.14 -58.37 10.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 74.129999999999995 110.889 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.74 -6.61 19.01 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.691 2.261 . . . . 71.230000000000004 112.354 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.8 -22.6 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.420000000000002 111.109 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.73 -27.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 111.119 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -62.63 -29.01 70.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -75.46 -47.21 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.049999999999997 110.901 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.87 28.42 3.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.953 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -74.33 -30.51 62.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 73.030000000000001 110.935 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -70.15 -10.92 60.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 75.319999999999993 110.923 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -108.18 -60.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 110.91 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mt -49.96 -33.7 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -80.24 -49.9 10.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 65.099999999999994 110.843 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -20.29 57.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 74.439999999999998 110.87 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -83.77 -58.39 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.884 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.0 pt -50.92 -29.58 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 74.430000000000007 111.176 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.5 -21.72 35.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 71.430000000000007 112.474 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.2 -74.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 74.519999999999996 110.879 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.15 46.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.743 . . . . 75.420000000000002 112.504 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.87 -179.65 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 65.109999999999999 110.962 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.92 -169.27 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 63.109999999999999 111.124 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 tt -98.5 -16.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 111.097 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -105.32 -20.62 13.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 60.32 110.893 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -58.68 -65.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 71.530000000000001 110.871 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.2 pt -49.01 -32.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 73.400000000000006 111.137 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.5 mt -65.54 -66.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 111.159 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.3 -19.95 57.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 74.439999999999998 110.886 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.4 -50.85 23.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 73.530000000000001 110.937 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mt -60.97 -59.77 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 75.420000000000002 111.116 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -51.61 -30.19 20.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 73.329999999999998 110.892 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -65.98 -41.37 91.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.340000000000003 110.882 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -69.52 -62.47 1.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 110.866 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.040000000000006 111.139 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.1 mm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.819 0.343 . . . . 73.310000000000002 111.112 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.04 -22.23 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 63.310000000000002 111.101 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -38.28 90.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 73.25 110.925 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.18 -22.3 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 65.540000000000006 110.914 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.71 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 74.310000000000002 111.128 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.09 -24.59 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 60.439999999999998 111.071 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -79.57 -52.63 7.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 73.519999999999996 110.928 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -104.26 -74.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.400000000000006 110.898 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.98 151.21 7.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.718 . . . . 51.240000000000002 112.535 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.525 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.2 -58.18 11.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.624 0.726 . . . . 75.430000000000007 110.931 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.72 -6.8 19.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.715 2.276 . . . . 50.240000000000002 112.371 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.8 mm -94.82 -23.09 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 111.15 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -93.99 -27.2 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 71.209999999999994 111.115 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -61.68 -28.27 69.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.310000000000002 110.884 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -77.14 -43.67 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 74.299999999999997 110.87 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -96.91 27.05 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 74.329999999999998 110.946 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.86 -1.09 41.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.430000000000007 110.932 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.29 -9.78 24.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 70.329999999999998 110.899 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -112.25 -51.16 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 70.519999999999996 110.889 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.8 mt -51.3 -68.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 72.219999999999999 111.167 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -25.66 51.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.209999999999994 110.852 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -75.21 -23.88 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 71.400000000000006 110.874 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -86.86 -50.85 6.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 75.409999999999997 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -51.16 -29.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 74.019999999999996 111.12 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.68 -22.01 38.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.77 -0.729 . . . . 74.200000000000003 112.501 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -93.65 -74.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 72.230000000000004 110.926 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.3 46.81 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.540000000000006 112.451 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -66.9 -179.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 74.519999999999996 110.916 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.22 -169.48 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 111.107 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tt -101.65 -21.41 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.349999999999994 111.161 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -114.84 19.25 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.97 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -91.46 -58.05 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 74.030000000000001 110.9 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.9 pt -50.7 -31.95 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 64.329999999999998 111.121 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.02 -59.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 111.128 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.83 -26.06 68.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 64.219999999999999 110.879 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.01 -53.82 40.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 75.420000000000002 110.883 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.0 mt -64.95 -45.3 95.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 111.127 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -34.29 56.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 74.200000000000003 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -93.81 42.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 72.219999999999999 110.893 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -148.3 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.099999999999994 110.838 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.109999999999999 111.119 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.89 52.39 1.95 Allowed Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.191 -0.913 . . . . 73.329999999999998 112.46 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.45 -54.66 3.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 74.129999999999995 111.098 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 36.3 mm -85.22 -34.81 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 72.409999999999997 111.113 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.53 35.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 63.43 111.096 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.7 -26.53 68.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 72.230000000000004 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -91.22 -24.63 19.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 72.439999999999998 110.935 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.3 t -70.39 -64.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 70.239999999999995 111.136 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.25 -25.74 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 111.045 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -82.43 -66.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 74.129999999999995 110.902 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -85.15 -75.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 110.844 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.57 153.74 8.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 72.019999999999996 112.462 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.525 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -53.33 -58.11 14.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 74.540000000000006 110.918 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.2 Cg_endo -69.73 -6.98 19.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.695 2.263 . . . . 73.129999999999995 112.343 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mm -94.88 -21.91 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 73.150000000000006 111.176 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -95.49 -25.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.340000000000003 111.12 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -25.05 66.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 110.896 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -79.88 -30.38 40.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.150000000000006 110.943 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -110.18 25.42 11.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 75.109999999999999 110.92 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.51 -25.18 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 73.329999999999998 110.891 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -76.04 -5.72 47.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 73.310000000000002 110.919 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -115.92 -56.35 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 65.219999999999999 110.888 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 mt -51.18 -69.45 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 72.239999999999995 111.115 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -23.94 50.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 52.43 110.858 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -77.12 -21.49 54.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 74.25 110.898 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -89.57 -48.77 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 74.349999999999994 110.866 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.7 pt -51.5 -29.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.097 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -21.26 39.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 65.340000000000003 112.488 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -93.08 -74.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 73.010000000000005 110.889 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.91 44.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 75.120000000000005 112.504 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -69.47 -179.96 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 74.209999999999994 110.915 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.6 -175.83 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 63.100000000000001 111.098 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tt -88.45 -19.85 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 70.049999999999997 111.142 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -101.84 22.02 13.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 110.827 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -112.1 -64.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 63.240000000000002 110.916 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 pt -50.87 -35.31 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 72.040000000000006 111.149 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.3 -64.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 75.299999999999997 111.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.93 -21.96 61.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.853 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -71.51 -56.39 6.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 75.439999999999998 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.9 mt -56.22 -58.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 75.450000000000003 111.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -35.01 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.875 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.58 -36.31 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 75.140000000000001 110.877 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -72.47 -62.51 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 74.109999999999999 110.869 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 pt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.109999999999999 111.152 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.39 19.93 10.09 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.132 -0.94 . . . . 65.409999999999997 112.489 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.21 -28.64 13.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.742 0.306 . . . . 72.530000000000001 111.124 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.1 mm -75.47 -33.24 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.430000000000007 111.141 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.67 -27.54 28.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 61.240000000000002 111.085 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.45 -32.06 71.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 75.019999999999996 110.929 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.38 -24.71 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.549999999999997 110.968 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.1 t -69.6 -59.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 75.109999999999999 111.11 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 64.239999999999995 111.09 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -81.11 -46.0 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.400000000000006 110.893 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -109.29 -74.83 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.150000000000006 110.862 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.31 150.77 7.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 74.310000000000002 112.476 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.514 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.71 -58.05 12.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 72.120000000000005 110.936 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.9 Cg_endo -69.79 -6.75 19.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 74.109999999999999 112.32 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.1 mm -94.49 -22.68 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 73.140000000000001 111.127 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.5 m -94.72 -27.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 63.130000000000003 111.097 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.85 -25.5 67.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.901 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.83 -30.67 40.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.877 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -109.8 28.04 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 75.109999999999999 110.948 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.59 -6.14 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 73.540000000000006 110.922 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -91.36 -11.26 38.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -109.77 -55.94 2.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 62.229999999999997 110.89 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.2 mt -51.62 -68.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 73.200000000000003 111.11 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 tpt -56.64 -24.94 51.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 74.400000000000006 110.848 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.76 -23.15 52.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 74.230000000000004 110.915 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -86.12 -49.42 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 73.219999999999999 110.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.5 pt -52.07 -28.37 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 71.530000000000001 111.091 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.46 -18.5 44.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.75 . . . . 62.119999999999997 112.532 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -97.7 -74.99 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 72.5 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.34 49.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 71.450000000000003 112.513 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -69.73 -179.76 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.322 . . . . 74.319999999999993 110.922 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.75 -169.47 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 71.129999999999995 111.125 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -101.58 -21.45 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 111.172 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -116.78 23.22 12.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 73.239999999999995 110.883 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.74 -55.37 3.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 74.200000000000003 110.945 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.5 pt -50.76 -35.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 111.109 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mp -65.26 -53.46 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 111.128 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -66.48 -25.13 66.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 61.119999999999997 110.884 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -65.41 -57.33 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 73.349999999999994 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 35.4 mt -60.32 -46.51 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 111.14 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -52.28 -32.25 36.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.878 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -75.55 -46.91 29.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.340000000000003 110.888 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.25 -62.91 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.847 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 pt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.209999999999994 111.177 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.82 51.46 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.177 -0.92 . . . . 72.450000000000003 112.448 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.86 -46.92 20.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 73.439999999999998 111.111 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 29.4 mm -102.04 -30.62 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 111.061 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.99 -24.62 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 72.239999999999995 111.154 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.28 -35.55 81.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 110.845 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.08 -26.2 56.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 74.120000000000005 110.882 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 98.0 t -68.44 -58.78 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 64.109999999999999 111.16 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.9 -24.96 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 62.439999999999998 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -79.9 -44.47 20.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 64.010000000000005 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -111.99 -74.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.120000000000005 110.914 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.63 150.79 6.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 74.299999999999997 112.479 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.2 11.47 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.571 0.7 . . . . 75.420000000000002 110.905 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.76 -6.77 19.39 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.655 2.237 . . . . 73.200000000000003 112.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.4 mm -95.02 -22.9 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 74.450000000000003 111.138 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.6 m -94.07 -27.25 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 75.25 111.119 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -66.32 -25.43 66.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.439999999999998 110.958 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -78.89 -28.35 44.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 72.530000000000001 110.867 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -113.66 25.59 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 72.430000000000007 110.908 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.88 -17.39 61.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.914 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -84.5 3.44 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 73.530000000000001 110.903 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -126.01 -56.34 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 110.938 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mt -51.2 -68.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 111.119 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 5.8 ttp -57.41 -23.56 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 74.400000000000006 110.867 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -78.27 -20.68 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 74.209999999999994 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.73 -49.23 6.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 71.120000000000005 110.893 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -51.17 -29.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 75.109999999999999 111.123 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.42 -22.06 36.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 64.319999999999993 112.542 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.72 -68.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 75.400000000000006 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.42 35.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 70.329999999999998 112.484 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -57.77 -179.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.804 0.335 . . . . 74.099999999999994 110.897 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.15 -169.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 75.219999999999999 111.057 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 tt -98.62 -10.01 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 111.124 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -111.09 -24.77 10.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 73.030000000000001 110.865 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -63.24 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.907 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.5 pt -50.51 -35.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 111.159 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.49 -60.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.349999999999994 111.112 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.69 -17.91 63.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 70.329999999999998 110.868 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -76.28 -58.62 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.905 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.0 mt -54.09 -55.0 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 75.510000000000005 111.167 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -34.53 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 70.099999999999994 110.931 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -53.2 -46.19 68.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.200000000000003 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.56 -72.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 72.510000000000005 110.904 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.157 179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.51 92.25 0.22 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.207 -0.906 . . . . 65.129999999999995 112.454 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.81 -53.2 2.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 73.439999999999998 111.095 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 mm -100.76 -32.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 71.049999999999997 111.133 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.48 -25.4 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 72.219999999999999 111.07 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -58.27 -37.91 75.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.109999999999999 110.923 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.3 -23.11 40.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 53.539999999999999 110.952 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.86 -67.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 75.129999999999995 111.148 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.96 -27.22 29.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 111.108 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -78.5 -70.0 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 110.895 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -82.61 -74.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 74.319999999999993 110.837 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.67 150.84 7.01 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 75.209999999999994 112.498 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.17 -58.27 11.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.587 0.708 . . . . 71.319999999999993 110.89 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.74 -6.92 19.74 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 63.25 112.325 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.4 mm -94.87 -22.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 111.086 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.2 m -94.5 -27.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 74.540000000000006 111.148 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -61.6 -25.44 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 75.209999999999994 110.914 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -81.36 -42.23 20.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 110.896 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -100.77 27.32 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 62.439999999999998 110.894 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.13 -34.57 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 73.120000000000005 110.905 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -71.9 -9.04 57.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.922 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -103.64 -52.38 3.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 110.92 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.0 mt -54.5 -65.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 111.113 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.6 ttt -56.74 -25.81 55.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.884 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -73.71 -20.75 60.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 110.94 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.67 -51.53 5.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 70.519999999999996 110.871 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.85 -29.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 73.319999999999993 111.172 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.39 -23.58 34.91 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.209999999999994 112.49 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 -75.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 63.310000000000002 110.875 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.44 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 64.340000000000003 112.512 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.04 -179.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 75.409999999999997 110.955 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -89.54 -169.35 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 74.109999999999999 111.099 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 tt -102.86 -13.31 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 72.25 111.107 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -122.42 20.46 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.893 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.36 -54.36 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 70.140000000000001 110.899 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.0 pt -50.11 -35.73 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.150000000000006 111.169 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mp -64.82 -56.66 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.010000000000005 111.146 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.92 -25.53 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 70.420000000000002 110.867 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -66.44 -48.72 69.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 70.519999999999996 110.912 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.0 mt -68.99 -36.35 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 75.120000000000005 111.141 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -38.91 92.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.908 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -73.87 -26.9 60.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 110.939 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.5 -61.84 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 110.859 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 75.019999999999996 111.09 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.17 32.52 0.95 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.171 -0.922 . . . . 71.299999999999997 112.459 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -122.02 -39.57 2.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.318 . . . . 75.430000000000007 111.121 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 mm -80.67 -29.85 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.450000000000003 111.113 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.05 -24.72 41.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 111.115 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.99 -41.92 84.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.895 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.2 -24.58 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 73.340000000000003 110.925 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.4 t -65.71 -43.54 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 74.120000000000005 111.129 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.41 37.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 111.11 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.34 -30.29 33.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 75.030000000000001 110.87 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -126.29 -75.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 63.240000000000002 110.872 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.88 151.98 7.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 75.049999999999997 112.5 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.518 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.7 -58.17 11.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.53 0.681 . . . . 74.349999999999994 110.908 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.76 -6.62 19.03 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 73.409999999999997 112.335 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.5 mm -95.06 -22.7 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 73.129999999999995 111.145 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 m -94.3 -27.18 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 111.119 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.48 -29.73 70.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 75.129999999999995 110.909 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -75.53 -32.82 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 75.25 110.921 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -104.87 24.76 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.299999999999997 110.904 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -11.44 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.503 . . . . 75.430000000000007 110.951 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -90.89 13.55 16.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 71.319999999999993 110.931 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -139.3 -51.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 72.010000000000005 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.9 mt -54.68 -65.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 73.439999999999998 111.136 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -58.7 -21.33 54.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 72.019999999999996 110.908 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -82.11 -21.99 36.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 73.310000000000002 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -86.96 -43.55 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 65.120000000000005 110.883 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -55.57 -25.5 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 73.319999999999993 111.099 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.07 -6.93 69.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.783 -0.722 . . . . 61.520000000000003 112.505 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.0 -71.48 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 65.129999999999995 110.908 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.87 49.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 74.319999999999993 112.473 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -82.52 -178.24 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 71.400000000000006 110.944 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.57 -175.6 2.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 63.310000000000002 111.116 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -86.38 -21.05 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.310000000000002 111.143 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -99.28 20.02 14.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.871 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -110.28 -68.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 pt -49.84 -31.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 72.439999999999998 111.152 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.3 mm -61.38 -67.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 111.113 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -61.38 -31.02 70.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.833 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -55.56 -37.69 68.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 75.519999999999996 110.891 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 44.9 mt -86.43 -37.63 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 75.319999999999993 111.081 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -61.02 -28.75 69.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 75.310000000000002 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -89.37 -26.73 20.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.299999999999997 110.888 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.22 -26.53 52.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.109999999999999 110.846 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 111.107 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.01 -47.32 0.41 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.143 -0.935 . . . . 73.420000000000002 112.486 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.84 -41.28 26.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 60.210000000000001 111.114 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.2 mm -77.01 -33.78 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 111.112 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.11 -24.86 43.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 61.340000000000003 111.147 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -35.08 70.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.319999999999993 110.92 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.53 -25.57 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 74.329999999999998 110.95 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.53 -35.31 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 71.299999999999997 111.15 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.01 17.14 11.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 62.539999999999999 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -130.49 -39.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 74.019999999999996 110.902 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -112.39 -75.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.129999999999995 110.931 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 149.09 5.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 31.309999999999999 112.5 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.516 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -50.79 -58.01 11.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.598 0.713 . . . . 74.200000000000003 110.922 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.82 -5.29 15.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 73.239999999999995 112.355 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.21 -22.28 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 75.400000000000006 111.139 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 m -92.99 -29.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 111.091 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -26.22 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 72.540000000000006 110.895 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -73.4 -21.12 60.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.030000000000001 110.88 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.91 21.51 11.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 73.209999999999994 110.909 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.86 -28.25 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 75.109999999999999 110.897 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.9 -9.35 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 75.439999999999998 110.936 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -109.02 -60.76 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.917 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.5 mt -51.37 -65.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 111.099 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 44.0 ttp -56.42 -28.48 59.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 110.859 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -75.22 -21.57 58.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 110.959 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -87.76 -50.35 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 75.299999999999997 110.908 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -51.95 -28.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 63.020000000000003 111.168 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -18.73 41.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.473 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -94.91 -69.18 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 75.230000000000004 110.906 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.66 36.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.757 . . . . 61.43 112.463 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -57.04 -179.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.793 0.33 . . . . 75.530000000000001 110.889 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.19 -169.33 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 74.129999999999995 111.107 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -101.54 -21.7 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 75.420000000000002 111.092 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -114.82 21.04 14.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 65.25 110.901 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -93.5 -58.02 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.879 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.5 pt -50.37 -31.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 74.549999999999997 111.138 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.71 -62.89 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 64.409999999999997 111.146 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -28.9 69.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 72.510000000000005 110.849 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -58.48 -53.79 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 73.420000000000002 110.951 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.8 mt -69.04 -40.08 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 111.14 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -52.01 -67.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 75.040000000000006 110.873 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -28.27 57.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 75.239999999999995 110.903 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -68.81 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 74.010000000000005 110.83 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.428 . . . . 75.209999999999994 111.132 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.18 72.47 1.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.155 -0.929 . . . . 71.400000000000006 112.486 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.54 -40.15 6.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.761 0.315 . . . . 70.299999999999997 111.121 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.1 mm -79.79 -34.84 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 74.5 111.145 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.5 -24.32 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 64.420000000000002 111.083 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -63.03 -25.03 68.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 110.883 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -92.02 -25.35 18.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 64.329999999999998 110.918 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.3 -68.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.150000000000006 111.125 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.59 -28.73 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.25 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -61.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.903 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -93.45 -74.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 71.340000000000003 110.907 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.92 151.64 7.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 74.530000000000001 112.508 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.517 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.44 -58.2 11.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 75.140000000000001 110.952 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.59 18.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 63.509999999999998 112.364 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.93 -22.44 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.114 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -94.81 -27.16 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 72.310000000000002 111.157 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -65.96 -25.42 67.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.872 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -25.74 39.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 74.209999999999994 110.924 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -114.49 24.94 11.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 73.230000000000004 110.913 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.18 -27.84 64.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 73.400000000000006 110.945 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -7.84 53.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 74.530000000000001 110.863 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -109.98 -60.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 74.030000000000001 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.3 mt -52.74 -65.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 111.143 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -56.64 -25.79 54.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 110.881 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.68 -22.27 50.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 63.210000000000001 110.895 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -85.34 -47.95 9.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.420000000000002 110.912 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.8 pt -53.32 -27.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 75.340000000000003 111.171 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.56 -14.68 55.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 75.439999999999998 112.454 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.54 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 73.129999999999995 110.864 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.88 48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 54.530000000000001 112.481 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -72.82 -179.23 3.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.765 0.317 . . . . 75.450000000000003 110.92 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -88.92 -169.55 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 70.310000000000002 111.058 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tt -101.54 -11.11 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 111.096 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -122.96 4.29 9.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 75.430000000000007 110.85 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -78.6 -56.72 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.93 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.5 pt -49.42 -37.48 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 75.030000000000001 111.089 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mp -65.37 -44.37 94.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 75.400000000000006 111.125 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -74.48 -20.84 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.891 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -71.24 -53.88 12.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 71.530000000000001 110.891 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.7 mt -62.4 -47.87 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 75.299999999999997 111.139 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -43.39 63.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.912 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -68.23 -39.58 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 110.924 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -64.75 -62.04 1.82 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 110.86 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 74.439999999999998 111.081 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.71 25.0 12.29 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.186 -0.916 . . . . 73.150000000000006 112.431 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.81 -52.13 3.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.823 0.344 . . . . 63.450000000000003 111.111 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.74 -33.37 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.019999999999996 111.127 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -21.15 58.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 63.32 111.114 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -64.52 -29.64 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 110.889 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -87.1 -25.08 24.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 73.329999999999998 110.931 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.61 -32.42 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 72.549999999999997 111.176 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.88 17.18 10.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 61.539999999999999 111.093 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -129.36 -45.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 75.409999999999997 110.909 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -107.77 -75.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.65 152.8 8.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.801 -0.714 . . . . 62.229999999999997 112.537 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.517 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.07 -58.14 12.46 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 75.430000000000007 110.957 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.78 -7.13 20.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 63.219999999999999 112.327 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.3 mm -95.28 -22.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 65.219999999999999 111.166 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.1 m -93.6 -26.22 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.239999999999995 111.144 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -65.37 -24.57 67.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 110.912 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -78.16 -47.97 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.9 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.26 22.22 8.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.931 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.53 -41.07 93.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 75.299999999999997 110.936 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.9 -56.47 21.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 74.510000000000005 110.854 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -56.24 -55.65 30.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.9 mt -50.97 -62.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 111.111 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -29.15 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 72.140000000000001 110.871 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -72.77 -23.63 60.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.319999999999993 110.905 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -86.8 -52.52 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.878 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.31 -29.84 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 75.409999999999997 111.059 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.5 38.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 74.129999999999995 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.0 -74.96 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 72.030000000000001 110.856 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.83 47.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 75.049999999999997 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -67.02 -179.65 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.782 0.325 . . . . 75.510000000000005 110.883 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -90.33 -169.45 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 111.091 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.39 -10.04 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.530000000000001 111.127 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -124.09 19.65 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.209999999999994 110.901 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -96.13 -56.17 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.150000000000006 110.893 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 pt -50.05 -31.29 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 72.239999999999995 111.145 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.1 mp -69.24 -50.74 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 71.549999999999997 111.126 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -69.53 -26.03 64.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 65.519999999999996 110.831 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -68.31 -44.08 76.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 72.010000000000005 110.955 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.3 mt -72.72 -45.2 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 65.299999999999997 111.129 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -55.95 -38.65 70.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 73.420000000000002 110.935 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -72.95 -26.28 61.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 72.299999999999997 110.916 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -77.86 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 74.310000000000002 110.865 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 111.082 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.8 33.35 6.57 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.166 -0.924 . . . . 73.200000000000003 112.482 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.08 -27.65 10.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 75.310000000000002 111.084 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.4 mm -102.66 -32.33 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 75.439999999999998 111.107 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.57 67.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 65.329999999999998 111.067 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.59 -37.62 50.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 75.329999999999998 110.907 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.27 -34.16 74.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 73.420000000000002 110.939 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.5 t -61.39 -66.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 75.150000000000006 111.184 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.3 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.051 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -77.29 -41.72 39.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -118.84 -75.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 75.530000000000001 110.882 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.1 149.11 6.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 71.439999999999998 112.496 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.516 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.67 -58.22 11.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.519 0.676 . . . . 64.439999999999998 110.918 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.67 -6.94 19.76 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.248 . . . . 73.140000000000001 112.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.31 -23.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.519999999999996 111.132 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -93.63 -27.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.161 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -66.23 -28.2 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 75.219999999999999 110.902 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.45 -24.57 53.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 71.530000000000001 110.898 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -117.59 25.4 10.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 74.510000000000005 110.898 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -24.6 63.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 110.918 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -77.91 -3.82 43.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 73.420000000000002 110.914 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -114.27 -58.83 2.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.841 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mt -51.4 -69.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 111.113 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -23.79 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 72.040000000000006 110.868 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -77.01 -21.82 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 110.916 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -89.65 -48.43 7.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.875 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.7 pt -51.95 -28.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 64.140000000000001 111.132 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.39 -18.41 43.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 74.25 112.478 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -97.7 -75.03 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 64.150000000000006 110.874 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.85 48.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.753 . . . . 61.5 112.48 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -68.05 -179.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 73.219999999999999 110.885 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.21 -169.34 2.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 62.43 111.078 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -103.33 -7.94 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 111.18 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -118.63 14.63 13.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -95.81 -61.01 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.937 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 pt -50.04 -30.82 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 74.420000000000002 111.169 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -67.26 -72.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 111.144 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.25 -35.06 59.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 65.150000000000006 110.878 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -52.68 -45.9 67.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 74.25 110.912 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.9 mt -77.37 -47.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 75.430000000000007 111.09 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -52.81 -32.54 44.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 73.400000000000006 110.89 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -79.41 -43.59 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 64.519999999999996 110.865 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.25 -63.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.239999999999995 110.864 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 111.148 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.81 46.53 17.3 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.183 -0.917 . . . . 75.019999999999996 112.454 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.05 -45.41 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.71 0.291 . . . . 73.019999999999996 111.058 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.9 mm -77.34 -34.19 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 75.230000000000004 111.118 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.46 47.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.030000000000001 111.071 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -61.3 -33.47 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 75.129999999999995 110.921 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -83.94 -21.23 31.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 65.340000000000003 110.923 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.2 t -68.28 -64.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.510000000000005 111.122 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.71 -24.95 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 70.5 111.086 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -79.81 -58.29 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 75.420000000000002 110.891 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -96.95 -75.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 75.230000000000004 110.892 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.85 151.78 7.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 63.439999999999998 112.479 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.518 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.58 -58.09 12.16 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.599 0.714 . . . . 72.25 110.933 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.83 19.54 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.692 2.262 . . . . 74.109999999999999 112.333 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 41.8 mm -94.6 -23.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.049999999999997 111.085 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 m -93.81 -27.36 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 64.219999999999999 111.124 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -62.61 -29.21 70.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.219999999999999 110.904 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -75.62 -36.36 60.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 74.349999999999994 110.913 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.07 26.21 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 73.319999999999993 110.933 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.45 -6.76 57.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 70.450000000000003 110.93 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -94.97 16.58 15.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 73.120000000000005 110.886 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -145.01 -50.17 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 72.120000000000005 110.943 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.7 mt -51.56 -67.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 111.133 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -57.51 -23.64 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.510000000000005 110.892 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.12 -19.55 50.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 74.099999999999994 110.905 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.35 -46.19 8.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 75.099999999999994 110.888 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.42 -23.46 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 65.340000000000003 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.28 9.46 70.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 74.439999999999998 112.454 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.37 -63.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 74.519999999999996 110.931 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.06 46.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 64.310000000000002 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -85.0 -178.66 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 75.239999999999995 110.945 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.33 -169.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 71.040000000000006 111.107 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.6 tt -101.19 -10.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.540000000000006 111.12 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -121.72 19.5 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.872 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -95.36 -58.34 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 74.230000000000004 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 pt -49.48 -33.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.453 . . . . 73.420000000000002 111.117 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 75.7 mt -60.58 -60.97 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 75.319999999999993 111.15 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -26.48 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 54.109999999999999 110.85 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -65.46 -30.03 70.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.510000000000005 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.3 mt -93.26 -30.98 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 72.299999999999997 111.084 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -38.78 78.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 74.319999999999993 110.909 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -70.21 -41.42 73.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 72.400000000000006 110.93 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.69 -64.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 73.400000000000006 110.859 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.510000000000005 111.134 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.73 56.9 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.135 -0.939 . . . . 64.439999999999998 112.488 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.02 -46.44 3.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 72.310000000000002 111.117 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 34.1 mm -75.65 -32.1 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 74.549999999999997 111.127 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -25.31 36.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 65.129999999999995 111.143 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -62.69 -32.67 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.889 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.67 -23.93 33.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 75.010000000000005 110.947 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.2 t -69.98 -56.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 53.43 111.153 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -26.17 66.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 111.094 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -79.97 -45.12 19.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 110.894 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -109.43 -74.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 73.409999999999997 110.87 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 150.9 6.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 60.399999999999999 112.492 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.52 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.26 11.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.572 0.701 . . . . 74.409999999999997 110.908 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.74 -6.59 18.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 64.420000000000002 112.36 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -95.13 -22.55 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 74.319999999999993 111.138 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.8 m -94.5 -27.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 75.450000000000003 111.113 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -64.44 -25.32 67.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 73.5 110.901 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -80.06 -32.48 39.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 75.030000000000001 110.884 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -106.52 24.44 12.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 64.420000000000002 110.902 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.82 -11.72 60.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 75.430000000000007 110.898 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -89.29 10.26 22.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 75.25 110.931 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -135.95 -54.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 73.329999999999998 110.897 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.6 mt -51.51 -68.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.108 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -23.78 51.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.239999999999995 110.859 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -78.18 -20.37 52.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 64.349999999999994 110.915 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -89.7 -47.5 7.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.897 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.2 -27.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 75.019999999999996 111.135 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.32 -21.97 35.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 62.109999999999999 112.502 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -93.45 -74.93 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 73.519999999999996 110.892 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.65 43.86 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 74.340000000000003 112.5 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -71.17 161.07 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.801 0.334 . . . . 74.140000000000001 110.924 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.86 -169.05 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 111.113 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.04 -0.07 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 73.099999999999994 111.136 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -115.84 -25.88 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 75.409999999999997 110.893 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -57.48 -62.8 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 110.913 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 pt -50.38 -35.37 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 64.340000000000003 111.111 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.88 -50.11 76.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.176 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.19 -3.79 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 75.150000000000006 110.868 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -90.43 -42.0 11.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 110.943 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.3 mt -72.29 -52.62 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 73.400000000000006 111.146 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -52.74 -30.59 33.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 72.530000000000001 110.87 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -67.25 -41.25 85.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 73.439999999999998 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -70.38 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.310000000000002 110.868 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 pt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.105 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.1 38.16 40.96 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.183 -0.917 . . . . 54.509999999999998 112.458 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.77 -54.17 49.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.312 . . . . 70.430000000000007 111.076 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.4 mm -90.67 -32.42 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 111.141 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.25 -20.95 58.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 75.439999999999998 111.059 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -68.25 -34.88 77.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 73.319999999999993 110.883 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.93 -22.73 49.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 74.299999999999997 110.903 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.6 t -68.59 -66.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 74.040000000000006 111.154 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.1 48.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 54.200000000000003 111.093 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -80.36 -56.74 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 110.902 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -98.47 -74.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 75.340000000000003 110.898 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.93 150.78 7.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 72.420000000000002 112.492 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.52 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.34 -58.32 11.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.568 0.699 . . . . 74.299999999999997 110.908 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.73 -6.65 19.09 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.687 2.258 . . . . 75.420000000000002 112.332 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.58 -22.54 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 63.409999999999997 111.124 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 m -94.95 -27.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.019999999999996 111.102 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.74 -25.07 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.922 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -80.16 -40.69 26.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 71.099999999999994 110.865 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -103.75 26.49 8.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 70.540000000000006 110.918 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.56 -35.01 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 110.953 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -71.86 -9.33 58.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 75.040000000000006 110.9 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.37 -51.8 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.329999999999998 110.951 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mt -56.44 -63.61 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 111.151 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ttt -57.17 -26.06 59.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.903 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.51 -18.64 60.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.239999999999995 110.871 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -91.9 -50.68 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.868 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.8 pt -51.09 -28.9 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 74.329999999999998 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.13 -23.57 32.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 73.230000000000004 112.51 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -92.06 -74.88 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 74.010000000000005 110.896 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.19 44.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 72.040000000000006 112.489 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.62 -179.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.78 0.324 . . . . 75.400000000000006 110.946 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.07 -169.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 73.230000000000004 111.134 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 tt -99.14 -10.03 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.239999999999995 111.146 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -111.04 -20.28 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.329999999999998 110.897 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -61.52 -59.2 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 73.430000000000007 110.921 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 pt -50.36 -31.35 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 111.182 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.82 -60.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 64.450000000000003 111.134 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.39 -25.06 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.852 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -67.21 -57.22 7.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.915 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.7 mt -62.7 -36.93 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 111.124 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -61.75 -61.36 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.540000000000006 110.924 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -52.7 -29.41 26.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.010000000000005 110.897 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -72.07 -68.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 73.409999999999997 110.859 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.150000000000006 111.129 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.73 58.39 0.48 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.131 -0.941 . . . . 53.009999999999998 112.453 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.41 -64.1 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 73.409999999999997 111.097 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.7 mm -75.22 -32.16 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 73.400000000000006 111.126 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.19 -19.95 56.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 111.114 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -67.62 -30.54 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 75.340000000000003 110.904 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -84.25 -26.06 28.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.933 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -61.04 -69.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 63.219999999999999 111.13 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -22.16 61.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 74.340000000000003 111.079 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.9 tptt -77.1 -37.48 54.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 72.209999999999994 110.909 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.04 -74.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.349999999999994 110.894 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.31 149.65 7.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.736 -0.745 . . . . 54.530000000000001 112.501 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.512 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.02 -58.11 12.55 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.554 0.693 . . . . 73.329999999999998 110.927 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.77 -6.41 18.55 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.669 2.246 . . . . 74.430000000000007 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mm -93.64 -23.29 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 73.140000000000001 111.127 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.0 m -94.37 -28.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 73.340000000000003 111.119 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.84 -35.66 81.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.869 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -73.25 -30.73 63.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 70.030000000000001 110.872 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -103.3 22.13 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 72.510000000000005 110.914 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.42 -26.17 63.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 74.510000000000005 110.958 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -75.59 -6.07 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 73.310000000000002 110.885 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -112.09 -60.84 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 71.549999999999997 110.903 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mt -51.19 -67.98 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.329999999999998 111.124 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -26.51 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.853 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -74.64 -23.27 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 75.209999999999994 110.885 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -87.36 -51.33 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 72.230000000000004 110.843 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -51.29 -29.5 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 75.129999999999995 111.118 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.24 -21.03 38.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.742 . . . . 73.010000000000005 112.465 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -93.35 -68.99 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 75.510000000000005 110.861 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.48 36.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.704 -0.76 . . . . 63.240000000000002 112.468 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -56.64 179.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.754 0.311 . . . . 75.329999999999998 110.966 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.05 -169.32 2.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 73.400000000000006 111.09 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -102.13 -21.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 111.178 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -116.65 22.09 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 74.409999999999997 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -94.63 -54.71 3.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 74.219999999999999 110.839 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 pt -50.23 -36.04 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 75.510000000000005 111.129 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mp -65.18 -48.89 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.549999999999997 111.113 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 -24.01 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.540000000000006 110.886 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -69.18 -49.94 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.26 -45.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 75.140000000000001 111.115 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -57.74 -29.07 64.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 75.120000000000005 110.855 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.53 23.48 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 75.400000000000006 110.917 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -126.69 -38.84 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.837 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.140000000000001 111.133 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.96 72.98 0.76 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.198 -0.91 . . . . 71.540000000000006 112.511 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.26 -75.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.752 0.31 . . . . 72.0 111.133 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm -82.61 -34.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 73.439999999999998 111.106 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.59 -21.79 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 60.109999999999999 111.073 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -67.62 -29.75 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 72.129999999999995 110.912 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.75 -27.65 28.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 75.530000000000001 110.885 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.68 -69.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.125 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.71 19.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 61.329999999999998 111.142 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -74.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 73.450000000000003 110.918 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -77.85 -74.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.835 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.07 150.89 7.11 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 63.409999999999997 112.462 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.33 11.02 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 75.209999999999994 110.928 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.85 19.58 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 60.119999999999997 112.324 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 46.0 mm -94.37 -23.21 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 111.134 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.8 m -94.12 -27.92 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.430000000000007 111.125 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -32.06 70.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 73.129999999999995 110.895 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.99 -42.29 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.88 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -99.58 27.72 5.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.95 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.85 -1.25 42.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.159 -0.473 . . . . 70.319999999999993 110.904 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 -11.79 22.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.91 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -109.74 -50.65 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 72.530000000000001 110.905 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mt -51.16 -69.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 111.122 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -24.72 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 75.230000000000004 110.885 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -75.65 -23.72 56.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 75.530000000000001 110.926 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -87.87 -50.2 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 72.25 110.865 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.4 pt -51.29 -29.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.52 -21.95 36.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 64.310000000000002 112.466 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -92.28 -74.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 65.329999999999998 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.0 41.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 52.310000000000002 112.491 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -68.43 -179.8 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.786 0.327 . . . . 72.409999999999997 110.892 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.42 -169.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 61.119999999999997 111.076 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -96.29 -21.93 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.128 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -99.7 -20.07 16.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.140000000000001 110.875 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.23 -63.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 73.239999999999995 110.865 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 pt -51.06 -35.26 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 74.5 111.101 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.87 -58.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 64.549999999999997 111.128 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.96 -25.29 67.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 75.340000000000003 110.861 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -66.88 -55.91 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 71.140000000000001 110.938 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 51.3 mt -63.58 -42.45 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 73.209999999999994 111.126 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -58.35 -38.49 77.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 71.349999999999994 110.909 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -69.07 -46.86 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.897 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -56.95 -61.3 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 75.340000000000003 110.86 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 70.450000000000003 111.139 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.49 74.89 1.26 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.148 -0.933 . . . . 70.549999999999997 112.472 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.07 -58.83 1.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 74.209999999999994 111.093 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.3 mm -90.6 -25.79 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 111.125 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.47 -28.95 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 62.130000000000003 111.123 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -54.98 -40.71 70.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 65.439999999999998 110.894 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.6 -28.43 51.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 110.91 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.35 -58.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 61.350000000000001 111.139 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.25 65.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -75.86 -38.98 57.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.934 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.74 -74.63 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 73.430000000000007 110.913 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.98 151.83 8.55 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 65.109999999999999 112.508 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.48 -58.21 11.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 75.450000000000003 110.912 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.56 18.91 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.693 2.262 . . . . 73.200000000000003 112.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.2 mm -93.93 -23.46 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 70.319999999999993 111.134 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.8 m -94.09 -28.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 74.030000000000001 111.134 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -60.29 -29.66 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.030000000000001 110.902 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -76.17 -43.07 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.885 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -98.17 26.46 5.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.897 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.31 -1.53 41.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 74.219999999999999 110.938 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -98.09 -8.55 27.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 75.349999999999994 110.922 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -113.62 -50.95 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 73.439999999999998 110.902 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.0 mt -51.32 -69.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 75.400000000000006 111.085 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -56.78 -24.57 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 73.299999999999997 110.885 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -76.32 -22.93 54.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 71.25 110.932 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -87.72 -49.74 6.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 75.140000000000001 110.881 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 pt -51.53 -29.12 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 72.540000000000006 111.206 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.96 39.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.545 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 -69.0 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 74.239999999999995 110.879 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.33 36.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.69 -0.767 . . . . 62.409999999999997 112.446 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -56.89 179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.310000000000002 110.891 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.25 -169.33 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.349999999999994 111.13 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.8 tp -100.97 -21.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 74.200000000000003 111.116 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -116.21 22.66 12.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.030000000000001 110.886 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp -95.41 -55.4 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 75.099999999999994 110.873 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.1 pt -50.19 -36.22 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 72.140000000000001 111.157 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mp -64.54 -55.96 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 73.010000000000005 111.113 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -64.84 -22.26 66.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -72.31 -53.11 13.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 72.040000000000006 110.963 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.55 -59.11 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 75.219999999999999 111.159 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -52.16 -34.82 46.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.319999999999993 110.923 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -65.91 -35.35 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 75.129999999999995 110.882 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.36 -61.89 1.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.869 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 111.157 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.48 38.93 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.188 -0.915 . . . . 50.009999999999998 112.505 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.77 -41.11 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.765 0.317 . . . . 75.310000000000002 111.058 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.5 mm -73.77 -27.44 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 111.136 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.94 53.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 111.118 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.53 -35.85 72.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.439999999999998 110.875 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.67 -22.02 29.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 75.200000000000003 110.884 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.19 -69.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 111.09 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.22 -29.48 22.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 75.430000000000007 111.154 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -76.5 -65.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 110.884 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -87.49 -75.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 73.329999999999998 110.872 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.77 152.41 7.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 63.229999999999997 112.477 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.69 -57.9 14.09 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 74.340000000000003 110.927 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.75 -7.12 20.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.684 2.256 . . . . 54.32 112.341 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.7 mm -94.57 -23.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 74.310000000000002 111.154 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 m -93.65 -26.6 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 75.230000000000004 111.128 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -62.2 -23.38 66.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.140000000000001 110.892 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -81.58 -47.5 12.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.861 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.83 24.99 5.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 110.881 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -50.59 64.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 72.230000000000004 110.951 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -50.98 -52.89 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 73.230000000000004 110.893 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -57.03 -58.83 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 73.239999999999995 110.894 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mt -50.75 -59.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 75.540000000000006 111.134 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -28.94 61.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.854 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -19.9 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 70.120000000000005 110.925 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.13 -48.61 6.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 71.209999999999994 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.47 -23.71 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 72.510000000000005 111.186 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.0 8.77 71.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 64.340000000000003 112.505 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.81 -65.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 70.299999999999997 110.849 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.96 48.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 72.239999999999995 112.491 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -85.94 -177.85 6.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 73.219999999999999 110.893 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.27 -168.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 75.319999999999993 111.13 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -100.57 -14.67 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.422 . . . . 64.420000000000002 111.117 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -119.28 19.6 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.902 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 mmpt? -95.24 -57.05 2.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 74.25 110.884 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 pt -48.01 -33.53 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.140000000000001 111.146 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -67.12 -49.45 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 74.129999999999995 111.105 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.01 -25.81 63.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 110.856 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -69.2 -42.9 75.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 75.310000000000002 110.904 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 72.2 mt -73.3 -41.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 75.5 111.097 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -56.94 -47.41 80.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.882 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -62.7 -44.51 96.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 110.88 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.24 -64.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 72.5 110.823 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.540000000000006 111.142 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.41 -49.86 0.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.189 -0.914 . . . . 72.140000000000001 112.451 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.56 -35.78 7.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.732 0.301 . . . . 75.420000000000002 111.055 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.37 -28.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 75.209999999999994 111.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.71 -26.51 34.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 75.230000000000004 111.077 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.94 -34.5 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 110.893 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.7 -25.1 23.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 75.439999999999998 110.935 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.7 t -64.6 -70.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 74.299999999999997 111.131 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.08 -29.83 23.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 73.209999999999994 111.098 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -74.24 -71.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.92 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -81.27 -74.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.010000000000005 110.857 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.01 150.13 6.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 75.219999999999999 112.444 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.519 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.33 -58.3 11.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.523 0.678 . . . . 74.230000000000004 110.896 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.72 -6.74 19.29 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 2.264 . . . . 73.239999999999995 112.358 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.66 -22.94 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.299999999999997 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 m -94.28 -28.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 72.450000000000003 111.105 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -60.85 -30.61 70.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.877 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -75.73 -38.76 58.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 73.439999999999998 110.906 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.2 27.91 6.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 74.400000000000006 110.916 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -82.8 -0.82 49.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 73.400000000000006 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.87 32.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 75.329999999999998 110.902 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -116.01 -47.09 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.5 110.912 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.4 mt -51.78 -67.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 74.450000000000003 111.11 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.1 ptm -57.12 -25.67 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.239999999999995 110.904 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.02 -19.46 60.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 74.540000000000006 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -94.5 -51.56 4.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 75.219999999999999 110.861 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.29 -29.49 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 111.116 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.77 -21.66 37.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 71.120000000000005 112.491 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -93.05 -74.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 73.409999999999997 110.884 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.79 41.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 53.32 112.476 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -64.77 177.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.737 0.303 . . . . 73.099999999999994 110.946 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.74 -171.55 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 111.122 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -102.73 0.71 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 62.409999999999997 111.101 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -129.08 5.82 5.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 75.140000000000001 110.893 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -86.35 -55.08 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 110.913 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.3 pt -50.21 -35.94 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 75.219999999999999 111.143 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -66.12 -62.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 72.120000000000005 111.171 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -57.79 -24.68 58.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 72.209999999999994 110.88 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -67.72 -60.97 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.908 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 63.2 mt -51.54 -42.64 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 74.150000000000006 111.128 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -42.38 98.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 64.109999999999999 110.92 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.06 -26.01 67.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 75.040000000000006 110.932 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -80.2 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 110.848 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 111.137 -179.966 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.79 49.92 0.71 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.131 -0.94 . . . . 73.439999999999998 112.459 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.09 -56.99 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 75.109999999999999 111.128 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 mm -104.34 -30.6 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 63.43 111.14 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.73 -25.09 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 72.540000000000006 111.089 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -59.64 -33.2 71.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 75.120000000000005 110.841 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -84.85 -25.83 27.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 74.409999999999997 110.934 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.8 t -61.38 -64.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 70.099999999999994 111.123 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.59 -23.96 44.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 71.099999999999994 111.129 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.3 tptt -77.67 -66.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 75.340000000000003 110.901 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -91.91 -75.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 110.843 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.15 155.19 11.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.699 -0.762 . . . . 73.140000000000001 112.47 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.526 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.77 -57.92 14.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.589 0.709 . . . . 74.200000000000003 110.889 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.78 -6.7 19.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.695 2.263 . . . . 73.120000000000005 112.332 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.8 mm -94.75 -23.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.310000000000002 111.124 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 m -93.71 -26.97 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 74.349999999999994 111.142 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.76 -20.75 66.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 75.120000000000005 110.885 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 -49.71 9.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 75.120000000000005 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -94.94 22.09 6.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 74.310000000000002 110.915 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -65.79 -40.67 92.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 70.140000000000001 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -55.48 34.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 70.239999999999995 110.906 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -56.77 -55.6 32.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 54.350000000000001 110.908 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.3 mt -50.52 -62.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.329999999999998 111.149 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.6 ttt -56.63 -29.78 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 110.872 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -72.86 -18.84 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 72.129999999999995 110.933 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.92 -51.79 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.450000000000003 110.886 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -51.31 -29.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 75.129999999999995 111.158 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.15 -21.33 38.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 71.409999999999997 112.478 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -95.29 -75.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 74.329999999999998 110.856 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.07 49.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 54.539999999999999 112.522 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -68.49 -179.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 75.0 110.906 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.97 -169.4 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 111.109 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.63 -21.26 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 75.310000000000002 111.121 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -115.49 17.05 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 75.540000000000006 110.88 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.3 mmtt -89.38 -57.74 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 75.340000000000003 110.918 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.2 pt -49.58 -32.11 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.019999999999996 111.113 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 74.9 mt -67.68 -58.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 71.150000000000006 111.112 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.78 -32.26 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 70.019999999999996 110.857 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.43 -47.63 85.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.929 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 64.2 mt -69.06 -42.66 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.158 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.49 -25.89 52.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 110.92 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -96.32 31.02 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 63.200000000000003 110.884 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -137.72 -49.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 73.340000000000003 110.815 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 111.126 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.25 -88.96 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.166 -0.924 . . . . 74.040000000000006 112.465 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.74 -28.94 12.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.318 . . . . 72.109999999999999 111.088 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.5 mm -75.93 -33.59 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 72.129999999999995 111.139 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.31 -26.18 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 54.43 111.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -61.31 -25.59 67.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 72.430000000000007 110.918 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.41 -22.97 20.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.239999999999995 110.897 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.57 -57.39 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 111.106 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.48 -24.07 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 65.530000000000001 111.084 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -78.37 -46.6 19.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 110.912 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -111.86 -74.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 110.896 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.7 151.65 7.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 75.150000000000006 112.435 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.518 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.14 -58.37 10.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 74.129999999999995 110.889 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.74 -6.61 19.01 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.691 2.261 . . . . 71.230000000000004 112.354 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.9 mm -94.8 -22.6 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.420000000000002 111.109 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.73 -27.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 73.409999999999997 111.119 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -62.63 -29.01 70.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -75.46 -47.21 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.049999999999997 110.901 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.87 28.42 3.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.953 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -74.33 -30.51 62.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 73.030000000000001 110.935 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -70.15 -10.92 60.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 75.319999999999993 110.923 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -108.18 -60.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 72.230000000000004 110.91 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mt -49.96 -33.7 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -80.24 -49.9 10.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 65.099999999999994 110.843 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -20.29 57.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 74.439999999999998 110.87 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -83.77 -58.39 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 110.884 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.0 pt -50.92 -29.58 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 74.430000000000007 111.176 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.5 -21.72 35.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 71.430000000000007 112.474 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.2 -74.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 74.519999999999996 110.879 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.15 46.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.743 . . . . 75.420000000000002 112.504 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.87 -179.65 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 65.109999999999999 110.962 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.92 -169.27 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 63.109999999999999 111.124 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 tt -98.5 -16.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 111.097 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -105.32 -20.62 13.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 60.32 110.893 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -58.68 -65.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 71.530000000000001 110.871 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.2 pt -49.01 -32.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 73.400000000000006 111.137 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 71.5 mt -65.54 -66.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 73.019999999999996 111.159 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.3 -19.95 57.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 74.439999999999998 110.886 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.4 -50.85 23.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 73.530000000000001 110.937 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mt -60.97 -59.77 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 75.420000000000002 111.116 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -51.61 -30.19 20.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 73.329999999999998 110.892 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -65.98 -41.37 91.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.340000000000003 110.882 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -69.52 -62.47 1.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 110.866 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.040000000000006 111.139 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.61 36.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.186 -0.915 . . . . 72.230000000000004 112.536 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.04 -64.85 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 72.430000000000007 111.092 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.1 mm -71.93 -33.58 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 111.112 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.04 -22.23 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 63.310000000000002 111.101 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -38.28 90.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 73.25 110.925 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.18 -22.3 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 65.540000000000006 110.914 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.71 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 74.310000000000002 111.128 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.09 -24.59 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 60.439999999999998 111.071 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -79.57 -52.63 7.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 73.519999999999996 110.928 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -104.26 -74.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.400000000000006 110.898 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.98 151.21 7.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.718 . . . . 51.240000000000002 112.535 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.525 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.2 -58.18 11.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.624 0.726 . . . . 75.430000000000007 110.931 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.72 -6.8 19.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.715 2.276 . . . . 50.240000000000002 112.371 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.8 mm -94.82 -23.09 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 74.200000000000003 111.15 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.4 m -93.99 -27.2 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 71.209999999999994 111.115 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -61.68 -28.27 69.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.310000000000002 110.884 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -77.14 -43.67 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 74.299999999999997 110.87 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -96.91 27.05 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 74.329999999999998 110.946 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.86 -1.09 41.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.430000000000007 110.932 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.29 -9.78 24.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 70.329999999999998 110.899 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -112.25 -51.16 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 70.519999999999996 110.889 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.8 mt -51.3 -68.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 72.219999999999999 111.167 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -25.66 51.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.209999999999994 110.852 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -75.21 -23.88 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 71.400000000000006 110.874 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -86.86 -50.85 6.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 75.409999999999997 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -51.16 -29.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 74.019999999999996 111.12 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.68 -22.01 38.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.77 -0.729 . . . . 74.200000000000003 112.501 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -93.65 -74.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 72.230000000000004 110.926 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.3 46.81 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.540000000000006 112.451 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -66.9 -179.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 74.519999999999996 110.916 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.22 -169.48 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 111.107 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tt -101.65 -21.41 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.349999999999994 111.161 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -114.84 19.25 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.97 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -91.46 -58.05 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 74.030000000000001 110.9 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.9 pt -50.7 -31.95 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 64.329999999999998 111.121 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.02 -59.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 111.128 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.83 -26.06 68.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 64.219999999999999 110.879 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.01 -53.82 40.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 75.420000000000002 110.883 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 56.0 mt -64.95 -45.3 95.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 111.127 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -34.29 56.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 74.200000000000003 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -93.81 42.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 72.219999999999999 110.893 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -148.3 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.099999999999994 110.838 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 73.109999999999999 111.119 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.778 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 36.3 mm . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.805 0.336 . . . . 70.400000000000006 111.113 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.53 35.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 54.329999999999998 111.096 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.7 -26.53 68.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 72.230000000000004 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.976 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -91.22 -24.63 19.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.450000000000003 110.935 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.733 HG22 HG21 ' A' ' 16' ' ' VAL . 87.3 t -70.39 -64.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 70.239999999999995 111.136 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.25 -25.74 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 73.5 111.045 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -82.43 -66.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 74.129999999999995 110.902 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.444 ' HB3' HG21 ' A' ' 15' ' ' ILE . 90.7 m-85 -85.15 -75.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 110.844 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.57 153.74 8.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 72.019999999999996 112.462 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -53.33 -58.11 14.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 72.319999999999993 110.918 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.2 Cg_endo -69.73 -6.98 19.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.695 2.263 . . . . 73.129999999999995 112.343 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.5 mm -94.88 -21.91 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 60.109999999999999 111.176 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.733 HG21 HG22 ' A' ' 8' ' ' VAL . 31.0 m -95.49 -25.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.340000000000003 111.12 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -25.05 66.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 110.896 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -79.88 -30.38 40.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.150000000000006 110.943 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -110.18 25.42 11.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 75.109999999999999 110.92 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.778 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -72.51 -25.18 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 73.329999999999998 110.891 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -76.04 -5.72 47.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 52.039999999999999 110.919 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -115.92 -56.35 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 64.329999999999998 110.888 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 mt -51.18 -69.45 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 61.229999999999997 111.115 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -23.94 50.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 52.119999999999997 110.858 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -77.12 -21.49 54.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 71.310000000000002 110.898 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -89.57 -48.77 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 74.230000000000004 110.866 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.7 pt -51.5 -29.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.097 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -21.26 39.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 65.340000000000003 112.488 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -93.08 -74.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 71.140000000000001 110.889 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.91 44.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 63.420000000000002 112.504 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -69.47 -179.96 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 74.209999999999994 110.915 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.6 -175.83 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 53.340000000000003 111.098 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tt -88.45 -19.85 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 60.539999999999999 111.142 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -101.84 22.02 13.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 110.827 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -112.1 -64.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 54.140000000000001 110.916 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.976 HD12 HD21 ' A' ' 7' ' ' LEU . 11.8 pt -50.87 -35.31 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 72.040000000000006 111.149 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.3 -64.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 75.299999999999997 111.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.93 -21.96 61.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.853 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -71.51 -56.39 6.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 70.230000000000004 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.434 HD12 HD12 ' A' ' 7' ' ' LEU . 51.9 mt -56.22 -58.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 63.100000000000001 111.149 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -35.01 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.875 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.58 -36.31 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 75.140000000000001 110.877 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -72.47 -62.51 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 65.239999999999995 110.869 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 pt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.0 111.152 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.78 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 37.1 mm . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.86 0.362 . . . . 73.239999999999995 111.141 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.67 -27.54 28.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 44.450000000000003 111.085 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.45 -32.06 71.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 73.420000000000002 110.929 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.085 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -84.38 -24.71 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.968 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.747 HG22 HG21 ' A' ' 16' ' ' VAL . 84.1 t -69.6 -59.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 75.109999999999999 111.11 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 35.350000000000001 111.09 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.549 ' HG2' HG23 ' A' ' 37' ' ' ILE . 3.3 tppp? -81.11 -46.0 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 64.439999999999998 110.893 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.423 ' HB3' HG21 ' A' ' 15' ' ' ILE . 91.8 m-85 -109.29 -74.83 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.150000000000006 110.862 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.31 150.77 7.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 74.310000000000002 112.476 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.527 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.71 -58.05 12.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 72.120000000000005 110.936 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.9 Cg_endo -69.79 -6.75 19.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 55.210000000000001 112.32 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.1 mm -94.49 -22.68 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 41.100000000000001 111.127 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.747 HG21 HG22 ' A' ' 8' ' ' VAL . 19.5 m -94.72 -27.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 63.130000000000003 111.097 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.85 -25.5 67.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.901 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.83 -30.67 40.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.877 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.588 ' O ' HD12 ' A' ' 23' ' ' ILE . 60.6 m-85 -109.8 28.04 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 52.329999999999998 110.948 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.78 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -77.59 -6.14 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 73.540000000000006 110.922 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -91.36 -11.26 38.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -109.77 -55.94 2.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 61.030000000000001 110.89 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 19' ' ' TYR . 7.2 mt -51.62 -68.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 73.200000000000003 111.11 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 tpt -56.64 -24.94 51.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 64.230000000000004 110.848 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.76 -23.15 52.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 74.049999999999997 110.915 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -86.12 -49.42 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 73.219999999999999 110.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.5 pt -52.07 -28.37 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 71.530000000000001 111.091 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.46 -18.5 44.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.75 . . . . 62.119999999999997 112.532 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -97.7 -74.99 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 72.5 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.34 49.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 71.450000000000003 112.513 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -69.73 -179.76 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.322 . . . . 73.140000000000001 110.922 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -85.75 -169.47 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 71.129999999999995 111.125 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -101.58 -21.45 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 111.172 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.589 ' HA ' HD13 ' A' ' 37' ' ' ILE . 17.8 p30 -116.78 23.22 12.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 73.239999999999995 110.883 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -95.74 -55.37 3.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 63.509999999999998 110.945 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.085 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.76 -35.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 111.109 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.589 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -65.26 -53.46 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 72.530000000000001 111.128 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -66.48 -25.13 66.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 61.119999999999997 110.884 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -65.41 -57.33 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.25 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 23' ' ' ILE . 35.4 mt -60.32 -46.51 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 111.14 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -52.28 -32.25 36.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.878 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -75.55 -46.91 29.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.888 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.25 -62.91 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.847 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 pt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.129999999999995 111.177 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.796 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 29.4 mm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.805 0.336 . . . . 72.530000000000001 111.061 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.99 -24.62 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 63.219999999999999 111.154 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.28 -35.55 81.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 65.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.882 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -76.08 -26.2 56.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 74.120000000000005 110.882 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.669 HG22 HG21 ' A' ' 16' ' ' VAL . 98.0 t -68.44 -58.78 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 61.240000000000002 111.16 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.9 -24.96 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 62.439999999999998 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -79.9 -44.47 20.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 64.010000000000005 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 44' ' ' ILE . 77.5 m-85 -111.99 -74.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 71.010000000000005 110.914 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.63 150.79 6.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 74.299999999999997 112.479 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.2 11.47 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.571 0.7 . . . . 61.439999999999998 110.905 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.76 -6.77 19.39 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.655 2.237 . . . . 73.200000000000003 112.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.4 mm -95.02 -22.9 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 74.450000000000003 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.669 HG21 HG22 ' A' ' 8' ' ' VAL . 21.6 m -94.07 -27.25 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 111.119 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -66.32 -25.43 66.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.420000000000002 110.958 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -78.89 -28.35 44.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 63.549999999999997 110.867 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.425 ' O ' HD12 ' A' ' 23' ' ' ILE . 74.4 m-85 -113.66 25.59 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 70.439999999999998 110.908 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.796 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -72.88 -17.39 61.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.914 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -84.5 3.44 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 73.530000000000001 110.903 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -126.01 -56.34 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 110.938 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 19' ' ' TYR . 8.9 mt -51.2 -68.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.54 ' HG3' HD11 ' A' ' 4' ' ' ILE . 5.8 ttp -57.41 -23.56 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 64.319999999999993 110.867 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -78.27 -20.68 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 73.25 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.73 -49.23 6.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 54.200000000000003 110.893 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -51.17 -29.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 72.530000000000001 111.123 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.42 -22.06 36.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 64.319999999999993 112.542 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.72 -68.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 75.400000000000006 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.42 35.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 70.329999999999998 112.484 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -57.77 -179.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.804 0.335 . . . . 64.5 110.897 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -98.15 -169.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 71.209999999999994 111.057 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 tt -98.62 -10.01 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.019999999999996 111.124 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.45 ' HA ' HD12 ' A' ' 37' ' ' ILE . 1.1 p-10 -111.09 -24.77 10.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 73.030000000000001 110.865 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -54.83 -63.24 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 71.120000000000005 110.907 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.882 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.51 -35.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 111.159 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 34' ' ' ASN . 68.5 mt -64.49 -60.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 72.430000000000007 111.112 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.69 -17.91 63.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 70.329999999999998 110.868 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -76.28 -58.62 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 74.019999999999996 110.905 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 7' ' ' LEU . 40.0 mt -54.09 -55.0 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 75.510000000000005 111.167 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -34.53 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 61.350000000000001 110.931 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -53.2 -46.19 68.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.200000000000003 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.56 -72.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 70.239999999999995 110.904 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.434 HD11 ' CE1' ' A' ' 11' ' ' PHE . 33.0 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.340000000000003 111.157 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.895 0.379 . . . . 71.049999999999997 111.133 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.48 -25.4 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 72.219999999999999 111.07 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -58.27 -37.91 75.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.109999999999999 110.923 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.083 HD21 HD12 ' A' ' 36' ' ' ILE . 2.7 mm? -80.3 -23.11 40.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 52.439999999999998 110.952 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.74 HG22 HG21 ' A' ' 16' ' ' VAL . 84.3 t -66.86 -67.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 73.530000000000001 111.148 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.96 -27.22 29.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 111.108 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -78.5 -70.0 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 110.895 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.432 ' HB3' HG21 ' A' ' 15' ' ' ILE . 72.9 m-85 -82.61 -74.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 74.319999999999993 110.837 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.67 150.84 7.01 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 75.209999999999994 112.498 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.17 -58.27 11.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.587 0.708 . . . . 71.219999999999999 110.89 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.74 -6.92 19.74 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 63.25 112.325 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' A' ' 11' ' ' PHE . 43.4 mm -94.87 -22.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 111.086 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.74 HG21 HG22 ' A' ' 8' ' ' VAL . 22.2 m -94.5 -27.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 71.430000000000007 111.148 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -61.6 -25.44 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.420000000000002 110.914 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -81.36 -42.23 20.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 110.896 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -100.77 27.32 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 62.049999999999997 110.894 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.13 -34.57 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 62.43 110.905 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -71.9 -9.04 57.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 60.210000000000001 110.922 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -103.64 -52.38 3.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 70.510000000000005 110.92 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 40' ' ' ILE . 18.0 mt -54.5 -65.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 62.439999999999998 111.113 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.6 ttt -56.74 -25.81 55.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.884 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -73.71 -20.75 60.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 110.94 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.67 -51.53 5.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 54.119999999999997 110.871 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.85 -29.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 64.439999999999998 111.172 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.39 -23.58 34.91 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.209999999999994 112.49 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 -75.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 62.409999999999997 110.875 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.44 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 61.100000000000001 112.512 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.04 -179.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 75.329999999999998 110.955 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -89.54 -169.35 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 32.109999999999999 111.099 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 tt -102.86 -13.31 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 65.510000000000005 111.107 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.582 ' HA ' HD13 ' A' ' 37' ' ' ILE . 21.5 m-80 -122.42 20.46 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 62.329999999999998 110.893 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -95.36 -54.36 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 70.140000000000001 110.899 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.083 HD12 HD21 ' A' ' 7' ' ' LEU . 10.0 pt -50.11 -35.73 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.150000000000006 111.169 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -64.82 -56.66 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.010000000000005 111.146 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.92 -25.53 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 70.420000000000002 110.867 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -66.44 -48.72 69.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 70.519999999999996 110.912 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 23' ' ' ILE . 46.0 mt -68.99 -36.35 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 111.141 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -38.91 92.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.908 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -73.87 -26.9 60.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 72.040000000000006 110.939 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.5 -61.84 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 110.859 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 72.340000000000003 111.09 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.78 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 31.2 mm . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.86 0.362 . . . . 75.450000000000003 111.113 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.05 -24.72 41.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 54.130000000000003 111.115 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.99 -41.92 84.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.895 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.032 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -76.2 -24.58 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 70.329999999999998 110.925 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.751 HG22 HG21 ' A' ' 16' ' ' VAL . 87.4 t -65.71 -43.54 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 65.230000000000004 111.129 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.41 37.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.150000000000006 111.11 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.713 ' HG2' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -81.34 -30.29 33.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.540000000000006 110.87 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.7 m-85 -126.29 -75.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 53.43 110.872 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.88 151.98 7.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 55.439999999999998 112.5 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.7 -58.17 11.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.53 0.681 . . . . 74.349999999999994 110.908 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.76 -6.62 19.03 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 65.319999999999993 112.335 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.5 mm -95.06 -22.7 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 72.420000000000002 111.145 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.751 HG21 HG22 ' A' ' 8' ' ' VAL . 21.3 m -94.3 -27.18 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 72.319999999999993 111.119 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.48 -29.73 70.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 71.200000000000003 110.909 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -75.53 -32.82 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 70.150000000000006 110.921 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.54 ' O ' HD12 ' A' ' 23' ' ' ILE . 80.0 m-85 -104.87 24.76 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.299999999999997 110.904 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.78 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -76.31 -11.44 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.503 . . . . 52.420000000000002 110.951 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -90.89 13.55 16.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 54.530000000000001 110.931 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -139.3 -51.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 55.539999999999999 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 19' ' ' TYR . 9.9 mt -54.68 -65.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 61.329999999999998 111.136 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.409 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -58.7 -21.33 54.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 71.299999999999997 110.908 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -82.11 -21.99 36.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 62.109999999999999 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -86.96 -43.55 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 63.32 110.883 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -55.57 -25.5 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 73.319999999999993 111.099 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.07 -6.93 69.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.783 -0.722 . . . . 61.520000000000003 112.505 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.0 -71.48 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 62.020000000000003 110.908 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.87 49.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 74.319999999999993 112.473 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -82.52 -178.24 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 71.400000000000006 110.944 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.57 -175.6 2.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 63.310000000000002 111.116 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.545 HG23 ' OD1' ' A' ' 34' ' ' ASN . 10.7 tp -86.38 -21.05 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.310000000000002 111.143 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 33' ' ' ILE . 26.6 m-20 -99.28 20.02 14.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.420000000000002 110.871 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -110.28 -68.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.510000000000005 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.032 HD12 HD21 ' A' ' 7' ' ' LEU . 9.8 pt -49.84 -31.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 72.439999999999998 111.152 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.713 HD12 ' HG2' ' A' ' 10' ' ' LYS . 44.3 mm -61.38 -67.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 43.439999999999998 111.113 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -61.38 -31.02 70.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.833 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -55.56 -37.69 68.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.891 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 44' ' ' ILE . 44.9 mt -86.43 -37.63 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 75.319999999999993 111.081 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -61.02 -28.75 69.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 65.319999999999993 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -89.37 -26.73 20.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.299999999999997 110.888 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.22 -26.53 52.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.109999999999999 110.846 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 40' ' ' ILE . 26.4 pt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 63.509999999999998 111.107 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.772 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 27.2 mm . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.827 0.346 . . . . 74.230000000000004 111.112 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.11 -24.86 43.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 54.43 111.147 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -35.08 70.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.319999999999993 110.92 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.022 HD21 HD12 ' A' ' 36' ' ' ILE . 1.8 mm? -84.53 -25.57 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 70.340000000000003 110.95 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.714 HG22 HG21 ' A' ' 16' ' ' VAL . 94.7 t -69.53 -35.31 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 64.120000000000005 111.15 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.01 17.14 11.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 45.329999999999998 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -130.49 -39.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 63.219999999999999 110.902 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -112.39 -75.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.129999999999995 110.931 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 149.09 5.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 23.440000000000001 112.5 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -50.79 -58.01 11.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.598 0.713 . . . . 74.200000000000003 110.922 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.82 -5.29 15.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 73.239999999999995 112.355 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.21 -22.28 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 75.400000000000006 111.139 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.714 HG21 HG22 ' A' ' 8' ' ' VAL . 27.1 m -92.99 -29.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 111.091 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -26.22 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 52.520000000000003 110.895 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -73.4 -21.12 60.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.0 110.88 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.91 21.51 11.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 73.209999999999994 110.909 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.86 -28.25 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 75.109999999999999 110.897 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.9 -9.35 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 63.140000000000001 110.936 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -109.02 -60.76 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.917 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 HD11 ' A' ' 40' ' ' ILE . 5.5 mt -51.37 -65.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 74.019999999999996 111.099 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 44.0 ttp -56.42 -28.48 59.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 72.430000000000007 110.859 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -75.22 -21.57 58.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 54.130000000000003 110.959 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -87.76 -50.35 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 61.020000000000003 110.908 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -51.95 -28.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 63.020000000000003 111.168 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -18.73 41.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.473 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -94.91 -69.18 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 75.230000000000004 110.906 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.66 36.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.757 . . . . 44.399999999999999 112.463 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -57.04 -179.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.793 0.33 . . . . 71.349999999999994 110.889 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -87.19 -169.33 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 64.409999999999997 111.107 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -101.54 -21.7 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 111.092 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.51 ' HA ' HD12 ' A' ' 37' ' ' ILE . 70.4 m-80 -114.82 21.04 14.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 61.030000000000001 110.901 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -93.5 -58.02 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.879 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.022 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.37 -31.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 74.549999999999997 111.138 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 34' ' ' ASN . 67.8 mt -63.71 -62.89 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 53.020000000000003 111.146 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -28.9 69.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 53.409999999999997 110.849 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -58.48 -53.79 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 72.030000000000001 110.951 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.442 HD11 HD11 ' A' ' 23' ' ' ILE . 22.8 mt -69.04 -40.08 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.209999999999994 111.14 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -52.01 -67.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 51.109999999999999 110.873 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -28.27 57.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 75.239999999999995 110.903 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -68.81 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 72.5 110.83 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.428 . . . . 75.209999999999994 111.132 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.786 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 30.1 mm . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.859 0.362 . . . . 72.319999999999993 111.145 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.5 -24.32 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 63.43 111.083 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -63.03 -25.03 68.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 110.883 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.06 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -92.02 -25.35 18.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 64.329999999999998 110.918 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 16' ' ' VAL . 91.7 t -67.3 -68.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 73.329999999999998 111.125 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.59 -28.73 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.25 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' HD2' HG23 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -76.47 -61.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 64.319999999999993 110.903 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.471 ' HB3' HG21 ' A' ' 15' ' ' ILE . 97.0 m-85 -93.45 -74.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 71.340000000000003 110.907 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.92 151.64 7.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 53.130000000000003 112.508 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.528 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.44 -58.2 11.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 75.140000000000001 110.952 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.59 18.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 63.509999999999998 112.364 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.4 mm -94.93 -22.44 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 64.439999999999998 111.114 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -94.81 -27.16 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 54.049999999999997 111.157 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -65.96 -25.42 67.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.872 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -25.74 39.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 62.509999999999998 110.924 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.578 ' O ' HD12 ' A' ' 23' ' ' ILE . 78.4 m-85 -114.49 24.94 11.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 73.230000000000004 110.913 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.786 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.18 -27.84 64.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 73.400000000000006 110.945 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -7.84 53.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 72.129999999999995 110.863 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -109.98 -60.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 73.099999999999994 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.3 mt -52.74 -65.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 111.143 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -56.64 -25.79 54.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 71.439999999999998 110.881 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.68 -22.27 50.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 54.310000000000002 110.895 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -85.34 -47.95 9.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.420000000000002 110.912 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.8 pt -53.32 -27.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 71.120000000000005 111.171 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.56 -14.68 55.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 75.439999999999998 112.454 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.54 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 73.129999999999995 110.864 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.88 48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 54.530000000000001 112.481 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -72.82 -179.23 3.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.765 0.317 . . . . 75.450000000000003 110.92 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -88.92 -169.55 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 64.129999999999995 111.058 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tt -101.54 -11.11 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 111.096 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.61 ' HA ' HD13 ' A' ' 37' ' ' ILE . 5.7 m120 -122.96 4.29 9.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 75.430000000000007 110.85 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 6.3 mmtm -78.6 -56.72 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.93 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.06 HD12 HD21 ' A' ' 7' ' ' LEU . 8.5 pt -49.42 -37.48 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 111.089 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.5 mp -65.37 -44.37 94.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 111.125 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -74.48 -20.84 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.891 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -71.24 -53.88 12.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 63.020000000000003 110.891 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.554 HD11 ' CD1' ' A' ' 23' ' ' ILE . 36.7 mt -62.4 -47.87 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 55.43 111.139 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -43.39 63.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.912 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -68.23 -39.58 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 71.209999999999994 110.924 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -64.75 -62.04 1.82 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 110.86 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 74.439999999999998 111.081 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.3 mm . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.834 0.35 . . . . 53.310000000000002 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -21.15 58.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 45.140000000000001 111.114 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -64.52 -29.64 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 61.5 110.889 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.99 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -87.1 -25.08 24.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 61.299999999999997 110.931 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.718 HG22 HG21 ' A' ' 16' ' ' VAL . 87.8 t -68.61 -32.42 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 72.549999999999997 111.176 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.88 17.18 10.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 61.539999999999999 111.093 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.539 ' HG2' HG23 ' A' ' 37' ' ' ILE . 11.3 tppt? -129.36 -45.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.319999999999993 110.909 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.476 ' HB3' HG21 ' A' ' 15' ' ' ILE . 94.4 m-85 -107.77 -75.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 64.109999999999999 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.65 152.8 8.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.801 -0.714 . . . . 50.140000000000001 112.537 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.07 -58.14 12.46 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 75.430000000000007 110.957 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.78 -7.13 20.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 63.219999999999999 112.327 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 11' ' ' PHE . 43.3 mm -95.28 -22.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 61.130000000000003 111.166 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.718 HG21 HG22 ' A' ' 8' ' ' VAL . 29.1 m -93.6 -26.22 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.239999999999995 111.144 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -65.37 -24.57 67.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.25 110.912 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -78.16 -47.97 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.9 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.26 22.22 8.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.931 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.53 -41.07 93.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 75.299999999999997 110.936 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.9 -56.47 21.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 64.329999999999998 110.854 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -56.24 -55.65 30.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 40' ' ' ILE . 41.9 mt -50.97 -62.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 111.111 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -29.15 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 60.420000000000002 110.871 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -72.77 -23.63 60.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 73.319999999999993 110.905 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -86.8 -52.52 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.878 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.31 -29.84 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 75.409999999999997 111.059 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.5 38.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 52.240000000000002 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.0 -74.96 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 71.150000000000006 110.856 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.83 47.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 75.049999999999997 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -67.02 -179.65 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.782 0.325 . . . . 75.510000000000005 110.883 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -90.33 -169.45 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 61.240000000000002 111.091 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.39 -10.04 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.530000000000001 111.127 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.639 ' HA ' HD13 ' A' ' 37' ' ' ILE . 21.0 p30 -124.09 19.65 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 63.130000000000003 110.901 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 10.4 mmtp -96.13 -56.17 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.150000000000006 110.893 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.99 HD12 HD21 ' A' ' 7' ' ' LEU . 9.4 pt -50.05 -31.29 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 71.230000000000004 111.145 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.639 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.1 mp -69.24 -50.74 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 55.340000000000003 111.126 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -69.53 -26.03 64.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 65.519999999999996 110.831 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -68.31 -44.08 76.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 71.450000000000003 110.955 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 23' ' ' ILE . 51.3 mt -72.72 -45.2 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 65.299999999999997 111.129 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -55.95 -38.65 70.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 64.019999999999996 110.935 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -72.95 -26.28 61.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 72.299999999999997 110.916 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -77.86 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 72.030000000000001 110.865 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 111.082 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.792 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 33.4 mm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.862 0.363 . . . . 61.409999999999997 111.107 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.57 67.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 65.329999999999998 111.067 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HG3' HD22 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -51.59 -37.62 50.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 72.530000000000001 110.907 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.095 HD21 HD12 ' A' ' 36' ' ' ILE . 3.6 mm? -69.27 -34.16 74.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 70.299999999999997 110.939 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 16' ' ' VAL . 66.5 t -61.39 -66.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 70.420000000000002 111.184 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.3 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.051 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -77.29 -41.72 39.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -118.84 -75.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 75.530000000000001 110.882 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.1 149.11 6.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 53.020000000000003 112.496 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.67 -58.22 11.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.519 0.676 . . . . 64.439999999999998 110.918 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.67 -6.94 19.76 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.248 . . . . 73.140000000000001 112.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.31 -23.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.519999999999996 111.132 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.661 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -93.63 -27.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.161 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -66.23 -28.2 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 73.340000000000003 110.902 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.45 -24.57 53.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 71.530000000000001 110.898 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.515 ' O ' HD12 ' A' ' 23' ' ' ILE . 78.4 m-85 -117.59 25.4 10.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 74.319999999999993 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.792 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.07 -24.6 63.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 65.510000000000005 110.918 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -77.91 -3.82 43.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 62.420000000000002 110.914 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -114.27 -58.83 2.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 75.049999999999997 110.841 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.7 mt -51.4 -69.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 111.113 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -23.79 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 71.409999999999997 110.868 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -77.01 -21.82 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 110.916 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -89.65 -48.43 7.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.875 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.7 pt -51.95 -28.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 55.340000000000003 111.132 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.39 -18.41 43.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 74.25 112.478 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -97.7 -75.03 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 64.150000000000006 110.874 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.85 48.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.753 . . . . 61.5 112.48 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -68.05 -179.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 73.140000000000001 110.885 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.21 -169.34 2.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 62.43 111.078 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -103.33 -7.94 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 111.18 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -118.63 14.63 13.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -95.81 -61.01 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.937 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.095 HD12 HD21 ' A' ' 7' ' ' LEU . 10.4 pt -50.04 -30.82 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 72.510000000000005 111.169 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -67.26 -72.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 71.439999999999998 111.144 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.25 -35.06 59.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 65.150000000000006 110.878 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -52.68 -45.9 67.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.510000000000005 110.912 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 7' ' ' LEU . 42.9 mt -77.37 -47.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 72.150000000000006 111.09 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -52.81 -32.54 44.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.89 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -79.41 -43.59 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 64.519999999999996 110.865 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.25 -63.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.239999999999995 110.864 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 64.209999999999994 111.148 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.77 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 30.9 mm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.848 0.356 . . . . 75.230000000000004 111.118 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.46 47.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.030000000000001 111.071 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -61.3 -33.47 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.921 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.015 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -83.94 -21.23 31.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 64.230000000000004 110.923 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.722 HG22 HG21 ' A' ' 16' ' ' VAL . 89.2 t -68.28 -64.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.510000000000005 111.122 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.71 -24.95 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 61.310000000000002 111.086 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 37' ' ' ILE . 3.5 tmtm? -79.81 -58.29 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 54.509999999999998 110.891 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.505 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.3 m-85 -96.95 -75.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 70.109999999999999 110.892 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.85 151.78 7.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 32.299999999999997 112.479 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.53 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.58 -58.09 12.16 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.599 0.714 . . . . 72.25 110.933 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.83 19.54 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.692 2.262 . . . . 63.240000000000002 112.333 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 11' ' ' PHE . 41.8 mm -94.6 -23.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.049999999999997 111.085 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.722 HG21 HG22 ' A' ' 8' ' ' VAL . 20.8 m -93.81 -27.36 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 44.149999999999999 111.124 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -62.61 -29.21 70.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.219999999999999 110.904 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -75.62 -36.36 60.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 74.349999999999994 110.913 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.07 26.21 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 110.933 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -79.45 -6.76 57.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 62.0 110.93 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -94.97 16.58 15.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 73.120000000000005 110.886 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -145.01 -50.17 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 62.039999999999999 110.943 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' A' ' 40' ' ' ILE . 37.7 mt -51.56 -67.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 111.133 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -57.51 -23.64 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 72.049999999999997 110.892 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.12 -19.55 50.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 71.120000000000005 110.905 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.35 -46.19 8.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 75.040000000000006 110.888 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.42 -23.46 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 65.340000000000003 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.28 9.46 70.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 72.329999999999998 112.454 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.37 -63.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 42.229999999999997 110.931 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.06 46.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 54.43 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -85.0 -178.66 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 75.239999999999995 110.945 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.33 -169.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 64.299999999999997 111.107 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.427 HG23 ' OD1' ' A' ' 34' ' ' ASN . 14.6 tt -101.19 -10.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.540000000000006 111.12 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HA ' HD12 ' A' ' 37' ' ' ILE . 4.0 m-20 -121.72 19.5 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.872 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -95.36 -58.34 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 73.329999999999998 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.015 HD12 HD21 ' A' ' 7' ' ' LEU . 9.0 pt -49.48 -33.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.453 . . . . 73.329999999999998 111.117 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 34' ' ' ASN . 75.7 mt -60.58 -60.97 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.15 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -26.48 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 53.049999999999997 110.85 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -65.46 -30.03 70.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.510000000000005 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.405 HD11 ' CD1' ' A' ' 23' ' ' ILE . 55.3 mt -93.26 -30.98 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 72.299999999999997 111.084 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -38.78 78.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 72.140000000000001 110.909 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -70.21 -41.42 73.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 64.109999999999999 110.93 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.69 -64.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 73.400000000000006 110.859 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.510000000000005 111.134 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.794 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 34.1 mm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.837 0.351 . . . . 71.430000000000007 111.127 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -25.31 36.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 65.129999999999995 111.143 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HD2' HD11 ' A' ' 33' ' ' ILE . 7.5 mmpt? -62.69 -32.67 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.889 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.022 HD21 HD12 ' A' ' 36' ' ' ILE . 2.3 mm? -82.67 -23.93 33.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 71.310000000000002 110.947 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.72 HG22 HG21 ' A' ' 16' ' ' VAL . 89.2 t -69.98 -56.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 53.399999999999999 111.153 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -26.17 66.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 111.094 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -79.97 -45.12 19.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 72.109999999999999 110.894 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.441 ' HB3' HG21 ' A' ' 15' ' ' ILE . 89.7 m-85 -109.43 -74.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 73.409999999999997 110.87 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 150.9 6.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 60.399999999999999 112.492 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.26 11.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.572 0.701 . . . . 74.409999999999997 110.908 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.74 -6.59 18.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 63.229999999999997 112.36 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' A' ' 11' ' ' PHE . 48.8 mm -95.13 -22.55 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 71.230000000000004 111.138 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.72 HG21 HG22 ' A' ' 8' ' ' VAL . 20.8 m -94.5 -27.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 75.450000000000003 111.113 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -64.44 -25.32 67.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 65.239999999999995 110.901 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -80.06 -32.48 39.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.884 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.552 ' O ' HD12 ' A' ' 23' ' ' ILE . 85.0 m-85 -106.52 24.44 12.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 50.340000000000003 110.902 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.794 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -75.82 -11.72 60.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 73.409999999999997 110.898 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -89.29 10.26 22.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 75.25 110.931 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -135.95 -54.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 73.329999999999998 110.897 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 19' ' ' TYR . 8.6 mt -51.51 -68.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.108 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.417 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -57.47 -23.78 51.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.239999999999995 110.859 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -78.18 -20.37 52.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 53.140000000000001 110.915 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -89.7 -47.5 7.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.897 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.2 -27.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 75.019999999999996 111.135 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.32 -21.97 35.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 62.109999999999999 112.502 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -93.45 -74.93 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 73.519999999999996 110.892 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.65 43.86 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 74.340000000000003 112.5 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -71.17 161.07 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.801 0.334 . . . . 74.140000000000001 110.924 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.573 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -84.86 -169.05 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 111.113 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.406 HD11 ' HD2' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -101.04 -0.07 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 54.229999999999997 111.136 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -115.84 -25.88 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 53.32 110.893 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 10.7 mttm -57.48 -62.8 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.040000000000006 110.913 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.022 HD12 HD21 ' A' ' 7' ' ' LEU . 11.5 pt -50.38 -35.37 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 64.340000000000003 111.111 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.88 -50.11 76.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.176 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.19 -3.79 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.549999999999997 110.868 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -90.43 -42.0 11.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 110.943 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 7' ' ' LEU . 28.3 mt -72.29 -52.62 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 63.450000000000003 111.146 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -52.74 -30.59 33.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 52.530000000000001 110.87 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -67.25 -41.25 85.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 63.43 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -70.38 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.310000000000002 110.868 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 pt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.105 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.4 mm . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.843 0.354 . . . . 72.549999999999997 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.25 -20.95 58.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 60.439999999999998 111.059 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.651 ' NZ ' HD11 ' A' ' 37' ' ' ILE . 21.1 tptm -68.25 -34.88 77.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 72.329999999999998 110.883 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.087 HD21 HD12 ' A' ' 36' ' ' ILE . 2.8 mm? -77.93 -22.73 49.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 74.299999999999997 110.903 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.747 HG22 HG21 ' A' ' 16' ' ' VAL . 88.6 t -68.59 -66.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 71.200000000000003 111.154 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.1 48.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 54.200000000000003 111.093 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.752 ' HE3' HD13 ' A' ' 37' ' ' ILE . 3.8 mttm -80.36 -56.74 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.902 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.435 ' HB3' HG21 ' A' ' 15' ' ' ILE . 87.2 m-85 -98.47 -74.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 110.898 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.93 150.78 7.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 72.420000000000002 112.492 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.34 -58.32 11.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.568 0.699 . . . . 74.299999999999997 110.908 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.73 -6.65 19.09 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.687 2.258 . . . . 75.420000000000002 112.332 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' A' ' 11' ' ' PHE . 48.9 mm -94.58 -22.54 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.310000000000002 111.124 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.747 HG21 HG22 ' A' ' 8' ' ' VAL . 19.3 m -94.95 -27.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 73.25 111.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.74 -25.07 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.922 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -80.16 -40.69 26.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 60.329999999999998 110.865 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -103.75 26.49 8.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 65.209999999999994 110.918 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.56 -35.01 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 72.319999999999993 110.953 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -71.86 -9.33 58.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 71.099999999999994 110.9 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.37 -51.8 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.209999999999994 110.951 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.55 HD11 HD11 ' A' ' 40' ' ' ILE . 13.5 mt -56.44 -63.61 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 111.151 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ttt -57.17 -26.06 59.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.903 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.51 -18.64 60.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.239999999999995 110.871 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -91.9 -50.68 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 64.530000000000001 110.868 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.8 pt -51.09 -28.9 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 72.129999999999995 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.13 -23.57 32.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 73.230000000000004 112.51 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -92.06 -74.88 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 62.130000000000003 110.896 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.19 44.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 52.210000000000001 112.489 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.62 -179.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.78 0.324 . . . . 75.140000000000001 110.946 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -102.07 -169.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 65.200000000000003 111.134 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 tt -99.14 -10.03 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.239999999999995 111.146 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.463 ' HA ' HD12 ' A' ' 37' ' ' ILE . 41.7 m-20 -111.04 -20.28 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.329999999999998 110.897 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 5.3 mmtp -61.52 -59.2 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.049999999999997 110.921 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.087 HD12 HD21 ' A' ' 7' ' ' LEU . 10.4 pt -50.36 -31.35 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 111.182 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.752 HD13 ' HE3' ' A' ' 10' ' ' LYS . 74.0 mt -66.82 -60.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 64.450000000000003 111.134 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.39 -25.06 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.852 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -67.21 -57.22 7.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.915 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 7' ' ' LEU . 42.7 mt -62.7 -36.93 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 53.210000000000001 111.124 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -61.75 -61.36 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.540000000000006 110.924 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -52.7 -29.41 26.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.010000000000005 110.897 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -72.07 -68.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 71.040000000000006 110.859 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.150000000000006 111.129 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.705 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 26.7 mm . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.823 0.344 . . . . 70.120000000000005 111.126 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.19 -19.95 56.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.114 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -67.62 -30.54 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.904 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.991 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -84.25 -26.06 28.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.933 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.743 HG22 HG21 ' A' ' 16' ' ' VAL . 83.9 t -61.04 -69.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 63.219999999999999 111.13 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -22.16 61.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 62.140000000000001 111.079 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' HG2' HG23 ' A' ' 37' ' ' ILE . 23.9 tptt -77.1 -37.48 54.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 72.209999999999994 110.909 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.04 -74.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.349999999999994 110.894 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.31 149.65 7.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.736 -0.745 . . . . 54.530000000000001 112.501 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.02 -58.11 12.55 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.554 0.693 . . . . 73.329999999999998 110.927 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.77 -6.41 18.55 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.669 2.246 . . . . 70.120000000000005 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mm -93.64 -23.29 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 64.349999999999994 111.127 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.743 HG21 HG22 ' A' ' 8' ' ' VAL . 17.0 m -94.37 -28.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 55.119999999999997 111.119 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.84 -35.66 81.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.869 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -73.25 -30.73 63.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 70.030000000000001 110.872 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.535 ' O ' HD12 ' A' ' 23' ' ' ILE . 59.1 m-85 -103.3 22.13 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 72.510000000000005 110.914 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.705 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.42 -26.17 63.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 74.510000000000005 110.958 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -75.59 -6.07 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 73.310000000000002 110.885 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -112.09 -60.84 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 71.549999999999997 110.903 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.6 mt -51.19 -67.98 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.310000000000002 111.124 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -26.51 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.853 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -74.64 -23.27 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 73.230000000000004 110.885 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -87.36 -51.33 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 71.140000000000001 110.843 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -51.29 -29.5 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 60.409999999999997 111.118 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.24 -21.03 38.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.742 . . . . 73.010000000000005 112.465 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -93.35 -68.99 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 75.510000000000005 110.861 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.48 36.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.704 -0.76 . . . . 63.240000000000002 112.468 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -56.64 179.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.754 0.311 . . . . 75.329999999999998 110.966 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -86.05 -169.32 2.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 71.439999999999998 111.09 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -102.13 -21.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 70.030000000000001 111.178 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.572 ' HA ' HD13 ' A' ' 37' ' ' ILE . 65.4 m-80 -116.65 22.09 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 70.519999999999996 110.877 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 12.1 mmtt -94.63 -54.71 3.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 73.299999999999997 110.839 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.991 HD12 HD21 ' A' ' 7' ' ' LEU . 10.3 pt -50.23 -36.04 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 75.510000000000005 111.129 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -65.18 -48.89 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.549999999999997 111.113 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 -24.01 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 61.450000000000003 110.886 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -69.18 -49.94 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.26 -45.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 75.140000000000001 111.115 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -57.74 -29.07 64.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 72.129999999999995 110.855 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.53 23.48 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 63.219999999999999 110.917 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -126.69 -38.84 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.837 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.120000000000005 111.133 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.798 0.332 . . . . 73.430000000000007 111.106 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.59 -21.79 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 53.340000000000003 111.073 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' A' ' 33' ' ' ILE . 17.2 tppt? -67.62 -29.75 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 64.239999999999995 110.912 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.926 HD21 HD12 ' A' ' 36' ' ' ILE . 2.7 mm? -83.75 -27.65 28.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 75.530000000000001 110.885 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.749 HG22 HG21 ' A' ' 16' ' ' VAL . 86.1 t -64.68 -69.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.125 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.71 19.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 53.119999999999997 111.142 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HD3' HG23 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -75.43 -74.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 72.420000000000002 110.918 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.448 ' HB3' HG21 ' A' ' 15' ' ' ILE . 79.0 m-85 -77.85 -74.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.835 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.07 150.89 7.11 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 50.420000000000002 112.462 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.33 11.02 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 75.209999999999994 110.928 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.85 19.58 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 51.219999999999999 112.324 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 11' ' ' PHE . 46.0 mm -94.37 -23.21 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.040000000000006 111.134 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 8' ' ' VAL . 19.8 m -94.12 -27.92 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.430000000000007 111.125 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -32.06 70.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 72.420000000000002 110.895 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.99 -42.29 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 72.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -99.58 27.72 5.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.95 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.85 -1.25 42.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.159 -0.473 . . . . 65.120000000000005 110.904 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 -11.79 22.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.91 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -109.74 -50.65 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 72.530000000000001 110.905 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 40' ' ' ILE . 26.4 mt -51.16 -69.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 63.5 111.122 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -24.72 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 54.420000000000002 110.885 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -75.65 -23.72 56.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 75.530000000000001 110.926 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -87.87 -50.2 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 72.25 110.865 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.4 pt -51.29 -29.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.209999999999994 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.52 -21.95 36.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 62.420000000000002 112.466 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -92.28 -74.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 65.329999999999998 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.0 41.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 52.310000000000002 112.491 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -68.43 -179.8 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.786 0.327 . . . . 64.409999999999997 110.892 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.638 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -102.42 -169.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 52.43 111.076 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.438 HD11 ' HG2' ' A' ' 6' ' ' LYS . 10.7 tp -96.29 -21.93 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.128 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.671 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.8 t30 -99.7 -20.07 16.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.140000000000001 110.875 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.638 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -58.23 -63.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 65.239999999999995 110.865 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.926 HD12 HD21 ' A' ' 7' ' ' LEU . 11.5 pt -51.06 -35.26 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 74.5 111.101 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 34' ' ' ASN . 81.9 mt -60.87 -58.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 61.549999999999997 111.128 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.96 -25.29 67.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.329999999999998 110.861 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -66.88 -55.91 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 71.140000000000001 110.938 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.495 HD11 ' CD1' ' A' ' 23' ' ' ILE . 51.3 mt -63.58 -42.45 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 42.240000000000002 111.126 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -58.35 -38.49 77.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 62.299999999999997 110.909 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -69.07 -46.86 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.897 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -56.95 -61.3 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 75.340000000000003 110.86 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 62.119999999999997 111.139 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.773 HD11 ' HG3' ' A' ' 24' ' ' MET . 27.3 mm . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.856 0.36 . . . . 72.329999999999998 111.125 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.47 -28.95 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 62.130000000000003 111.123 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HE2' HD11 ' A' ' 33' ' ' ILE . 20.1 mmmt -54.98 -40.71 70.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 65.439999999999998 110.894 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.914 HD21 HD12 ' A' ' 36' ' ' ILE . 2.8 mm? -77.6 -28.43 51.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 110.91 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG22 HG21 ' A' ' 16' ' ' VAL . 87.7 t -61.35 -58.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 54.030000000000001 111.139 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.25 65.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 53.350000000000001 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -75.86 -38.98 57.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 73.319999999999993 110.934 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.504 ' HB3' HG21 ' A' ' 15' ' ' ILE . 86.5 m-85 -121.74 -74.63 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 63.340000000000003 110.913 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.98 151.83 8.55 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 64.230000000000004 112.508 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.48 -58.21 11.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 75.450000000000003 110.912 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.56 18.91 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.693 2.262 . . . . 54.109999999999999 112.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.2 mm -93.93 -23.46 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 70.319999999999993 111.134 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.717 HG21 HG22 ' A' ' 8' ' ' VAL . 17.8 m -94.09 -28.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 73.019999999999996 111.134 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -60.29 -29.66 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.030000000000001 110.902 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -76.17 -43.07 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.885 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.5 ' O ' HD12 ' A' ' 23' ' ' ILE . 60.7 m-85 -98.17 26.46 5.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.31 -1.53 41.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 74.219999999999999 110.938 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -98.09 -8.55 27.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 75.349999999999994 110.922 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -113.62 -50.95 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 73.439999999999998 110.902 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.5 HD12 ' O ' ' A' ' 19' ' ' TYR . 16.0 mt -51.32 -69.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 75.400000000000006 111.085 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.773 ' HG3' HD11 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -56.78 -24.57 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 73.299999999999997 110.885 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -76.32 -22.93 54.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 70.010000000000005 110.932 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -87.72 -49.74 6.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 62.409999999999997 110.881 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 pt -51.53 -29.12 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 72.540000000000006 111.206 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.96 39.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 61.350000000000001 112.545 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 -69.0 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 74.209999999999994 110.879 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.33 36.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.69 -0.767 . . . . 33.450000000000003 112.446 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -56.89 179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.310000000000002 110.891 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -87.25 -169.33 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.319999999999993 111.13 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.405 HD11 ' HE2' ' A' ' 6' ' ' LYS . 8.8 tp -100.97 -21.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 50.420000000000002 111.116 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.574 ' HA ' HD13 ' A' ' 37' ' ' ILE . 2.2 m120 -116.21 22.66 12.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.030000000000001 110.886 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 2.7 mmtp -95.41 -55.4 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 75.099999999999994 110.873 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.914 HD12 HD21 ' A' ' 7' ' ' LEU . 10.1 pt -50.19 -36.22 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 35.32 111.157 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -64.54 -55.96 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 111.113 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -64.84 -22.26 66.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -72.31 -53.11 13.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 70.150000000000006 110.963 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.458 HD12 HD12 ' A' ' 7' ' ' LEU . 48.1 mt -58.55 -59.11 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 71.200000000000003 111.159 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -52.16 -34.82 46.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.923 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -65.91 -35.35 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 72.25 110.882 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.36 -61.89 1.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.869 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 111.157 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.776 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 27.5 mm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.851 0.358 . . . . 63.219999999999999 111.136 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.94 53.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 111.118 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.53 -35.85 72.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.439999999999998 110.875 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.025 HD21 HD12 ' A' ' 36' ' ' ILE . 1.6 mm? -84.67 -22.02 29.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 75.200000000000003 110.884 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.715 HG22 HG21 ' A' ' 16' ' ' VAL . 88.8 t -68.19 -69.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 111.09 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.22 -29.48 22.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 75.430000000000007 111.154 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.432 ' HD2' HG23 ' A' ' 37' ' ' ILE . 2.3 tmtt? -76.5 -65.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 71.200000000000003 110.884 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.467 ' HB3' HG21 ' A' ' 15' ' ' ILE . 87.2 m-85 -87.49 -75.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 73.329999999999998 110.872 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.77 152.41 7.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 63.229999999999997 112.477 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.69 -57.9 14.09 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 74.340000000000003 110.927 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.75 -7.12 20.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.684 2.256 . . . . 54.32 112.341 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 11' ' ' PHE . 42.7 mm -94.57 -23.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 72.209999999999994 111.154 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.715 HG21 HG22 ' A' ' 8' ' ' VAL . 24.3 m -93.65 -26.6 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 111.128 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -62.2 -23.38 66.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.140000000000001 110.892 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -81.58 -47.5 12.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 71.209999999999994 110.861 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.83 24.99 5.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 53.210000000000001 110.881 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -65.59 -50.59 64.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 63.229999999999997 110.951 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -50.98 -52.89 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 72.349999999999994 110.893 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -57.03 -58.83 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 71.010000000000005 110.894 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.718 HD11 HD11 ' A' ' 40' ' ' ILE . 35.7 mt -50.75 -59.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 75.540000000000006 111.134 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -28.94 61.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 72.209999999999994 110.854 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -19.9 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 70.120000000000005 110.925 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.13 -48.61 6.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 71.209999999999994 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.47 -23.71 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 60.130000000000003 111.186 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.0 8.77 71.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 43.219999999999999 112.505 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.81 -65.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 55.219999999999999 110.849 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.96 48.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 72.239999999999995 112.491 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -85.94 -177.85 6.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 73.219999999999999 110.893 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -96.27 -168.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 71.239999999999995 111.13 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -100.57 -14.67 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.422 . . . . 61.229999999999997 111.117 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.618 ' HA ' HD13 ' A' ' 37' ' ' ILE . 88.9 m-20 -119.28 19.6 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.902 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 2.2 mmpt? -95.24 -57.05 2.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.239999999999995 110.884 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.025 HD12 HD21 ' A' ' 7' ' ' LEU . 6.3 pt -48.01 -33.53 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.140000000000001 111.146 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.0 mp -67.12 -49.45 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 62.399999999999999 111.105 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.01 -25.81 63.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 110.856 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -69.2 -42.9 75.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 73.510000000000005 110.904 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.718 HD11 HD11 ' A' ' 23' ' ' ILE . 72.2 mt -73.3 -41.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 75.5 111.097 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -56.94 -47.41 80.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.882 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -62.7 -44.51 96.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 70.129999999999995 110.88 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.24 -64.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 72.5 110.823 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.540000000000006 111.142 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.5 mm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.13 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.71 -26.51 34.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 75.230000000000004 111.077 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.94 -34.5 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.040000000000006 110.893 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.988 HD21 HD12 ' A' ' 36' ' ' ILE . 2.4 mm? -87.7 -25.1 23.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 110.935 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.752 HG22 HG21 ' A' ' 16' ' ' VAL . 85.7 t -64.6 -70.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 51.119999999999997 111.131 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.08 -29.83 23.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 63.299999999999997 111.098 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -74.24 -71.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.420000000000002 110.92 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -81.27 -74.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.010000000000005 110.857 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.01 150.13 6.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 75.219999999999999 112.444 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.33 -58.3 11.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.523 0.678 . . . . 64.510000000000005 110.896 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.72 -6.74 19.29 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 2.264 . . . . 73.239999999999995 112.358 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.66 -22.94 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.129999999999995 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.752 HG21 HG22 ' A' ' 8' ' ' VAL . 20.0 m -94.28 -28.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 63.039999999999999 111.105 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -60.85 -30.61 70.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.877 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -75.73 -38.76 58.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 55.520000000000003 110.906 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.2 27.91 6.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 70.109999999999999 110.916 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -82.8 -0.82 49.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 71.340000000000003 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.87 32.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 75.329999999999998 110.902 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -116.01 -47.09 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 110.912 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 40' ' ' ILE . 35.4 mt -51.78 -67.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 73.439999999999998 111.11 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.1 ptm -57.12 -25.67 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.239999999999995 110.904 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.02 -19.46 60.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 74.540000000000006 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -94.5 -51.56 4.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 62.119999999999997 110.861 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.29 -29.49 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 50.119999999999997 111.116 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.77 -21.66 37.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 22.109999999999999 112.491 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -93.05 -74.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 73.409999999999997 110.884 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.79 41.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 53.32 112.476 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -64.77 177.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.737 0.303 . . . . 73.099999999999994 110.946 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 35' ' ' LYS . . . -91.74 -171.55 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 111.122 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -102.73 0.71 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 61.240000000000002 111.101 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.652 ' HA ' HD13 ' A' ' 37' ' ' ILE . 16.5 m120 -129.08 5.82 5.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 65.049999999999997 110.893 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 25.0 mmtp -86.35 -55.08 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 71.329999999999998 110.913 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.988 HD12 HD21 ' A' ' 7' ' ' LEU . 10.3 pt -50.21 -35.94 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.230000000000004 111.143 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.652 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.0 mp -66.12 -62.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 61.229999999999997 111.171 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -57.79 -24.68 58.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 72.209999999999994 110.88 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -67.72 -60.97 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.908 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 23' ' ' ILE . 63.2 mt -51.54 -42.64 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 72.120000000000005 111.128 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -42.38 98.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 62.520000000000003 110.92 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.06 -26.01 67.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 63.130000000000003 110.932 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -80.2 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 110.848 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 111.137 -179.966 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 mm . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.853 0.358 . . . . 63.219999999999999 111.14 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.73 -25.09 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 72.540000000000006 111.089 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -59.64 -33.2 71.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 64.340000000000003 110.841 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -84.85 -25.83 27.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 74.409999999999997 110.934 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.742 HG22 HG21 ' A' ' 16' ' ' VAL . 86.8 t -61.38 -64.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 33.329999999999998 111.123 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.59 -23.96 44.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 71.099999999999994 111.129 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 37' ' ' ILE . 16.3 tptt -77.67 -66.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 75.340000000000003 110.901 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.577 ' HB3' HG21 ' A' ' 15' ' ' ILE . 96.6 m-85 -91.91 -75.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 110.843 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.15 155.19 11.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.699 -0.762 . . . . 73.140000000000001 112.47 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.538 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.77 -57.92 14.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.589 0.709 . . . . 74.200000000000003 110.889 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.78 -6.7 19.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.695 2.263 . . . . 73.120000000000005 112.332 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.577 HG21 ' HB3' ' A' ' 11' ' ' PHE . 42.8 mm -94.75 -23.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 74.25 111.124 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.742 HG21 HG22 ' A' ' 8' ' ' VAL . 21.4 m -93.71 -26.97 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 71.140000000000001 111.142 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.76 -20.75 66.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 75.120000000000005 110.885 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 -49.71 9.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 74.219999999999999 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -94.94 22.09 6.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 74.310000000000002 110.915 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -65.79 -40.67 92.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 70.140000000000001 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -55.48 34.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 54.43 110.906 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -56.77 -55.6 32.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 54.350000000000001 110.908 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 40' ' ' ILE . 40.3 mt -50.52 -62.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 72.299999999999997 111.149 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.6 ttt -56.63 -29.78 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.872 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -72.86 -18.84 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 72.129999999999995 110.933 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.92 -51.79 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.450000000000003 110.886 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -51.31 -29.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 75.129999999999995 111.158 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.15 -21.33 38.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 71.409999999999997 112.478 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -95.29 -75.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 74.329999999999998 110.856 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.07 49.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 32.219999999999999 112.522 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -68.49 -179.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 75.0 110.906 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.629 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -86.97 -169.4 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 111.109 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.63 -21.26 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 75.310000000000002 111.121 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -115.49 17.05 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 75.540000000000006 110.88 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.629 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 33.3 mmtt -89.38 -57.74 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 75.340000000000003 110.918 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.037 HD12 HD21 ' A' ' 7' ' ' LEU . 8.2 pt -49.58 -32.11 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.019999999999996 111.113 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 10' ' ' LYS . 74.9 mt -67.68 -58.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 71.150000000000006 111.112 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.78 -32.26 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 70.019999999999996 110.857 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.43 -47.63 85.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.929 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 23' ' ' ILE . 64.2 mt -69.06 -42.66 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.158 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.49 -25.89 52.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 110.92 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -96.32 31.02 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 54.229999999999997 110.884 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -137.72 -49.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 71.409999999999997 110.815 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 111.126 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.5 mm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.821 0.343 . . . . 72.040000000000006 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.31 -26.18 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 54.43 111.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -61.31 -25.59 67.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 64.129999999999995 110.918 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.844 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -91.41 -22.97 20.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.239999999999995 110.897 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.681 HG22 HG21 ' A' ' 16' ' ' VAL . 93.0 t -65.57 -57.39 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 73.040000000000006 111.106 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.48 -24.07 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 65.530000000000001 111.084 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -78.37 -46.6 19.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 110.912 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.479 ' HB3' HG21 ' A' ' 15' ' ' ILE . 82.8 m-85 -111.86 -74.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 110.896 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.7 151.65 7.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 75.150000000000006 112.435 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.14 -58.37 10.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 63.450000000000003 110.889 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.74 -6.61 19.01 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.691 2.261 . . . . 65.319999999999993 112.354 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 11' ' ' PHE . 45.9 mm -94.8 -22.6 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.420000000000002 111.109 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.681 HG21 HG22 ' A' ' 8' ' ' VAL . 19.7 m -94.73 -27.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 65.310000000000002 111.119 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -62.63 -29.01 70.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 71.540000000000006 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -75.46 -47.21 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 64.310000000000002 110.901 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.87 28.42 3.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 62.149999999999999 110.953 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -74.33 -30.51 62.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 73.030000000000001 110.935 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -70.15 -10.92 60.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 52.130000000000003 110.923 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -108.18 -60.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.91 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mt -49.96 -33.7 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -80.24 -49.9 10.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 65.099999999999994 110.843 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -20.29 57.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 74.439999999999998 110.87 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -83.77 -58.39 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 71.430000000000007 110.884 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.0 pt -50.92 -29.58 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 73.040000000000006 111.176 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.5 -21.72 35.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 71.430000000000007 112.474 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.2 -74.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 74.519999999999996 110.879 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.15 46.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.743 . . . . 53.310000000000002 112.504 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.87 -179.65 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 62.450000000000003 110.962 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.711 ' HB3' ' HG2' ' A' ' 35' ' ' LYS . . . -98.92 -169.27 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 63.109999999999999 111.124 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 tt -98.5 -16.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 111.097 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.551 ' HA ' HD12 ' A' ' 37' ' ' ILE . 12.3 t-20 -105.32 -20.62 13.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 60.32 110.893 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.711 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 21.5 mmtp -58.68 -65.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 71.530000000000001 110.871 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.844 HD12 HD21 ' A' ' 7' ' ' LEU . 6.2 pt -49.01 -32.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 73.400000000000006 111.137 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 34' ' ' ASN . 71.5 mt -65.54 -66.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 62.200000000000003 111.159 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.3 -19.95 57.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 72.329999999999998 110.886 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.4 -50.85 23.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 73.349999999999994 110.937 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mt -60.97 -59.77 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 52.420000000000002 111.116 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -51.61 -30.19 20.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 63.32 110.892 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -65.98 -41.37 91.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.109999999999999 110.882 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -69.52 -62.47 1.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 110.866 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.040000000000006 111.139 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.606 HD11 ' HG3' ' A' ' 24' ' ' MET . 27.1 mm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.819 0.343 . . . . 73.310000000000002 111.112 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.04 -22.23 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 63.310000000000002 111.101 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -38.28 90.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 64.540000000000006 110.925 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 36' ' ' ILE . 3.0 mm? -75.18 -22.3 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 65.540000000000006 110.914 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.697 HG22 HG21 ' A' ' 16' ' ' VAL . 94.3 t -67.71 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 71.140000000000001 111.128 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.09 -24.59 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 34.219999999999999 111.071 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.736 ' HD2' HG23 ' A' ' 37' ' ' ILE . 4.5 tmtt? -79.57 -52.63 7.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 63.539999999999999 110.928 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HB3' HG21 ' A' ' 15' ' ' ILE . 81.3 m-85 -104.26 -74.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.400000000000006 110.898 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.98 151.21 7.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.718 . . . . 42.240000000000002 112.535 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.2 -58.18 11.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.624 0.726 . . . . 75.430000000000007 110.931 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.72 -6.8 19.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.715 2.276 . . . . 44.399999999999999 112.371 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.47 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.8 mm -94.82 -23.09 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.340000000000003 111.15 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -93.99 -27.2 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 71.209999999999994 111.115 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -61.68 -28.27 69.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.310000000000002 110.884 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -77.14 -43.67 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 73.299999999999997 110.87 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.484 ' O ' HD12 ' A' ' 23' ' ' ILE . 63.1 m-85 -96.91 27.05 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 71.409999999999997 110.946 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.86 -1.09 41.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.430000000000007 110.932 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.29 -9.78 24.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 65.239999999999995 110.899 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -112.25 -51.16 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 70.230000000000004 110.889 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.536 ' CD1' HD11 ' A' ' 40' ' ' ILE . 17.8 mt -51.3 -68.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 64.409999999999997 111.167 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.606 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -56.46 -25.66 51.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.129999999999995 110.852 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -75.21 -23.88 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 65.340000000000003 110.874 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -86.86 -50.85 6.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 75.409999999999997 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -51.16 -29.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 64.209999999999994 111.12 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.68 -22.01 38.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.77 -0.729 . . . . 44.130000000000003 112.501 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -93.65 -74.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 72.230000000000004 110.926 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.3 46.81 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.540000000000006 112.451 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -66.9 -179.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 74.519999999999996 110.916 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -87.22 -169.48 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 111.107 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tt -101.65 -21.41 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.299999999999997 111.161 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HA ' HD12 ' A' ' 37' ' ' ILE . 32.6 m120 -114.84 19.25 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.97 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.548 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 12.6 mmtp -91.46 -58.05 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 73.409999999999997 110.9 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 7' ' ' LEU . 10.9 pt -50.7 -31.95 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 64.329999999999998 111.121 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.736 HG23 ' HD2' ' A' ' 10' ' ' LYS . 67.6 mt -65.02 -59.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 70.219999999999999 111.128 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.83 -26.06 68.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 64.219999999999999 110.879 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.01 -53.82 40.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 70.439999999999998 110.883 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.607 HD12 HD12 ' A' ' 7' ' ' LEU . 56.0 mt -64.95 -45.3 95.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 111.127 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -34.29 56.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 74.200000000000003 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -93.81 42.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 62.399999999999999 110.893 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -148.3 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.099999999999994 110.838 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 64.140000000000001 111.119 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.89 52.39 1.95 Allowed Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.191 -0.913 . . . . 73.329999999999998 112.46 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.45 -54.66 3.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 55.409999999999997 111.098 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.778 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 36.3 mm -85.22 -34.81 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 70.400000000000006 111.113 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.53 35.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 54.329999999999998 111.096 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.7 -26.53 68.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 72.230000000000004 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.976 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -91.22 -24.63 19.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.450000000000003 110.935 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.733 HG22 HG21 ' A' ' 16' ' ' VAL . 87.3 t -70.39 -64.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 70.239999999999995 111.136 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.25 -25.74 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 73.5 111.045 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -82.43 -66.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 74.129999999999995 110.902 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' HB3' HG21 ' A' ' 15' ' ' ILE . 90.7 m-85 -85.15 -75.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 71.409999999999997 110.844 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.57 153.74 8.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 72.019999999999996 112.462 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -53.33 -58.11 14.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 72.319999999999993 110.918 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.2 Cg_endo -69.73 -6.98 19.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.695 2.263 . . . . 73.129999999999995 112.343 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.5 mm -94.88 -21.91 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 60.109999999999999 111.176 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.733 HG21 HG22 ' A' ' 8' ' ' VAL . 31.0 m -95.49 -25.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.340000000000003 111.12 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -25.05 66.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 110.896 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -79.88 -30.38 40.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.150000000000006 110.943 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -110.18 25.42 11.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 75.109999999999999 110.92 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.778 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -72.51 -25.18 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 73.329999999999998 110.891 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -76.04 -5.72 47.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 52.039999999999999 110.919 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -115.92 -56.35 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 64.329999999999998 110.888 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 mt -51.18 -69.45 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 61.229999999999997 111.115 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -23.94 50.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 52.119999999999997 110.858 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -77.12 -21.49 54.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 71.310000000000002 110.898 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -89.57 -48.77 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 74.230000000000004 110.866 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.7 pt -51.5 -29.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.097 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -21.26 39.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 65.340000000000003 112.488 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -93.08 -74.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 71.140000000000001 110.889 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.91 44.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 63.420000000000002 112.504 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -69.47 -179.96 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 74.209999999999994 110.915 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.6 -175.83 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 53.340000000000003 111.098 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tt -88.45 -19.85 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 60.539999999999999 111.142 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -101.84 22.02 13.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 71.140000000000001 110.827 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -112.1 -64.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 54.140000000000001 110.916 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.976 HD12 HD21 ' A' ' 7' ' ' LEU . 11.8 pt -50.87 -35.31 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 72.040000000000006 111.149 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.3 -64.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 75.299999999999997 111.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.93 -21.96 61.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 71.230000000000004 110.853 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -71.51 -56.39 6.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 70.230000000000004 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.434 HD12 HD12 ' A' ' 7' ' ' LEU . 51.9 mt -56.22 -58.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 63.100000000000001 111.149 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -35.01 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 110.875 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.58 -36.31 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 75.140000000000001 110.877 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -72.47 -62.51 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 65.239999999999995 110.869 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 pt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.0 111.152 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.39 19.93 10.09 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.132 -0.94 . . . . 34.329999999999998 112.489 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.21 -28.64 13.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.742 0.306 . . . . 72.420000000000002 111.124 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.78 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 37.1 mm -75.47 -33.24 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 73.239999999999995 111.141 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.67 -27.54 28.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 44.450000000000003 111.085 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.45 -32.06 71.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 73.420000000000002 110.929 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.085 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -84.38 -24.71 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.968 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.747 HG22 HG21 ' A' ' 16' ' ' VAL . 84.1 t -69.6 -59.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 75.109999999999999 111.11 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 35.350000000000001 111.09 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.549 ' HG2' HG23 ' A' ' 37' ' ' ILE . 3.3 tppp? -81.11 -46.0 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 64.439999999999998 110.893 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.423 ' HB3' HG21 ' A' ' 15' ' ' ILE . 91.8 m-85 -109.29 -74.83 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.150000000000006 110.862 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.31 150.77 7.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 74.310000000000002 112.476 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.527 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.71 -58.05 12.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 72.120000000000005 110.936 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.9 Cg_endo -69.79 -6.75 19.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 55.210000000000001 112.32 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.1 mm -94.49 -22.68 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 41.100000000000001 111.127 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.747 HG21 HG22 ' A' ' 8' ' ' VAL . 19.5 m -94.72 -27.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 63.130000000000003 111.097 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.85 -25.5 67.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.901 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.83 -30.67 40.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.877 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.588 ' O ' HD12 ' A' ' 23' ' ' ILE . 60.6 m-85 -109.8 28.04 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 52.329999999999998 110.948 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.78 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -77.59 -6.14 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 73.540000000000006 110.922 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -91.36 -11.26 38.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -109.77 -55.94 2.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 61.030000000000001 110.89 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 19' ' ' TYR . 7.2 mt -51.62 -68.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 73.200000000000003 111.11 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 tpt -56.64 -24.94 51.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 64.230000000000004 110.848 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.76 -23.15 52.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 74.049999999999997 110.915 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -86.12 -49.42 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 73.219999999999999 110.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.5 pt -52.07 -28.37 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 71.530000000000001 111.091 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.46 -18.5 44.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.75 . . . . 62.119999999999997 112.532 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -97.7 -74.99 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 72.5 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.34 49.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 71.450000000000003 112.513 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -69.73 -179.76 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.322 . . . . 73.140000000000001 110.922 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -85.75 -169.47 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 71.129999999999995 111.125 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -101.58 -21.45 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.340000000000003 111.172 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.589 ' HA ' HD13 ' A' ' 37' ' ' ILE . 17.8 p30 -116.78 23.22 12.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 73.239999999999995 110.883 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -95.74 -55.37 3.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 63.509999999999998 110.945 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.085 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.76 -35.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 111.109 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.589 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -65.26 -53.46 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 72.530000000000001 111.128 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -66.48 -25.13 66.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 61.119999999999997 110.884 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -65.41 -57.33 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.25 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 23' ' ' ILE . 35.4 mt -60.32 -46.51 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 111.14 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -52.28 -32.25 36.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.878 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -75.55 -46.91 29.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.888 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.25 -62.91 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 73.430000000000007 110.847 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 pt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.129999999999995 111.177 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.82 51.46 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.177 -0.92 . . . . 72.450000000000003 112.448 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.86 -46.92 20.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 73.439999999999998 111.111 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.796 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 29.4 mm -102.04 -30.62 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 72.530000000000001 111.061 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.99 -24.62 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 63.219999999999999 111.154 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.28 -35.55 81.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 65.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.882 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -76.08 -26.2 56.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 74.120000000000005 110.882 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.669 HG22 HG21 ' A' ' 16' ' ' VAL . 98.0 t -68.44 -58.78 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 61.240000000000002 111.16 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.9 -24.96 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 62.439999999999998 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -79.9 -44.47 20.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 64.010000000000005 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 44' ' ' ILE . 77.5 m-85 -111.99 -74.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 71.010000000000005 110.914 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.63 150.79 6.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 74.299999999999997 112.479 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.2 11.47 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.571 0.7 . . . . 61.439999999999998 110.905 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.76 -6.77 19.39 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.655 2.237 . . . . 73.200000000000003 112.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.4 mm -95.02 -22.9 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 74.450000000000003 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.669 HG21 HG22 ' A' ' 8' ' ' VAL . 21.6 m -94.07 -27.25 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 111.119 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -66.32 -25.43 66.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.420000000000002 110.958 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -78.89 -28.35 44.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 63.549999999999997 110.867 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.425 ' O ' HD12 ' A' ' 23' ' ' ILE . 74.4 m-85 -113.66 25.59 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 70.439999999999998 110.908 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.796 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -72.88 -17.39 61.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.914 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -84.5 3.44 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 73.530000000000001 110.903 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -126.01 -56.34 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 110.938 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 19' ' ' TYR . 8.9 mt -51.2 -68.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.54 ' HG3' HD11 ' A' ' 4' ' ' ILE . 5.8 ttp -57.41 -23.56 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 64.319999999999993 110.867 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -78.27 -20.68 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 73.25 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.73 -49.23 6.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 54.200000000000003 110.893 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -51.17 -29.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 72.530000000000001 111.123 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.42 -22.06 36.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 64.319999999999993 112.542 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.72 -68.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 75.400000000000006 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.42 35.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 70.329999999999998 112.484 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -57.77 -179.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.804 0.335 . . . . 64.5 110.897 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -98.15 -169.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 71.209999999999994 111.057 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 tt -98.62 -10.01 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.019999999999996 111.124 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.45 ' HA ' HD12 ' A' ' 37' ' ' ILE . 1.1 p-10 -111.09 -24.77 10.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 73.030000000000001 110.865 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -54.83 -63.24 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 71.120000000000005 110.907 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.882 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.51 -35.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.010000000000005 111.159 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 34' ' ' ASN . 68.5 mt -64.49 -60.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 72.430000000000007 111.112 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.69 -17.91 63.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 70.329999999999998 110.868 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -76.28 -58.62 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 74.019999999999996 110.905 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 7' ' ' LEU . 40.0 mt -54.09 -55.0 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 75.510000000000005 111.167 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -34.53 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 61.350000000000001 110.931 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -53.2 -46.19 68.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.200000000000003 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.56 -72.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 70.239999999999995 110.904 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.434 HD11 ' CE1' ' A' ' 11' ' ' PHE . 33.0 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.340000000000003 111.157 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.51 92.25 0.22 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.207 -0.906 . . . . 64.549999999999997 112.454 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.81 -53.2 2.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 63.409999999999997 111.095 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 mm -100.76 -32.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 71.049999999999997 111.133 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.48 -25.4 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 72.219999999999999 111.07 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -58.27 -37.91 75.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.109999999999999 110.923 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.083 HD21 HD12 ' A' ' 36' ' ' ILE . 2.7 mm? -80.3 -23.11 40.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 52.439999999999998 110.952 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.74 HG22 HG21 ' A' ' 16' ' ' VAL . 84.3 t -66.86 -67.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 73.530000000000001 111.148 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.96 -27.22 29.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 111.108 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -78.5 -70.0 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 110.895 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.432 ' HB3' HG21 ' A' ' 15' ' ' ILE . 72.9 m-85 -82.61 -74.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 74.319999999999993 110.837 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.67 150.84 7.01 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 75.209999999999994 112.498 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.17 -58.27 11.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.587 0.708 . . . . 71.219999999999999 110.89 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.74 -6.92 19.74 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 63.25 112.325 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' A' ' 11' ' ' PHE . 43.4 mm -94.87 -22.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 111.086 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.74 HG21 HG22 ' A' ' 8' ' ' VAL . 22.2 m -94.5 -27.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 71.430000000000007 111.148 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -61.6 -25.44 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.420000000000002 110.914 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -81.36 -42.23 20.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 110.896 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -100.77 27.32 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 62.049999999999997 110.894 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.13 -34.57 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 62.43 110.905 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -71.9 -9.04 57.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 60.210000000000001 110.922 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -103.64 -52.38 3.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 70.510000000000005 110.92 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 40' ' ' ILE . 18.0 mt -54.5 -65.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 62.439999999999998 111.113 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.6 ttt -56.74 -25.81 55.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.884 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -73.71 -20.75 60.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 110.94 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.67 -51.53 5.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 54.119999999999997 110.871 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.85 -29.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 64.439999999999998 111.172 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.39 -23.58 34.91 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.209999999999994 112.49 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 -75.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 62.409999999999997 110.875 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.44 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 61.100000000000001 112.512 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.04 -179.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 75.329999999999998 110.955 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -89.54 -169.35 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 32.109999999999999 111.099 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 tt -102.86 -13.31 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 65.510000000000005 111.107 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.582 ' HA ' HD13 ' A' ' 37' ' ' ILE . 21.5 m-80 -122.42 20.46 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 62.329999999999998 110.893 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -95.36 -54.36 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 70.140000000000001 110.899 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.083 HD12 HD21 ' A' ' 7' ' ' LEU . 10.0 pt -50.11 -35.73 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.150000000000006 111.169 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -64.82 -56.66 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.010000000000005 111.146 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.92 -25.53 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 70.420000000000002 110.867 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -66.44 -48.72 69.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 70.519999999999996 110.912 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 23' ' ' ILE . 46.0 mt -68.99 -36.35 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.209999999999994 111.141 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -38.91 92.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 53.310000000000002 110.908 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -73.87 -26.9 60.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 72.040000000000006 110.939 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.5 -61.84 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 110.859 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 72.340000000000003 111.09 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.17 32.52 0.95 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.171 -0.922 . . . . 71.299999999999997 112.459 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -122.02 -39.57 2.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.318 . . . . 75.430000000000007 111.121 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.78 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 31.2 mm -80.67 -29.85 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.450000000000003 111.113 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.05 -24.72 41.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 54.130000000000003 111.115 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.99 -41.92 84.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.895 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.032 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -76.2 -24.58 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 70.329999999999998 110.925 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.751 HG22 HG21 ' A' ' 16' ' ' VAL . 87.4 t -65.71 -43.54 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 65.230000000000004 111.129 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.41 37.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.150000000000006 111.11 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.713 ' HG2' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -81.34 -30.29 33.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.540000000000006 110.87 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.7 m-85 -126.29 -75.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 53.43 110.872 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.88 151.98 7.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 55.439999999999998 112.5 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.7 -58.17 11.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.53 0.681 . . . . 74.349999999999994 110.908 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.76 -6.62 19.03 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 65.319999999999993 112.335 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.5 mm -95.06 -22.7 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 72.420000000000002 111.145 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.751 HG21 HG22 ' A' ' 8' ' ' VAL . 21.3 m -94.3 -27.18 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 72.319999999999993 111.119 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.48 -29.73 70.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 71.200000000000003 110.909 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -75.53 -32.82 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 70.150000000000006 110.921 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.54 ' O ' HD12 ' A' ' 23' ' ' ILE . 80.0 m-85 -104.87 24.76 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.299999999999997 110.904 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.78 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -76.31 -11.44 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.503 . . . . 52.420000000000002 110.951 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -90.89 13.55 16.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 54.530000000000001 110.931 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -139.3 -51.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 55.539999999999999 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 19' ' ' TYR . 9.9 mt -54.68 -65.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 61.329999999999998 111.136 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.409 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -58.7 -21.33 54.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 71.299999999999997 110.908 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -82.11 -21.99 36.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 62.109999999999999 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -86.96 -43.55 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 63.32 110.883 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -55.57 -25.5 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 73.319999999999993 111.099 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.07 -6.93 69.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.783 -0.722 . . . . 61.520000000000003 112.505 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.0 -71.48 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 62.020000000000003 110.908 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.87 49.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 74.319999999999993 112.473 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -82.52 -178.24 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 71.400000000000006 110.944 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.57 -175.6 2.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 63.310000000000002 111.116 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.545 HG23 ' OD1' ' A' ' 34' ' ' ASN . 10.7 tp -86.38 -21.05 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.310000000000002 111.143 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 33' ' ' ILE . 26.6 m-20 -99.28 20.02 14.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.420000000000002 110.871 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -110.28 -68.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.510000000000005 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.032 HD12 HD21 ' A' ' 7' ' ' LEU . 9.8 pt -49.84 -31.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 72.439999999999998 111.152 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.713 HD12 ' HG2' ' A' ' 10' ' ' LYS . 44.3 mm -61.38 -67.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 43.439999999999998 111.113 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -61.38 -31.02 70.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.030000000000001 110.833 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -55.56 -37.69 68.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.891 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 44' ' ' ILE . 44.9 mt -86.43 -37.63 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 75.319999999999993 111.081 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -61.02 -28.75 69.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 65.319999999999993 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -89.37 -26.73 20.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.299999999999997 110.888 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.22 -26.53 52.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.109999999999999 110.846 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 40' ' ' ILE . 26.4 pt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 63.509999999999998 111.107 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.01 -47.32 0.41 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.143 -0.935 . . . . 73.420000000000002 112.486 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.84 -41.28 26.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 60.210000000000001 111.114 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.772 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 27.2 mm -77.01 -33.78 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.230000000000004 111.112 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.11 -24.86 43.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 54.43 111.147 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -35.08 70.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.319999999999993 110.92 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.022 HD21 HD12 ' A' ' 36' ' ' ILE . 1.8 mm? -84.53 -25.57 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 70.340000000000003 110.95 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.714 HG22 HG21 ' A' ' 16' ' ' VAL . 94.7 t -69.53 -35.31 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 64.120000000000005 111.15 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.01 17.14 11.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 45.329999999999998 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -130.49 -39.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 63.219999999999999 110.902 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -112.39 -75.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.129999999999995 110.931 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 149.09 5.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 23.440000000000001 112.5 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -50.79 -58.01 11.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.598 0.713 . . . . 74.200000000000003 110.922 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.82 -5.29 15.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 73.239999999999995 112.355 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.21 -22.28 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 75.400000000000006 111.139 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.714 HG21 HG22 ' A' ' 8' ' ' VAL . 27.1 m -92.99 -29.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 111.091 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -26.22 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 52.520000000000003 110.895 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -73.4 -21.12 60.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.0 110.88 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.91 21.51 11.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 73.209999999999994 110.909 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.86 -28.25 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 75.109999999999999 110.897 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.9 -9.35 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 63.140000000000001 110.936 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -109.02 -60.76 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.917 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 HD11 ' A' ' 40' ' ' ILE . 5.5 mt -51.37 -65.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 74.019999999999996 111.099 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 44.0 ttp -56.42 -28.48 59.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 72.430000000000007 110.859 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -75.22 -21.57 58.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 54.130000000000003 110.959 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -87.76 -50.35 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 61.020000000000003 110.908 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -51.95 -28.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 63.020000000000003 111.168 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -18.73 41.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 73.439999999999998 112.473 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -94.91 -69.18 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 75.230000000000004 110.906 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.66 36.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.757 . . . . 44.399999999999999 112.463 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -57.04 -179.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.793 0.33 . . . . 71.349999999999994 110.889 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -87.19 -169.33 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 64.409999999999997 111.107 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -101.54 -21.7 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 73.230000000000004 111.092 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.51 ' HA ' HD12 ' A' ' 37' ' ' ILE . 70.4 m-80 -114.82 21.04 14.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 61.030000000000001 110.901 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -93.5 -58.02 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.879 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.022 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.37 -31.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 74.549999999999997 111.138 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 34' ' ' ASN . 67.8 mt -63.71 -62.89 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 53.020000000000003 111.146 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -28.9 69.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 53.409999999999997 110.849 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -58.48 -53.79 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 72.030000000000001 110.951 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.442 HD11 HD11 ' A' ' 23' ' ' ILE . 22.8 mt -69.04 -40.08 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.209999999999994 111.14 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -52.01 -67.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 51.109999999999999 110.873 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -28.27 57.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 75.239999999999995 110.903 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -68.81 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 72.5 110.83 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.428 . . . . 75.209999999999994 111.132 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.18 72.47 1.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.155 -0.929 . . . . 53.539999999999999 112.486 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.54 -40.15 6.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.761 0.315 . . . . 52.119999999999997 111.121 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.786 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 30.1 mm -79.79 -34.84 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 111.145 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.5 -24.32 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 63.43 111.083 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -63.03 -25.03 68.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 110.883 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.06 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -92.02 -25.35 18.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 64.329999999999998 110.918 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 16' ' ' VAL . 91.7 t -67.3 -68.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 73.329999999999998 111.125 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.59 -28.73 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.25 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' HD2' HG23 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -76.47 -61.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 64.319999999999993 110.903 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.471 ' HB3' HG21 ' A' ' 15' ' ' ILE . 97.0 m-85 -93.45 -74.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 71.340000000000003 110.907 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.92 151.64 7.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 53.130000000000003 112.508 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.528 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.44 -58.2 11.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 75.140000000000001 110.952 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.59 18.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 63.509999999999998 112.364 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.4 mm -94.93 -22.44 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 64.439999999999998 111.114 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -94.81 -27.16 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 54.049999999999997 111.157 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -65.96 -25.42 67.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.450000000000003 110.872 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -25.74 39.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 62.509999999999998 110.924 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.578 ' O ' HD12 ' A' ' 23' ' ' ILE . 78.4 m-85 -114.49 24.94 11.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 73.230000000000004 110.913 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.786 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.18 -27.84 64.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 73.400000000000006 110.945 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -7.84 53.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 72.129999999999995 110.863 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -109.98 -60.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 73.099999999999994 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.3 mt -52.74 -65.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 111.143 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -56.64 -25.79 54.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 71.439999999999998 110.881 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.68 -22.27 50.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 54.310000000000002 110.895 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -85.34 -47.95 9.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.420000000000002 110.912 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.8 pt -53.32 -27.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 71.120000000000005 111.171 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.56 -14.68 55.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 75.439999999999998 112.454 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.54 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 73.129999999999995 110.864 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.88 48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 54.530000000000001 112.481 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -72.82 -179.23 3.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.765 0.317 . . . . 75.450000000000003 110.92 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -88.92 -169.55 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 64.129999999999995 111.058 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tt -101.54 -11.11 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.209999999999994 111.096 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.61 ' HA ' HD13 ' A' ' 37' ' ' ILE . 5.7 m120 -122.96 4.29 9.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 75.430000000000007 110.85 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 6.3 mmtm -78.6 -56.72 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.93 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.06 HD12 HD21 ' A' ' 7' ' ' LEU . 8.5 pt -49.42 -37.48 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 111.089 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.5 mp -65.37 -44.37 94.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 111.125 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -74.48 -20.84 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 72.420000000000002 110.891 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -71.24 -53.88 12.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 63.020000000000003 110.891 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.554 HD11 ' CD1' ' A' ' 23' ' ' ILE . 36.7 mt -62.4 -47.87 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 55.43 111.139 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -43.39 63.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.912 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -68.23 -39.58 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 71.209999999999994 110.924 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -64.75 -62.04 1.82 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.340000000000003 110.86 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 74.439999999999998 111.081 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.71 25.0 12.29 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.186 -0.916 . . . . 52.420000000000002 112.431 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.81 -52.13 3.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.823 0.344 . . . . 63.450000000000003 111.111 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.74 -33.37 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 53.310000000000002 111.127 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -21.15 58.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 45.140000000000001 111.114 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -64.52 -29.64 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 61.5 110.889 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.99 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -87.1 -25.08 24.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 61.299999999999997 110.931 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.718 HG22 HG21 ' A' ' 16' ' ' VAL . 87.8 t -68.61 -32.42 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 72.549999999999997 111.176 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.88 17.18 10.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 61.539999999999999 111.093 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.539 ' HG2' HG23 ' A' ' 37' ' ' ILE . 11.3 tppt? -129.36 -45.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.319999999999993 110.909 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.476 ' HB3' HG21 ' A' ' 15' ' ' ILE . 94.4 m-85 -107.77 -75.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 64.109999999999999 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.65 152.8 8.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.801 -0.714 . . . . 50.140000000000001 112.537 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.07 -58.14 12.46 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 75.430000000000007 110.957 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.78 -7.13 20.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 63.219999999999999 112.327 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 11' ' ' PHE . 43.3 mm -95.28 -22.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 61.130000000000003 111.166 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.718 HG21 HG22 ' A' ' 8' ' ' VAL . 29.1 m -93.6 -26.22 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.239999999999995 111.144 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -65.37 -24.57 67.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.25 110.912 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -78.16 -47.97 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 74.430000000000007 110.9 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.26 22.22 8.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.931 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.53 -41.07 93.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 75.299999999999997 110.936 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.9 -56.47 21.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 64.329999999999998 110.854 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -56.24 -55.65 30.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 40' ' ' ILE . 41.9 mt -50.97 -62.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 111.111 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -29.15 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 60.420000000000002 110.871 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -72.77 -23.63 60.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 73.319999999999993 110.905 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -86.8 -52.52 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 73.430000000000007 110.878 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.31 -29.84 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 75.409999999999997 111.059 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.5 38.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 52.240000000000002 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.0 -74.96 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 71.150000000000006 110.856 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.83 47.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 75.049999999999997 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -67.02 -179.65 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.782 0.325 . . . . 75.510000000000005 110.883 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -90.33 -169.45 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 61.240000000000002 111.091 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.39 -10.04 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.530000000000001 111.127 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.639 ' HA ' HD13 ' A' ' 37' ' ' ILE . 21.0 p30 -124.09 19.65 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 63.130000000000003 110.901 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 10.4 mmtp -96.13 -56.17 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.150000000000006 110.893 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.99 HD12 HD21 ' A' ' 7' ' ' LEU . 9.4 pt -50.05 -31.29 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 71.230000000000004 111.145 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.639 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.1 mp -69.24 -50.74 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 55.340000000000003 111.126 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -69.53 -26.03 64.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 65.519999999999996 110.831 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -68.31 -44.08 76.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 71.450000000000003 110.955 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 23' ' ' ILE . 51.3 mt -72.72 -45.2 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 65.299999999999997 111.129 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -55.95 -38.65 70.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 64.019999999999996 110.935 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -72.95 -26.28 61.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 72.299999999999997 110.916 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -77.86 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 72.030000000000001 110.865 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 111.082 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.8 33.35 6.57 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.166 -0.924 . . . . 73.200000000000003 112.482 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.08 -27.65 10.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 75.310000000000002 111.084 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.792 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 33.4 mm -102.66 -32.33 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 61.409999999999997 111.107 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.57 67.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 65.329999999999998 111.067 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HG3' HD22 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -51.59 -37.62 50.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 72.530000000000001 110.907 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.095 HD21 HD12 ' A' ' 36' ' ' ILE . 3.6 mm? -69.27 -34.16 74.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 70.299999999999997 110.939 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 16' ' ' VAL . 66.5 t -61.39 -66.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 70.420000000000002 111.184 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.3 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.051 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -77.29 -41.72 39.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -118.84 -75.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 75.530000000000001 110.882 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.1 149.11 6.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 53.020000000000003 112.496 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.67 -58.22 11.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.519 0.676 . . . . 64.439999999999998 110.918 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.67 -6.94 19.76 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.248 . . . . 73.140000000000001 112.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.31 -23.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.519999999999996 111.132 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.661 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -93.63 -27.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 111.161 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -66.23 -28.2 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 73.340000000000003 110.902 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.45 -24.57 53.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 71.530000000000001 110.898 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.515 ' O ' HD12 ' A' ' 23' ' ' ILE . 78.4 m-85 -117.59 25.4 10.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 74.319999999999993 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.792 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.07 -24.6 63.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 65.510000000000005 110.918 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -77.91 -3.82 43.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 62.420000000000002 110.914 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -114.27 -58.83 2.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 75.049999999999997 110.841 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.7 mt -51.4 -69.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 72.439999999999998 111.113 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -23.79 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 71.409999999999997 110.868 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.7 tp60 -77.01 -21.82 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 110.916 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -89.65 -48.43 7.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.875 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.7 pt -51.95 -28.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 55.340000000000003 111.132 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.39 -18.41 43.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 74.25 112.478 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -97.7 -75.03 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 64.150000000000006 110.874 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.85 48.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.753 . . . . 61.5 112.48 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -68.05 -179.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 73.140000000000001 110.885 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.21 -169.34 2.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 62.43 111.078 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -103.33 -7.94 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 75.400000000000006 111.18 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -118.63 14.63 13.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -95.81 -61.01 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.937 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.095 HD12 HD21 ' A' ' 7' ' ' LEU . 10.4 pt -50.04 -30.82 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 72.510000000000005 111.169 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -67.26 -72.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 71.439999999999998 111.144 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.25 -35.06 59.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 65.150000000000006 110.878 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -52.68 -45.9 67.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.510000000000005 110.912 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 7' ' ' LEU . 42.9 mt -77.37 -47.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 72.150000000000006 111.09 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -52.81 -32.54 44.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.89 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -79.41 -43.59 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 64.519999999999996 110.865 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.25 -63.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.239999999999995 110.864 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 64.209999999999994 111.148 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.81 46.53 17.3 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.183 -0.917 . . . . 75.019999999999996 112.454 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.05 -45.41 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.71 0.291 . . . . 53.299999999999997 111.058 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.77 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 30.9 mm -77.34 -34.19 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 75.230000000000004 111.118 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.46 47.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.030000000000001 111.071 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -61.3 -33.47 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.921 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.015 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -83.94 -21.23 31.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 64.230000000000004 110.923 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.722 HG22 HG21 ' A' ' 16' ' ' VAL . 89.2 t -68.28 -64.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.510000000000005 111.122 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.71 -24.95 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 61.310000000000002 111.086 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 37' ' ' ILE . 3.5 tmtm? -79.81 -58.29 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 54.509999999999998 110.891 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.505 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.3 m-85 -96.95 -75.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 70.109999999999999 110.892 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.85 151.78 7.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 32.299999999999997 112.479 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.53 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.58 -58.09 12.16 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.599 0.714 . . . . 72.25 110.933 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.83 19.54 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.692 2.262 . . . . 63.240000000000002 112.333 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 11' ' ' PHE . 41.8 mm -94.6 -23.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.049999999999997 111.085 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.722 HG21 HG22 ' A' ' 8' ' ' VAL . 20.8 m -93.81 -27.36 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 44.149999999999999 111.124 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -62.61 -29.21 70.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.219999999999999 110.904 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -75.62 -36.36 60.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 74.349999999999994 110.913 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.07 26.21 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 110.933 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -79.45 -6.76 57.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 62.0 110.93 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -94.97 16.58 15.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 73.120000000000005 110.886 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -145.01 -50.17 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 62.039999999999999 110.943 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' A' ' 40' ' ' ILE . 37.7 mt -51.56 -67.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 71.439999999999998 111.133 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -57.51 -23.64 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 72.049999999999997 110.892 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.12 -19.55 50.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 71.120000000000005 110.905 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.35 -46.19 8.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 75.040000000000006 110.888 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.42 -23.46 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 65.340000000000003 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.28 9.46 70.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 72.329999999999998 112.454 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.37 -63.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 42.229999999999997 110.931 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.06 46.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 54.43 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -85.0 -178.66 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 75.239999999999995 110.945 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.33 -169.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 64.299999999999997 111.107 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.427 HG23 ' OD1' ' A' ' 34' ' ' ASN . 14.6 tt -101.19 -10.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.540000000000006 111.12 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HA ' HD12 ' A' ' 37' ' ' ILE . 4.0 m-20 -121.72 19.5 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.872 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -95.36 -58.34 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 73.329999999999998 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.015 HD12 HD21 ' A' ' 7' ' ' LEU . 9.0 pt -49.48 -33.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.453 . . . . 73.329999999999998 111.117 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 34' ' ' ASN . 75.7 mt -60.58 -60.97 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 111.15 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -26.48 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 53.049999999999997 110.85 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -65.46 -30.03 70.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.510000000000005 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.405 HD11 ' CD1' ' A' ' 23' ' ' ILE . 55.3 mt -93.26 -30.98 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 72.299999999999997 111.084 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -38.78 78.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 72.140000000000001 110.909 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -70.21 -41.42 73.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 64.109999999999999 110.93 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.69 -64.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 73.400000000000006 110.859 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.510000000000005 111.134 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.73 56.9 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.135 -0.939 . . . . 64.439999999999998 112.488 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.02 -46.44 3.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 72.310000000000002 111.117 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.794 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 34.1 mm -75.65 -32.1 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 111.127 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -25.31 36.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 65.129999999999995 111.143 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HD2' HD11 ' A' ' 33' ' ' ILE . 7.5 mmpt? -62.69 -32.67 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.889 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.022 HD21 HD12 ' A' ' 36' ' ' ILE . 2.3 mm? -82.67 -23.93 33.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 71.310000000000002 110.947 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.72 HG22 HG21 ' A' ' 16' ' ' VAL . 89.2 t -69.98 -56.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 53.399999999999999 111.153 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -26.17 66.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 111.094 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -79.97 -45.12 19.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 72.109999999999999 110.894 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.441 ' HB3' HG21 ' A' ' 15' ' ' ILE . 89.7 m-85 -109.43 -74.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 73.409999999999997 110.87 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 150.9 6.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 60.399999999999999 112.492 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.26 11.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.572 0.701 . . . . 74.409999999999997 110.908 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.74 -6.59 18.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 63.229999999999997 112.36 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' A' ' 11' ' ' PHE . 48.8 mm -95.13 -22.55 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 71.230000000000004 111.138 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.72 HG21 HG22 ' A' ' 8' ' ' VAL . 20.8 m -94.5 -27.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 75.450000000000003 111.113 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -64.44 -25.32 67.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 65.239999999999995 110.901 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -80.06 -32.48 39.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.884 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.552 ' O ' HD12 ' A' ' 23' ' ' ILE . 85.0 m-85 -106.52 24.44 12.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 50.340000000000003 110.902 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.794 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -75.82 -11.72 60.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 73.409999999999997 110.898 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -89.29 10.26 22.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 75.25 110.931 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -135.95 -54.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 73.329999999999998 110.897 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 19' ' ' TYR . 8.6 mt -51.51 -68.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.108 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.417 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -57.47 -23.78 51.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.239999999999995 110.859 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -78.18 -20.37 52.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 53.140000000000001 110.915 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -89.7 -47.5 7.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.897 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.2 -27.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 75.019999999999996 111.135 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.32 -21.97 35.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 62.109999999999999 112.502 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -93.45 -74.93 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 73.519999999999996 110.892 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.65 43.86 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 74.340000000000003 112.5 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -71.17 161.07 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.801 0.334 . . . . 74.140000000000001 110.924 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -84.86 -169.05 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 111.113 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.406 HD11 ' HD2' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -101.04 -0.07 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 54.229999999999997 111.136 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -115.84 -25.88 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 53.32 110.893 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 10.7 mttm -57.48 -62.8 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.040000000000006 110.913 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.022 HD12 HD21 ' A' ' 7' ' ' LEU . 11.5 pt -50.38 -35.37 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 64.340000000000003 111.111 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.88 -50.11 76.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.176 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.19 -3.79 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.549999999999997 110.868 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -90.43 -42.0 11.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 74.340000000000003 110.943 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 7' ' ' LEU . 28.3 mt -72.29 -52.62 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 63.450000000000003 111.146 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -52.74 -30.59 33.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 52.530000000000001 110.87 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -67.25 -41.25 85.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 63.43 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -70.38 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.310000000000002 110.868 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 pt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 111.105 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.1 38.16 40.96 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.183 -0.917 . . . . 40.329999999999998 112.458 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.77 -54.17 49.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.312 . . . . 61.520000000000003 111.076 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.4 mm -90.67 -32.42 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.549999999999997 111.141 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.25 -20.95 58.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 60.439999999999998 111.059 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.651 ' NZ ' HD11 ' A' ' 37' ' ' ILE . 21.1 tptm -68.25 -34.88 77.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 72.329999999999998 110.883 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.087 HD21 HD12 ' A' ' 36' ' ' ILE . 2.8 mm? -77.93 -22.73 49.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 74.299999999999997 110.903 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.747 HG22 HG21 ' A' ' 16' ' ' VAL . 88.6 t -68.59 -66.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 71.200000000000003 111.154 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.1 48.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 54.200000000000003 111.093 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.752 ' HE3' HD13 ' A' ' 37' ' ' ILE . 3.8 mttm -80.36 -56.74 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.902 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.435 ' HB3' HG21 ' A' ' 15' ' ' ILE . 87.2 m-85 -98.47 -74.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 110.898 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.93 150.78 7.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 72.420000000000002 112.492 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.34 -58.32 11.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.568 0.699 . . . . 74.299999999999997 110.908 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.73 -6.65 19.09 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.687 2.258 . . . . 75.420000000000002 112.332 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' A' ' 11' ' ' PHE . 48.9 mm -94.58 -22.54 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.310000000000002 111.124 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.747 HG21 HG22 ' A' ' 8' ' ' VAL . 19.3 m -94.95 -27.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 73.25 111.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.74 -25.07 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.329999999999998 110.922 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -80.16 -40.69 26.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 60.329999999999998 110.865 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -103.75 26.49 8.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 65.209999999999994 110.918 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.56 -35.01 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 72.319999999999993 110.953 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -71.86 -9.33 58.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 71.099999999999994 110.9 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.37 -51.8 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.209999999999994 110.951 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.55 HD11 HD11 ' A' ' 40' ' ' ILE . 13.5 mt -56.44 -63.61 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.099999999999994 111.151 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ttt -57.17 -26.06 59.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 74.230000000000004 110.903 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.51 -18.64 60.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.239999999999995 110.871 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -91.9 -50.68 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 64.530000000000001 110.868 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.8 pt -51.09 -28.9 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 72.129999999999995 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.13 -23.57 32.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 73.230000000000004 112.51 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -92.06 -74.88 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 62.130000000000003 110.896 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.19 44.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 52.210000000000001 112.489 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.62 -179.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.78 0.324 . . . . 75.140000000000001 110.946 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -102.07 -169.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 65.200000000000003 111.134 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 tt -99.14 -10.03 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.239999999999995 111.146 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.463 ' HA ' HD12 ' A' ' 37' ' ' ILE . 41.7 m-20 -111.04 -20.28 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.329999999999998 110.897 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 5.3 mmtp -61.52 -59.2 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.049999999999997 110.921 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.087 HD12 HD21 ' A' ' 7' ' ' LEU . 10.4 pt -50.36 -31.35 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 73.329999999999998 111.182 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.752 HD13 ' HE3' ' A' ' 10' ' ' LYS . 74.0 mt -66.82 -60.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 64.450000000000003 111.134 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.39 -25.06 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.409999999999997 110.852 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -67.21 -57.22 7.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.915 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 7' ' ' LEU . 42.7 mt -62.7 -36.93 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 53.210000000000001 111.124 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -61.75 -61.36 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.540000000000006 110.924 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -52.7 -29.41 26.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.010000000000005 110.897 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -72.07 -68.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 71.040000000000006 110.859 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.150000000000006 111.129 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.73 58.39 0.48 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.131 -0.941 . . . . 43.140000000000001 112.453 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.41 -64.1 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 73.409999999999997 111.097 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.705 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 26.7 mm -75.22 -32.16 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 70.120000000000005 111.126 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.19 -19.95 56.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.114 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -67.62 -30.54 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.904 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.991 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -84.25 -26.06 28.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.933 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.743 HG22 HG21 ' A' ' 16' ' ' VAL . 83.9 t -61.04 -69.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 63.219999999999999 111.13 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -22.16 61.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 62.140000000000001 111.079 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' HG2' HG23 ' A' ' 37' ' ' ILE . 23.9 tptt -77.1 -37.48 54.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 72.209999999999994 110.909 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.04 -74.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.349999999999994 110.894 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.31 149.65 7.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.736 -0.745 . . . . 54.530000000000001 112.501 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.02 -58.11 12.55 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.554 0.693 . . . . 73.329999999999998 110.927 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.77 -6.41 18.55 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.669 2.246 . . . . 70.120000000000005 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mm -93.64 -23.29 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 64.349999999999994 111.127 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.743 HG21 HG22 ' A' ' 8' ' ' VAL . 17.0 m -94.37 -28.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 55.119999999999997 111.119 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.84 -35.66 81.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.430000000000007 110.869 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -73.25 -30.73 63.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 70.030000000000001 110.872 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.535 ' O ' HD12 ' A' ' 23' ' ' ILE . 59.1 m-85 -103.3 22.13 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 72.510000000000005 110.914 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.705 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.42 -26.17 63.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 74.510000000000005 110.958 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -75.59 -6.07 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 73.310000000000002 110.885 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -112.09 -60.84 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 71.549999999999997 110.903 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.6 mt -51.19 -67.98 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.310000000000002 111.124 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -26.51 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.853 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.9 tp60 -74.64 -23.27 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 73.230000000000004 110.885 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -87.36 -51.33 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 71.140000000000001 110.843 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -51.29 -29.5 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 60.409999999999997 111.118 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.24 -21.03 38.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.742 . . . . 73.010000000000005 112.465 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -93.35 -68.99 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 75.510000000000005 110.861 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.48 36.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.704 -0.76 . . . . 63.240000000000002 112.468 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -56.64 179.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.754 0.311 . . . . 75.329999999999998 110.966 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -86.05 -169.32 2.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 71.439999999999998 111.09 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -102.13 -21.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 70.030000000000001 111.178 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.572 ' HA ' HD13 ' A' ' 37' ' ' ILE . 65.4 m-80 -116.65 22.09 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 70.519999999999996 110.877 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 12.1 mmtt -94.63 -54.71 3.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 73.299999999999997 110.839 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.991 HD12 HD21 ' A' ' 7' ' ' LEU . 10.3 pt -50.23 -36.04 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 75.510000000000005 111.129 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -65.18 -48.89 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.549999999999997 111.113 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 -24.01 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 61.450000000000003 110.886 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -69.18 -49.94 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.26 -45.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 75.140000000000001 111.115 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -57.74 -29.07 64.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 72.129999999999995 110.855 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.53 23.48 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 63.219999999999999 110.917 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -126.69 -38.84 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 110.837 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.120000000000005 111.133 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.96 72.98 0.76 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.198 -0.91 . . . . 64.209999999999994 112.511 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.26 -75.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.752 0.31 . . . . 72.0 111.133 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm -82.61 -34.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 73.430000000000007 111.106 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.59 -21.79 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 53.340000000000003 111.073 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' A' ' 33' ' ' ILE . 17.2 tppt? -67.62 -29.75 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 64.239999999999995 110.912 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.926 HD21 HD12 ' A' ' 36' ' ' ILE . 2.7 mm? -83.75 -27.65 28.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 75.530000000000001 110.885 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.749 HG22 HG21 ' A' ' 16' ' ' VAL . 86.1 t -64.68 -69.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 111.125 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.71 19.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 53.119999999999997 111.142 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HD3' HG23 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -75.43 -74.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 72.420000000000002 110.918 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.448 ' HB3' HG21 ' A' ' 15' ' ' ILE . 79.0 m-85 -77.85 -74.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.835 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.07 150.89 7.11 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 50.420000000000002 112.462 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.33 11.02 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 75.209999999999994 110.928 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.85 19.58 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 51.219999999999999 112.324 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 11' ' ' PHE . 46.0 mm -94.37 -23.21 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.040000000000006 111.134 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 8' ' ' VAL . 19.8 m -94.12 -27.92 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.430000000000007 111.125 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -32.06 70.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 72.420000000000002 110.895 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.99 -42.29 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 72.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -99.58 27.72 5.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 75.519999999999996 110.95 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.85 -1.25 42.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.159 -0.473 . . . . 65.120000000000005 110.904 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 -11.79 22.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.91 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -109.74 -50.65 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 72.530000000000001 110.905 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 40' ' ' ILE . 26.4 mt -51.16 -69.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 63.5 111.122 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -24.72 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 54.420000000000002 110.885 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -75.65 -23.72 56.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 75.530000000000001 110.926 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -87.87 -50.2 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 72.25 110.865 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.4 pt -51.29 -29.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.209999999999994 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.52 -21.95 36.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 62.420000000000002 112.466 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -92.28 -74.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 65.329999999999998 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.0 41.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 52.310000000000002 112.491 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -68.43 -179.8 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.786 0.327 . . . . 64.409999999999997 110.892 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.638 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -102.42 -169.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 52.43 111.076 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.438 HD11 ' HG2' ' A' ' 6' ' ' LYS . 10.7 tp -96.29 -21.93 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 111.128 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.671 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.8 t30 -99.7 -20.07 16.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.140000000000001 110.875 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.638 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -58.23 -63.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 65.239999999999995 110.865 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.926 HD12 HD21 ' A' ' 7' ' ' LEU . 11.5 pt -51.06 -35.26 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 74.5 111.101 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 34' ' ' ASN . 81.9 mt -60.87 -58.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 61.549999999999997 111.128 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.96 -25.29 67.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.329999999999998 110.861 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -66.88 -55.91 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 71.140000000000001 110.938 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.495 HD11 ' CD1' ' A' ' 23' ' ' ILE . 51.3 mt -63.58 -42.45 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 42.240000000000002 111.126 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -58.35 -38.49 77.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 62.299999999999997 110.909 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -69.07 -46.86 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.099999999999994 110.897 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -56.95 -61.3 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 75.340000000000003 110.86 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 62.119999999999997 111.139 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.49 74.89 1.26 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.148 -0.933 . . . . 70.549999999999997 112.472 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.07 -58.83 1.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 54.350000000000001 111.093 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.773 HD11 ' HG3' ' A' ' 24' ' ' MET . 27.3 mm -90.6 -25.79 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 111.125 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.47 -28.95 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 62.130000000000003 111.123 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HE2' HD11 ' A' ' 33' ' ' ILE . 20.1 mmmt -54.98 -40.71 70.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 65.439999999999998 110.894 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.914 HD21 HD12 ' A' ' 36' ' ' ILE . 2.8 mm? -77.6 -28.43 51.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 110.91 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG22 HG21 ' A' ' 16' ' ' VAL . 87.7 t -61.35 -58.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 54.030000000000001 111.139 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.25 65.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 53.350000000000001 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -75.86 -38.98 57.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 73.319999999999993 110.934 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.504 ' HB3' HG21 ' A' ' 15' ' ' ILE . 86.5 m-85 -121.74 -74.63 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 63.340000000000003 110.913 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.98 151.83 8.55 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 64.230000000000004 112.508 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.48 -58.21 11.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 75.450000000000003 110.912 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.56 18.91 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.693 2.262 . . . . 54.109999999999999 112.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.2 mm -93.93 -23.46 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 70.319999999999993 111.134 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.717 HG21 HG22 ' A' ' 8' ' ' VAL . 17.8 m -94.09 -28.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 73.019999999999996 111.134 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -60.29 -29.66 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.030000000000001 110.902 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -76.17 -43.07 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.885 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.5 ' O ' HD12 ' A' ' 23' ' ' ILE . 60.7 m-85 -98.17 26.46 5.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.31 -1.53 41.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 74.219999999999999 110.938 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -98.09 -8.55 27.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 75.349999999999994 110.922 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -113.62 -50.95 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 73.439999999999998 110.902 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.5 HD12 ' O ' ' A' ' 19' ' ' TYR . 16.0 mt -51.32 -69.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 75.400000000000006 111.085 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.773 ' HG3' HD11 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -56.78 -24.57 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 73.299999999999997 110.885 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -76.32 -22.93 54.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 70.010000000000005 110.932 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -87.72 -49.74 6.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 62.409999999999997 110.881 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 pt -51.53 -29.12 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 72.540000000000006 111.206 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.96 39.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 61.350000000000001 112.545 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 -69.0 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 74.209999999999994 110.879 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.33 36.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.69 -0.767 . . . . 33.450000000000003 112.446 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -56.89 179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.310000000000002 110.891 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -87.25 -169.33 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.319999999999993 111.13 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.405 HD11 ' HE2' ' A' ' 6' ' ' LYS . 8.8 tp -100.97 -21.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 50.420000000000002 111.116 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.574 ' HA ' HD13 ' A' ' 37' ' ' ILE . 2.2 m120 -116.21 22.66 12.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.030000000000001 110.886 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 2.7 mmtp -95.41 -55.4 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 75.099999999999994 110.873 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.914 HD12 HD21 ' A' ' 7' ' ' LEU . 10.1 pt -50.19 -36.22 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 35.32 111.157 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -64.54 -55.96 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 72.340000000000003 111.113 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -64.84 -22.26 66.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -72.31 -53.11 13.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 70.150000000000006 110.963 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.458 HD12 HD12 ' A' ' 7' ' ' LEU . 48.1 mt -58.55 -59.11 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 71.200000000000003 111.159 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -52.16 -34.82 46.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.923 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -65.91 -35.35 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 72.25 110.882 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.36 -61.89 1.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.869 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 111.157 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.48 38.93 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.188 -0.915 . . . . 44.25 112.505 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.77 -41.11 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.765 0.317 . . . . 70.230000000000004 111.058 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.776 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 27.5 mm -73.77 -27.44 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 63.219999999999999 111.136 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.94 53.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 111.118 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.53 -35.85 72.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.439999999999998 110.875 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.025 HD21 HD12 ' A' ' 36' ' ' ILE . 1.6 mm? -84.67 -22.02 29.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 75.200000000000003 110.884 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.715 HG22 HG21 ' A' ' 16' ' ' VAL . 88.8 t -68.19 -69.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.329999999999998 111.09 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.22 -29.48 22.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 75.430000000000007 111.154 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.432 ' HD2' HG23 ' A' ' 37' ' ' ILE . 2.3 tmtt? -76.5 -65.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 71.200000000000003 110.884 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.467 ' HB3' HG21 ' A' ' 15' ' ' ILE . 87.2 m-85 -87.49 -75.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 73.329999999999998 110.872 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.77 152.41 7.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 63.229999999999997 112.477 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.69 -57.9 14.09 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 74.340000000000003 110.927 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.75 -7.12 20.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.684 2.256 . . . . 54.32 112.341 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 11' ' ' PHE . 42.7 mm -94.57 -23.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 72.209999999999994 111.154 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.715 HG21 HG22 ' A' ' 8' ' ' VAL . 24.3 m -93.65 -26.6 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 111.128 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -62.2 -23.38 66.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.140000000000001 110.892 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -81.58 -47.5 12.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 71.209999999999994 110.861 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.83 24.99 5.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 53.210000000000001 110.881 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -65.59 -50.59 64.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 63.229999999999997 110.951 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -50.98 -52.89 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 72.349999999999994 110.893 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -57.03 -58.83 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 71.010000000000005 110.894 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.718 HD11 HD11 ' A' ' 40' ' ' ILE . 35.7 mt -50.75 -59.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 75.540000000000006 111.134 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -28.94 61.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 72.209999999999994 110.854 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -19.9 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 70.120000000000005 110.925 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.13 -48.61 6.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 71.209999999999994 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.47 -23.71 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 60.130000000000003 111.186 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.0 8.77 71.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 43.219999999999999 112.505 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.81 -65.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 55.219999999999999 110.849 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.96 48.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 72.239999999999995 112.491 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -85.94 -177.85 6.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 73.219999999999999 110.893 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -96.27 -168.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 71.239999999999995 111.13 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -100.57 -14.67 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.422 . . . . 61.229999999999997 111.117 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.618 ' HA ' HD13 ' A' ' 37' ' ' ILE . 88.9 m-20 -119.28 19.6 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.902 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 2.2 mmpt? -95.24 -57.05 2.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.239999999999995 110.884 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.025 HD12 HD21 ' A' ' 7' ' ' LEU . 6.3 pt -48.01 -33.53 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.140000000000001 111.146 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.0 mp -67.12 -49.45 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 62.399999999999999 111.105 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.01 -25.81 63.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 110.856 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -69.2 -42.9 75.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 73.510000000000005 110.904 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.718 HD11 HD11 ' A' ' 23' ' ' ILE . 72.2 mt -73.3 -41.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 75.5 111.097 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -56.94 -47.41 80.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.882 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -62.7 -44.51 96.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 70.129999999999995 110.88 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.24 -64.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 72.5 110.823 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.540000000000006 111.142 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.41 -49.86 0.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.189 -0.914 . . . . 72.140000000000001 112.451 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.56 -35.78 7.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.732 0.301 . . . . 71.420000000000002 111.055 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.37 -28.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.71 -26.51 34.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 75.230000000000004 111.077 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.94 -34.5 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.040000000000006 110.893 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.988 HD21 HD12 ' A' ' 36' ' ' ILE . 2.4 mm? -87.7 -25.1 23.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 110.935 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.752 HG22 HG21 ' A' ' 16' ' ' VAL . 85.7 t -64.6 -70.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 51.119999999999997 111.131 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.08 -29.83 23.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 63.299999999999997 111.098 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -74.24 -71.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.420000000000002 110.92 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -81.27 -74.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.010000000000005 110.857 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.01 150.13 6.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 75.219999999999999 112.444 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.33 -58.3 11.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.523 0.678 . . . . 64.510000000000005 110.896 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.72 -6.74 19.29 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 2.264 . . . . 73.239999999999995 112.358 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.66 -22.94 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.129999999999995 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.752 HG21 HG22 ' A' ' 8' ' ' VAL . 20.0 m -94.28 -28.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 63.039999999999999 111.105 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -60.85 -30.61 70.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 72.439999999999998 110.877 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -75.73 -38.76 58.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 55.520000000000003 110.906 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.2 27.91 6.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 70.109999999999999 110.916 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -82.8 -0.82 49.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 71.340000000000003 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.87 32.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 75.329999999999998 110.902 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -116.01 -47.09 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.140000000000001 110.912 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 40' ' ' ILE . 35.4 mt -51.78 -67.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 73.439999999999998 111.11 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.1 ptm -57.12 -25.67 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.239999999999995 110.904 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.02 -19.46 60.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 74.540000000000006 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -94.5 -51.56 4.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 62.119999999999997 110.861 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.29 -29.49 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 50.119999999999997 111.116 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.77 -21.66 37.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 22.109999999999999 112.491 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -93.05 -74.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 73.409999999999997 110.884 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.79 41.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 53.32 112.476 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -64.77 177.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.737 0.303 . . . . 73.099999999999994 110.946 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 35' ' ' LYS . . . -91.74 -171.55 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 73.430000000000007 111.122 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -102.73 0.71 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 61.240000000000002 111.101 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.652 ' HA ' HD13 ' A' ' 37' ' ' ILE . 16.5 m120 -129.08 5.82 5.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 65.049999999999997 110.893 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 25.0 mmtp -86.35 -55.08 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 71.329999999999998 110.913 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.988 HD12 HD21 ' A' ' 7' ' ' LEU . 10.3 pt -50.21 -35.94 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.230000000000004 111.143 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.652 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.0 mp -66.12 -62.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 61.229999999999997 111.171 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -57.79 -24.68 58.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 72.209999999999994 110.88 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -67.72 -60.97 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.908 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 23' ' ' ILE . 63.2 mt -51.54 -42.64 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 72.120000000000005 111.128 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -42.38 98.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 62.520000000000003 110.92 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.06 -26.01 67.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 63.130000000000003 110.932 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -80.2 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 110.848 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 73.420000000000002 111.137 -179.966 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.79 49.92 0.71 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.131 -0.94 . . . . 65.150000000000006 112.459 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.09 -56.99 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 75.109999999999999 111.128 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 mm -104.34 -30.6 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 63.219999999999999 111.14 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.73 -25.09 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 72.540000000000006 111.089 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -59.64 -33.2 71.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 64.340000000000003 110.841 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -84.85 -25.83 27.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 74.409999999999997 110.934 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.742 HG22 HG21 ' A' ' 16' ' ' VAL . 86.8 t -61.38 -64.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 33.329999999999998 111.123 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.59 -23.96 44.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 71.099999999999994 111.129 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 37' ' ' ILE . 16.3 tptt -77.67 -66.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 75.340000000000003 110.901 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.577 ' HB3' HG21 ' A' ' 15' ' ' ILE . 96.6 m-85 -91.91 -75.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 110.843 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.15 155.19 11.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.699 -0.762 . . . . 73.140000000000001 112.47 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.538 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.77 -57.92 14.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.589 0.709 . . . . 74.200000000000003 110.889 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.78 -6.7 19.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.695 2.263 . . . . 73.120000000000005 112.332 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.577 HG21 ' HB3' ' A' ' 11' ' ' PHE . 42.8 mm -94.75 -23.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 74.25 111.124 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.742 HG21 HG22 ' A' ' 8' ' ' VAL . 21.4 m -93.71 -26.97 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 71.140000000000001 111.142 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.76 -20.75 66.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 75.120000000000005 110.885 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 -49.71 9.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 74.219999999999999 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -94.94 22.09 6.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 74.310000000000002 110.915 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -65.79 -40.67 92.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 70.140000000000001 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -55.48 34.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 54.43 110.906 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -56.77 -55.6 32.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 54.350000000000001 110.908 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 40' ' ' ILE . 40.3 mt -50.52 -62.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 72.299999999999997 111.149 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.6 ttt -56.63 -29.78 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.872 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -72.86 -18.84 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 72.129999999999995 110.933 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.92 -51.79 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.450000000000003 110.886 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -51.31 -29.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 75.129999999999995 111.158 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.15 -21.33 38.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 71.409999999999997 112.478 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -95.29 -75.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 74.329999999999998 110.856 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.07 49.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 32.219999999999999 112.522 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -68.49 -179.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 75.0 110.906 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.629 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -86.97 -169.4 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 111.109 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.63 -21.26 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 75.310000000000002 111.121 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -115.49 17.05 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 75.540000000000006 110.88 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.629 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 33.3 mmtt -89.38 -57.74 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 75.340000000000003 110.918 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.037 HD12 HD21 ' A' ' 7' ' ' LEU . 8.2 pt -49.58 -32.11 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.019999999999996 111.113 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 10' ' ' LYS . 74.9 mt -67.68 -58.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 71.150000000000006 111.112 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.78 -32.26 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 70.019999999999996 110.857 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.43 -47.63 85.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.929 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 23' ' ' ILE . 64.2 mt -69.06 -42.66 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.158 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.49 -25.89 52.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.129999999999995 110.92 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -96.32 31.02 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 54.229999999999997 110.884 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -137.72 -49.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 71.409999999999997 110.815 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 111.126 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.25 -88.96 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.166 -0.924 . . . . 74.040000000000006 112.465 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.74 -28.94 12.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.318 . . . . 51.030000000000001 111.088 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.5 mm -75.93 -33.59 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 72.040000000000006 111.139 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.31 -26.18 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 54.43 111.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -61.31 -25.59 67.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 64.129999999999995 110.918 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.844 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -91.41 -22.97 20.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.239999999999995 110.897 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.681 HG22 HG21 ' A' ' 16' ' ' VAL . 93.0 t -65.57 -57.39 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 73.040000000000006 111.106 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.48 -24.07 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 65.530000000000001 111.084 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -78.37 -46.6 19.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 74.439999999999998 110.912 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.479 ' HB3' HG21 ' A' ' 15' ' ' ILE . 82.8 m-85 -111.86 -74.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 110.896 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.7 151.65 7.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 75.150000000000006 112.435 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.14 -58.37 10.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 63.450000000000003 110.889 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.74 -6.61 19.01 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.691 2.261 . . . . 65.319999999999993 112.354 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 11' ' ' PHE . 45.9 mm -94.8 -22.6 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.420000000000002 111.109 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.681 HG21 HG22 ' A' ' 8' ' ' VAL . 19.7 m -94.73 -27.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 65.310000000000002 111.119 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -62.63 -29.01 70.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 71.540000000000006 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -75.46 -47.21 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 64.310000000000002 110.901 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.87 28.42 3.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 62.149999999999999 110.953 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -74.33 -30.51 62.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 73.030000000000001 110.935 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -70.15 -10.92 60.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 52.130000000000003 110.923 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -108.18 -60.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.91 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mt -49.96 -33.7 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -80.24 -49.9 10.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 65.099999999999994 110.843 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -20.29 57.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 74.439999999999998 110.87 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -83.77 -58.39 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 71.430000000000007 110.884 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.0 pt -50.92 -29.58 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 73.040000000000006 111.176 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.5 -21.72 35.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 71.430000000000007 112.474 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.2 -74.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 74.519999999999996 110.879 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.15 46.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.743 . . . . 53.310000000000002 112.504 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.87 -179.65 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 62.450000000000003 110.962 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.711 ' HB3' ' HG2' ' A' ' 35' ' ' LYS . . . -98.92 -169.27 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 63.109999999999999 111.124 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 tt -98.5 -16.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 111.097 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.551 ' HA ' HD12 ' A' ' 37' ' ' ILE . 12.3 t-20 -105.32 -20.62 13.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 60.32 110.893 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.711 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 21.5 mmtp -58.68 -65.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 71.530000000000001 110.871 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.844 HD12 HD21 ' A' ' 7' ' ' LEU . 6.2 pt -49.01 -32.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 73.400000000000006 111.137 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 34' ' ' ASN . 71.5 mt -65.54 -66.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 62.200000000000003 111.159 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.3 -19.95 57.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 72.329999999999998 110.886 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.4 -50.85 23.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 73.349999999999994 110.937 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mt -60.97 -59.77 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 52.420000000000002 111.116 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -51.61 -30.19 20.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 63.32 110.892 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -65.98 -41.37 91.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.109999999999999 110.882 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -69.52 -62.47 1.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 75.319999999999993 110.866 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.040000000000006 111.139 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.61 36.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.186 -0.915 . . . . 52.530000000000001 112.536 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.04 -64.85 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 72.430000000000007 111.092 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.606 HD11 ' HG3' ' A' ' 24' ' ' MET . 27.1 mm -71.93 -33.58 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 111.112 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.04 -22.23 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 63.310000000000002 111.101 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -38.28 90.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 64.540000000000006 110.925 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 36' ' ' ILE . 3.0 mm? -75.18 -22.3 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 65.540000000000006 110.914 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.697 HG22 HG21 ' A' ' 16' ' ' VAL . 94.3 t -67.71 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 71.140000000000001 111.128 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.09 -24.59 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 34.219999999999999 111.071 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.736 ' HD2' HG23 ' A' ' 37' ' ' ILE . 4.5 tmtt? -79.57 -52.63 7.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 63.539999999999999 110.928 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HB3' HG21 ' A' ' 15' ' ' ILE . 81.3 m-85 -104.26 -74.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.400000000000006 110.898 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.98 151.21 7.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.718 . . . . 42.240000000000002 112.535 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.2 -58.18 11.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.624 0.726 . . . . 75.430000000000007 110.931 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.72 -6.8 19.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.715 2.276 . . . . 44.399999999999999 112.371 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.47 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.8 mm -94.82 -23.09 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.340000000000003 111.15 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -93.99 -27.2 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 71.209999999999994 111.115 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -61.68 -28.27 69.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.310000000000002 110.884 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -77.14 -43.67 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 73.299999999999997 110.87 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.484 ' O ' HD12 ' A' ' 23' ' ' ILE . 63.1 m-85 -96.91 27.05 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 71.409999999999997 110.946 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.86 -1.09 41.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.430000000000007 110.932 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.29 -9.78 24.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 65.239999999999995 110.899 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -112.25 -51.16 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 70.230000000000004 110.889 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.536 ' CD1' HD11 ' A' ' 40' ' ' ILE . 17.8 mt -51.3 -68.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 64.409999999999997 111.167 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.606 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -56.46 -25.66 51.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.129999999999995 110.852 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -75.21 -23.88 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 65.340000000000003 110.874 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -86.86 -50.85 6.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 75.409999999999997 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -51.16 -29.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 64.209999999999994 111.12 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.68 -22.01 38.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.77 -0.729 . . . . 44.130000000000003 112.501 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -93.65 -74.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 72.230000000000004 110.926 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.3 46.81 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.540000000000006 112.451 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -66.9 -179.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 74.519999999999996 110.916 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -87.22 -169.48 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 74.030000000000001 111.107 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tt -101.65 -21.41 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.299999999999997 111.161 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HA ' HD12 ' A' ' 37' ' ' ILE . 32.6 m120 -114.84 19.25 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.97 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.548 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 12.6 mmtp -91.46 -58.05 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 73.409999999999997 110.9 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 7' ' ' LEU . 10.9 pt -50.7 -31.95 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 64.329999999999998 111.121 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.736 HG23 ' HD2' ' A' ' 10' ' ' LYS . 67.6 mt -65.02 -59.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 70.219999999999999 111.128 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.83 -26.06 68.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 64.219999999999999 110.879 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.01 -53.82 40.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 70.439999999999998 110.883 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.607 HD12 HD12 ' A' ' 7' ' ' LEU . 56.0 mt -64.95 -45.3 95.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 74.230000000000004 111.127 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -34.29 56.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 74.200000000000003 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -93.81 42.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 62.399999999999999 110.893 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -148.3 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.099999999999994 110.838 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 64.140000000000001 111.119 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.778 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 36.3 mm . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.805 0.336 . . . . 70.4 111.113 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.53 35.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 54.33 111.096 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.7 -26.53 68.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 72.23 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.976 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -91.22 -24.63 19.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.45 110.935 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.733 HG22 HG21 ' A' ' 16' ' ' VAL . 87.3 t -70.39 -64.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 70.24 111.136 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.25 -25.74 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 73.5 111.045 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -82.43 -66.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 74.13 110.902 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.444 ' HB3' HG21 ' A' ' 15' ' ' ILE . 90.7 m-85 -85.15 -75.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 71.41 110.844 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.57 153.74 8.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 72.02 112.462 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -53.33 -58.11 14.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 72.32 110.918 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.2 Cg_endo -69.73 -6.98 19.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.695 2.263 . . . . 73.13 112.343 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.5 mm -94.88 -21.91 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 60.11 111.176 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.733 HG21 HG22 ' A' ' 8' ' ' VAL . 31.0 m -95.49 -25.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.34 111.12 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -25.05 66.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.05 110.896 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -79.88 -30.38 40.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.15 110.943 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -110.18 25.42 11.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 75.11 110.92 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.778 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -72.51 -25.18 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.891 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -76.04 -5.72 47.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 52.04 110.919 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -115.92 -56.35 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 64.33 110.888 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 mt -51.18 -69.45 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 61.23 111.115 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -23.94 50.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 52.12 110.858 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -77.12 -21.49 54.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 71.31 110.898 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -89.57 -48.77 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.866 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.7 pt -51.5 -29.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.43 111.097 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -21.26 39.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 65.34 112.488 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -93.08 -74.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 71.14 110.889 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.91 44.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 63.42 112.504 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -69.47 -179.96 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 74.21 110.915 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.6 -175.83 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 53.34 111.098 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tt -88.45 -19.85 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 60.54 111.142 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -101.84 22.02 13.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 71.14 110.827 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -112.1 -64.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 54.14 110.916 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.976 HD12 HD21 ' A' ' 7' ' ' LEU . 11.8 pt -50.87 -35.31 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 72.04 111.149 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.3 -64.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 75.3 111.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.93 -21.96 61.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.853 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -71.51 -56.39 6.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 70.23 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.434 HD12 HD12 ' A' ' 7' ' ' LEU . 51.9 mt -56.22 -58.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 63.1 111.149 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -35.01 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 75.21 110.875 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.58 -36.31 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.877 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -72.47 -62.51 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 65.24 110.869 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 pt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.0 111.152 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.78 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 37.1 mm . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.86 0.362 . . . . 73.24 111.141 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.67 -27.54 28.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 44.45 111.085 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.45 -32.06 71.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 73.42 110.929 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.085 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -84.38 -24.71 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.968 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.747 HG22 HG21 ' A' ' 16' ' ' VAL . 84.1 t -69.6 -59.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 75.11 111.11 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 35.35 111.09 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.549 ' HG2' HG23 ' A' ' 37' ' ' ILE . 3.3 tppp? -81.11 -46.0 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 64.44 110.893 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.423 ' HB3' HG21 ' A' ' 15' ' ' ILE . 91.8 m-85 -109.29 -74.83 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.15 110.862 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.31 150.77 7.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 74.31 112.476 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.527 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.71 -58.05 12.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 72.12 110.936 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.9 Cg_endo -69.79 -6.75 19.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 55.21 112.32 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.1 mm -94.49 -22.68 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 41.1 111.127 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.747 HG21 HG22 ' A' ' 8' ' ' VAL . 19.5 m -94.72 -27.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 63.13 111.097 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.85 -25.5 67.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.901 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.83 -30.67 40.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.54 110.877 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.588 ' O ' HD12 ' A' ' 23' ' ' ILE . 60.6 m-85 -109.8 28.04 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 52.33 110.948 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.78 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -77.59 -6.14 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 73.54 110.922 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -91.36 -11.26 38.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -109.77 -55.94 2.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 61.03 110.89 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 19' ' ' TYR . 7.2 mt -51.62 -68.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 73.2 111.11 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 tpt -56.64 -24.94 51.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 64.23 110.848 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.76 -23.15 52.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 74.05 110.915 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -86.12 -49.42 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 73.22 110.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.5 pt -52.07 -28.37 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 71.53 111.091 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.46 -18.5 44.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.75 . . . . 62.12 112.532 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -97.7 -74.99 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 72.5 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.34 49.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 71.45 112.513 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -69.73 -179.76 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.322 . . . . 73.14 110.922 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -85.75 -169.47 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 71.13 111.125 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -101.58 -21.45 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.34 111.172 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.589 ' HA ' HD13 ' A' ' 37' ' ' ILE . 17.8 p30 -116.78 23.22 12.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 73.24 110.883 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -95.74 -55.37 3.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 63.51 110.945 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.085 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.76 -35.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.14 111.109 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.589 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -65.26 -53.46 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 72.53 111.128 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -66.48 -25.13 66.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 61.12 110.884 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -65.41 -57.33 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.25 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 23' ' ' ILE . 35.4 mt -60.32 -46.51 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.35 111.14 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -52.28 -32.25 36.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.878 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -75.55 -46.91 29.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.888 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.25 -62.91 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.847 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 pt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.13 111.177 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.796 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 29.4 mm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.805 0.336 . . . . 72.53 111.061 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.99 -24.62 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.154 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.28 -35.55 81.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 65.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.882 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -76.08 -26.2 56.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 74.12 110.882 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.669 HG22 HG21 ' A' ' 16' ' ' VAL . 98.0 t -68.44 -58.78 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 61.24 111.16 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.9 -24.96 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 62.44 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -79.9 -44.47 20.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 64.01 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 44' ' ' ILE . 77.5 m-85 -111.99 -74.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 71.01 110.914 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.63 150.79 6.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 74.3 112.479 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.2 11.47 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.571 0.7 . . . . 61.44 110.905 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.76 -6.77 19.39 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.655 2.237 . . . . 73.2 112.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.4 mm -95.02 -22.9 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 74.45 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.669 HG21 HG22 ' A' ' 8' ' ' VAL . 21.6 m -94.07 -27.25 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.31 111.119 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -66.32 -25.43 66.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.42 110.958 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -78.89 -28.35 44.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 63.55 110.867 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.425 ' O ' HD12 ' A' ' 23' ' ' ILE . 74.4 m-85 -113.66 25.59 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 70.44 110.908 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.796 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -72.88 -17.39 61.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 75.33 110.914 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -84.5 3.44 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 73.53 110.903 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -126.01 -56.34 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.13 110.938 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 19' ' ' TYR . 8.9 mt -51.2 -68.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 71.31 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.54 ' HG3' HD11 ' A' ' 4' ' ' ILE . 5.8 ttp -57.41 -23.56 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 64.32 110.867 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -78.27 -20.68 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 73.25 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.73 -49.23 6.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 54.2 110.893 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -51.17 -29.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 72.53 111.123 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.42 -22.06 36.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 64.32 112.542 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.72 -68.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 75.4 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.42 35.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 70.33 112.484 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -57.77 -179.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.804 0.335 . . . . 64.5 110.897 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -98.15 -169.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 71.21 111.057 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 tt -98.62 -10.01 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.02 111.124 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.45 ' HA ' HD12 ' A' ' 37' ' ' ILE . 1.1 p-10 -111.09 -24.77 10.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 73.03 110.865 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -54.83 -63.24 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 71.12 110.907 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.882 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.51 -35.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.01 111.159 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 34' ' ' ASN . 68.5 mt -64.49 -60.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 72.43 111.112 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.69 -17.91 63.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 70.33 110.868 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -76.28 -58.62 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 74.02 110.905 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 7' ' ' LEU . 40.0 mt -54.09 -55.0 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 75.51 111.167 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -34.53 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 61.35 110.931 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -53.2 -46.19 68.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.2 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.56 -72.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 70.24 110.904 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.434 HD11 ' CE1' ' A' ' 11' ' ' PHE . 33.0 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.34 111.157 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.895 0.379 . . . . 71.05 111.133 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.48 -25.4 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 72.22 111.07 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -58.27 -37.91 75.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.923 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.083 HD21 HD12 ' A' ' 36' ' ' ILE . 2.7 mm? -80.3 -23.11 40.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 52.44 110.952 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.74 HG22 HG21 ' A' ' 16' ' ' VAL . 84.3 t -66.86 -67.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 73.53 111.148 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.96 -27.22 29.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 71.42 111.108 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -78.5 -70.0 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.895 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.432 ' HB3' HG21 ' A' ' 15' ' ' ILE . 72.9 m-85 -82.61 -74.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 74.32 110.837 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.67 150.84 7.01 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 75.21 112.498 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.17 -58.27 11.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.587 0.708 . . . . 71.22 110.89 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.74 -6.92 19.74 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 63.25 112.325 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' A' ' 11' ' ' PHE . 43.4 mm -94.87 -22.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 75.31 111.086 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.74 HG21 HG22 ' A' ' 8' ' ' VAL . 22.2 m -94.5 -27.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 71.43 111.148 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -61.6 -25.44 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.42 110.914 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -81.36 -42.23 20.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 72.34 110.896 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -100.77 27.32 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 62.05 110.894 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.13 -34.57 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 62.43 110.905 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -71.9 -9.04 57.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 60.21 110.922 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -103.64 -52.38 3.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 70.51 110.92 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 40' ' ' ILE . 18.0 mt -54.5 -65.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 62.44 111.113 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.6 ttt -56.74 -25.81 55.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.42 110.884 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -73.71 -20.75 60.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.24 110.94 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.67 -51.53 5.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 54.12 110.871 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.85 -29.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 64.44 111.172 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.39 -23.58 34.91 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.21 112.49 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 -75.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 62.41 110.875 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.44 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 61.1 112.512 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.04 -179.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 75.33 110.955 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -89.54 -169.35 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 32.11 111.099 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 tt -102.86 -13.31 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 65.51 111.107 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.582 ' HA ' HD13 ' A' ' 37' ' ' ILE . 21.5 m-80 -122.42 20.46 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 62.33 110.893 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -95.36 -54.36 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 70.14 110.899 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.083 HD12 HD21 ' A' ' 7' ' ' LEU . 10.0 pt -50.11 -35.73 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.15 111.169 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -64.82 -56.66 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.01 111.146 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.92 -25.53 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 70.42 110.867 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -66.44 -48.72 69.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 70.52 110.912 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 23' ' ' ILE . 46.0 mt -68.99 -36.35 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.21 111.141 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -38.91 92.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 53.31 110.908 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -73.87 -26.9 60.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 72.04 110.939 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.5 -61.84 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 75.21 110.859 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 72.34 111.09 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.78 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 31.2 mm . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.86 0.362 . . . . 75.45 111.113 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.05 -24.72 41.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 54.13 111.115 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.99 -41.92 84.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.895 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.032 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -76.2 -24.58 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 70.33 110.925 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.751 HG22 HG21 ' A' ' 16' ' ' VAL . 87.4 t -65.71 -43.54 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 65.23 111.129 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.41 37.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.15 111.11 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.713 ' HG2' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -81.34 -30.29 33.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.54 110.87 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.7 m-85 -126.29 -75.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 53.43 110.872 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.88 151.98 7.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 55.44 112.5 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.7 -58.17 11.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.53 0.681 . . . . 74.35 110.908 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.76 -6.62 19.03 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 65.32 112.335 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.5 mm -95.06 -22.7 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 72.42 111.145 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.751 HG21 HG22 ' A' ' 8' ' ' VAL . 21.3 m -94.3 -27.18 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 72.32 111.119 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.48 -29.73 70.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 71.2 110.909 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -75.53 -32.82 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 70.15 110.921 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.54 ' O ' HD12 ' A' ' 23' ' ' ILE . 80.0 m-85 -104.87 24.76 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.3 110.904 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.78 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -76.31 -11.44 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.503 . . . . 52.42 110.951 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -90.89 13.55 16.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 54.53 110.931 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -139.3 -51.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 55.54 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 19' ' ' TYR . 9.9 mt -54.68 -65.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 61.33 111.136 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.409 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -58.7 -21.33 54.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 71.3 110.908 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -82.11 -21.99 36.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 62.11 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -86.96 -43.55 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 63.32 110.883 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -55.57 -25.5 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 73.32 111.099 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.07 -6.93 69.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.783 -0.722 . . . . 61.52 112.505 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.0 -71.48 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 62.02 110.908 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.87 49.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 74.32 112.473 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -82.52 -178.24 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 71.4 110.944 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.57 -175.6 2.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 63.31 111.116 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.545 HG23 ' OD1' ' A' ' 34' ' ' ASN . 10.7 tp -86.38 -21.05 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.31 111.143 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 33' ' ' ILE . 26.6 m-20 -99.28 20.02 14.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.42 110.871 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -110.28 -68.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.51 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.032 HD12 HD21 ' A' ' 7' ' ' LEU . 9.8 pt -49.84 -31.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 72.44 111.152 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.713 HD12 ' HG2' ' A' ' 10' ' ' LYS . 44.3 mm -61.38 -67.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 43.44 111.113 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -61.38 -31.02 70.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.833 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -55.56 -37.69 68.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.891 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 44' ' ' ILE . 44.9 mt -86.43 -37.63 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 75.32 111.081 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -61.02 -28.75 69.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 65.32 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -89.37 -26.73 20.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.3 110.888 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.22 -26.53 52.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.11 110.846 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 40' ' ' ILE . 26.4 pt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 63.51 111.107 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.772 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 27.2 mm . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.827 0.346 . . . . 74.23 111.112 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.11 -24.86 43.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 54.43 111.147 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -35.08 70.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.32 110.92 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.022 HD21 HD12 ' A' ' 36' ' ' ILE . 1.8 mm? -84.53 -25.57 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 70.34 110.95 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.714 HG22 HG21 ' A' ' 16' ' ' VAL . 94.7 t -69.53 -35.31 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 64.12 111.15 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.01 17.14 11.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 45.33 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -130.49 -39.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 63.22 110.902 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -112.39 -75.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.931 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 149.09 5.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 23.44 112.5 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -50.79 -58.01 11.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.598 0.713 . . . . 74.2 110.922 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.82 -5.29 15.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 73.24 112.355 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.21 -22.28 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 75.4 111.139 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.714 HG21 HG22 ' A' ' 8' ' ' VAL . 27.1 m -92.99 -29.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.14 111.091 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -26.22 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 52.52 110.895 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -73.4 -21.12 60.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.0 110.88 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.91 21.51 11.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 73.21 110.909 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.86 -28.25 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 75.11 110.897 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.9 -9.35 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 63.14 110.936 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -109.02 -60.76 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.917 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 HD11 ' A' ' 40' ' ' ILE . 5.5 mt -51.37 -65.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 74.02 111.099 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 44.0 ttp -56.42 -28.48 59.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 72.43 110.859 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -75.22 -21.57 58.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 54.13 110.959 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -87.76 -50.35 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 61.02 110.908 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -51.95 -28.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 63.02 111.168 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -18.73 41.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 73.44 112.473 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -94.91 -69.18 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 75.23 110.906 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.66 36.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.757 . . . . 44.4 112.463 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -57.04 -179.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.793 0.33 . . . . 71.35 110.889 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -87.19 -169.33 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 64.41 111.107 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -101.54 -21.7 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 73.23 111.092 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.51 ' HA ' HD12 ' A' ' 37' ' ' ILE . 70.4 m-80 -114.82 21.04 14.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 61.03 110.901 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -93.5 -58.02 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.879 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.022 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.37 -31.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 74.55 111.138 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 34' ' ' ASN . 67.8 mt -63.71 -62.89 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 53.02 111.146 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -28.9 69.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 53.41 110.849 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -58.48 -53.79 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 72.03 110.951 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.442 HD11 HD11 ' A' ' 23' ' ' ILE . 22.8 mt -69.04 -40.08 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.21 111.14 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -52.01 -67.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 51.11 110.873 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -28.27 57.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 75.24 110.903 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -68.81 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 72.5 110.83 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.428 . . . . 75.21 111.132 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.786 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 30.1 mm . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.859 0.362 . . . . 72.32 111.145 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.5 -24.32 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 63.43 111.083 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -63.03 -25.03 68.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.54 110.883 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.06 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -92.02 -25.35 18.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 64.33 110.918 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 16' ' ' VAL . 91.7 t -67.3 -68.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 73.33 111.125 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.59 -28.73 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.25 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' HD2' HG23 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -76.47 -61.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 64.32 110.903 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.471 ' HB3' HG21 ' A' ' 15' ' ' ILE . 97.0 m-85 -93.45 -74.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 71.34 110.907 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.92 151.64 7.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 53.13 112.508 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.528 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.44 -58.2 11.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 75.14 110.952 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.59 18.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 63.51 112.364 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.4 mm -94.93 -22.44 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 64.44 111.114 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -94.81 -27.16 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 54.05 111.157 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -65.96 -25.42 67.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.45 110.872 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -25.74 39.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 62.51 110.924 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.578 ' O ' HD12 ' A' ' 23' ' ' ILE . 78.4 m-85 -114.49 24.94 11.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 73.23 110.913 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.786 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.18 -27.84 64.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 73.4 110.945 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -7.84 53.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.863 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -109.98 -60.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 73.1 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.3 mt -52.74 -65.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.03 111.143 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -56.64 -25.79 54.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 71.44 110.881 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.68 -22.27 50.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 54.31 110.895 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -85.34 -47.95 9.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.42 110.912 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.8 pt -53.32 -27.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 71.12 111.171 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.56 -14.68 55.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 75.44 112.454 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.54 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 73.13 110.864 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.88 48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 54.53 112.481 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -72.82 -179.23 3.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.765 0.317 . . . . 75.45 110.92 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -88.92 -169.55 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 64.13 111.058 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tt -101.54 -11.11 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.21 111.096 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.61 ' HA ' HD13 ' A' ' 37' ' ' ILE . 5.7 m120 -122.96 4.29 9.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.85 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 6.3 mmtm -78.6 -56.72 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.93 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.06 HD12 HD21 ' A' ' 7' ' ' LEU . 8.5 pt -49.42 -37.48 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 74.21 111.089 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.5 mp -65.37 -44.37 94.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.34 111.125 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -74.48 -20.84 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.891 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -71.24 -53.88 12.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 63.02 110.891 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.554 HD11 ' CD1' ' A' ' 23' ' ' ILE . 36.7 mt -62.4 -47.87 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 55.43 111.139 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -43.39 63.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 73.14 110.912 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -68.23 -39.58 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 71.21 110.924 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -64.75 -62.04 1.82 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.86 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 74.44 111.081 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.3 mm . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.834 0.35 . . . . 53.31 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -21.15 58.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 45.14 111.114 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -64.52 -29.64 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 61.5 110.889 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.99 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -87.1 -25.08 24.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 61.3 110.931 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.718 HG22 HG21 ' A' ' 16' ' ' VAL . 87.8 t -68.61 -32.42 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 72.55 111.176 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.88 17.18 10.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 61.54 111.093 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.539 ' HG2' HG23 ' A' ' 37' ' ' ILE . 11.3 tppt? -129.36 -45.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.909 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.476 ' HB3' HG21 ' A' ' 15' ' ' ILE . 94.4 m-85 -107.77 -75.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 64.11 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.65 152.8 8.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.801 -0.714 . . . . 50.14 112.537 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.07 -58.14 12.46 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 75.43 110.957 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.78 -7.13 20.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 63.22 112.327 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 11' ' ' PHE . 43.3 mm -95.28 -22.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 61.13 111.166 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.718 HG21 HG22 ' A' ' 8' ' ' VAL . 29.1 m -93.6 -26.22 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.24 111.144 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -65.37 -24.57 67.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.25 110.912 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -78.16 -47.97 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.9 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.26 22.22 8.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.931 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.53 -41.07 93.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 75.3 110.936 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.9 -56.47 21.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 64.33 110.854 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -56.24 -55.65 30.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 40' ' ' ILE . 41.9 mt -50.97 -62.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.111 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -29.15 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 60.42 110.871 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -72.77 -23.63 60.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 73.32 110.905 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -86.8 -52.52 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.878 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.31 -29.84 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.059 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.5 38.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 52.24 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.0 -74.96 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 71.15 110.856 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.83 47.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 75.05 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -67.02 -179.65 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.782 0.325 . . . . 75.51 110.883 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -90.33 -169.45 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 61.24 111.091 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.39 -10.04 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.53 111.127 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.639 ' HA ' HD13 ' A' ' 37' ' ' ILE . 21.0 p30 -124.09 19.65 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 63.13 110.901 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 10.4 mmtp -96.13 -56.17 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.15 110.893 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.99 HD12 HD21 ' A' ' 7' ' ' LEU . 9.4 pt -50.05 -31.29 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 71.23 111.145 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.639 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.1 mp -69.24 -50.74 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 55.34 111.126 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -69.53 -26.03 64.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 65.52 110.831 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -68.31 -44.08 76.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 71.45 110.955 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 23' ' ' ILE . 51.3 mt -72.72 -45.2 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 65.3 111.129 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -55.95 -38.65 70.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 64.02 110.935 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -72.95 -26.28 61.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 72.3 110.916 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -77.86 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 72.03 110.865 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.44 111.082 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.792 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 33.4 mm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.862 0.363 . . . . 61.41 111.107 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.57 67.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 65.33 111.067 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HG3' HD22 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -51.59 -37.62 50.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 72.53 110.907 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.095 HD21 HD12 ' A' ' 36' ' ' ILE . 3.6 mm? -69.27 -34.16 74.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 70.3 110.939 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 16' ' ' VAL . 66.5 t -61.39 -66.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 70.42 111.184 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.3 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.051 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -77.29 -41.72 39.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.43 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -118.84 -75.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 75.53 110.882 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.1 149.11 6.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 53.02 112.496 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.67 -58.22 11.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.519 0.676 . . . . 64.44 110.918 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.67 -6.94 19.76 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.248 . . . . 73.14 112.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.31 -23.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.52 111.132 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.661 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -93.63 -27.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 74.33 111.161 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -66.23 -28.2 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 73.34 110.902 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.45 -24.57 53.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 71.53 110.898 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.515 ' O ' HD12 ' A' ' 23' ' ' ILE . 78.4 m-85 -117.59 25.4 10.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.792 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.07 -24.6 63.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 65.51 110.918 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -77.91 -3.82 43.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 62.42 110.914 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -114.27 -58.83 2.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 75.05 110.841 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.7 mt -51.4 -69.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 72.44 111.113 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -23.79 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 71.41 110.868 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -77.01 -21.82 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.916 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -89.65 -48.43 7.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.875 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.7 pt -51.95 -28.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 55.34 111.132 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.39 -18.41 43.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 74.25 112.478 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -97.7 -75.03 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 64.15 110.874 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.85 48.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.753 . . . . 61.5 112.48 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -68.05 -179.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 73.14 110.885 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.21 -169.34 2.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 62.43 111.078 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -103.33 -7.94 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 75.4 111.18 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -118.63 14.63 13.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -95.81 -61.01 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.937 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.095 HD12 HD21 ' A' ' 7' ' ' LEU . 10.4 pt -50.04 -30.82 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 72.51 111.169 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -67.26 -72.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 71.44 111.144 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.25 -35.06 59.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 65.15 110.878 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -52.68 -45.9 67.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.912 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 7' ' ' LEU . 42.9 mt -77.37 -47.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 72.15 111.09 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -52.81 -32.54 44.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 73.23 110.89 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -79.41 -43.59 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 64.52 110.865 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.25 -63.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.864 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 64.21 111.148 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.77 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 30.9 mm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.848 0.356 . . . . 75.23 111.118 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.46 47.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.03 111.071 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -61.3 -33.47 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.34 110.921 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.015 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -83.94 -21.23 31.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 64.23 110.923 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.722 HG22 HG21 ' A' ' 16' ' ' VAL . 89.2 t -68.28 -64.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.51 111.122 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.71 -24.95 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 61.31 111.086 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 37' ' ' ILE . 3.5 tmtm? -79.81 -58.29 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 54.51 110.891 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.505 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.3 m-85 -96.95 -75.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 70.11 110.892 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.85 151.78 7.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 32.3 112.479 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.53 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.58 -58.09 12.16 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.599 0.714 . . . . 72.25 110.933 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.83 19.54 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.692 2.262 . . . . 63.24 112.333 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 11' ' ' PHE . 41.8 mm -94.6 -23.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.05 111.085 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.722 HG21 HG22 ' A' ' 8' ' ' VAL . 20.8 m -93.81 -27.36 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 44.15 111.124 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -62.61 -29.21 70.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.22 110.904 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -75.62 -36.36 60.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 74.35 110.913 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.07 26.21 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.933 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -79.45 -6.76 57.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 62.0 110.93 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -94.97 16.58 15.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 73.12 110.886 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -145.01 -50.17 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 62.04 110.943 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' A' ' 40' ' ' ILE . 37.7 mt -51.56 -67.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 71.44 111.133 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -57.51 -23.64 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 72.05 110.892 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.12 -19.55 50.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 71.12 110.905 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.35 -46.19 8.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 75.04 110.888 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.42 -23.46 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 65.34 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.28 9.46 70.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 72.33 112.454 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.37 -63.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 42.23 110.931 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.06 46.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 54.43 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -85.0 -178.66 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 75.24 110.945 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.33 -169.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 64.3 111.107 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.427 HG23 ' OD1' ' A' ' 34' ' ' ASN . 14.6 tt -101.19 -10.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.54 111.12 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HA ' HD12 ' A' ' 37' ' ' ILE . 4.0 m-20 -121.72 19.5 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.24 110.872 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -95.36 -58.34 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.015 HD12 HD21 ' A' ' 7' ' ' LEU . 9.0 pt -49.48 -33.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.453 . . . . 73.33 111.117 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 34' ' ' ASN . 75.7 mt -60.58 -60.97 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.44 111.15 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -26.48 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 53.05 110.85 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -65.46 -30.03 70.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.51 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.405 HD11 ' CD1' ' A' ' 23' ' ' ILE . 55.3 mt -93.26 -30.98 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 72.3 111.084 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -38.78 78.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 72.14 110.909 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -70.21 -41.42 73.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 64.11 110.93 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.69 -64.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 73.4 110.859 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.51 111.134 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.794 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 34.1 mm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.837 0.351 . . . . 71.43 111.127 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -25.31 36.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 65.13 111.143 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HD2' HD11 ' A' ' 33' ' ' ILE . 7.5 mmpt? -62.69 -32.67 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.889 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.022 HD21 HD12 ' A' ' 36' ' ' ILE . 2.3 mm? -82.67 -23.93 33.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 71.31 110.947 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.72 HG22 HG21 ' A' ' 16' ' ' VAL . 89.2 t -69.98 -56.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 53.4 111.153 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -26.17 66.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 72.14 111.094 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -79.97 -45.12 19.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 72.11 110.894 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.441 ' HB3' HG21 ' A' ' 15' ' ' ILE . 89.7 m-85 -109.43 -74.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 73.41 110.87 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 150.9 6.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 60.4 112.492 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.26 11.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.572 0.701 . . . . 74.41 110.908 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.74 -6.59 18.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 63.23 112.36 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' A' ' 11' ' ' PHE . 48.8 mm -95.13 -22.55 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 71.23 111.138 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.72 HG21 HG22 ' A' ' 8' ' ' VAL . 20.8 m -94.5 -27.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 75.45 111.113 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -64.44 -25.32 67.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 65.24 110.901 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -80.06 -32.48 39.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.884 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.552 ' O ' HD12 ' A' ' 23' ' ' ILE . 85.0 m-85 -106.52 24.44 12.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 50.34 110.902 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.794 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -75.82 -11.72 60.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 73.41 110.898 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -89.29 10.26 22.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 75.25 110.931 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -135.95 -54.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 73.33 110.897 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 19' ' ' TYR . 8.6 mt -51.51 -68.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.11 111.108 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.417 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -57.47 -23.78 51.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.24 110.859 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -78.18 -20.37 52.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 53.14 110.915 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -89.7 -47.5 7.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.897 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.2 -27.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 75.02 111.135 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.32 -21.97 35.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 62.11 112.502 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -93.45 -74.93 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 73.52 110.892 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.65 43.86 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 74.34 112.5 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -71.17 161.07 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.801 0.334 . . . . 74.14 110.924 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.573 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -84.86 -169.05 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 72.33 111.113 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.406 HD11 ' HD2' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -101.04 -0.07 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 54.23 111.136 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -115.84 -25.88 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 53.32 110.893 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 10.7 mttm -57.48 -62.8 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.04 110.913 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.022 HD12 HD21 ' A' ' 7' ' ' LEU . 11.5 pt -50.38 -35.37 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 64.34 111.111 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.88 -50.11 76.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.176 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.19 -3.79 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.55 110.868 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -90.43 -42.0 11.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.943 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 7' ' ' LEU . 28.3 mt -72.29 -52.62 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 63.45 111.146 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -52.74 -30.59 33.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 52.53 110.87 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -67.25 -41.25 85.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 63.43 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -70.38 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.31 110.868 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 pt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 73.34 111.105 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.4 mm . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.843 0.354 . . . . 72.55 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.25 -20.95 58.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 60.44 111.059 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.651 ' NZ ' HD11 ' A' ' 37' ' ' ILE . 21.1 tptm -68.25 -34.88 77.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 72.33 110.883 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.087 HD21 HD12 ' A' ' 36' ' ' ILE . 2.8 mm? -77.93 -22.73 49.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 74.3 110.903 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.747 HG22 HG21 ' A' ' 16' ' ' VAL . 88.6 t -68.59 -66.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 71.2 111.154 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.1 48.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 54.2 111.093 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.752 ' HE3' HD13 ' A' ' 37' ' ' ILE . 3.8 mttm -80.36 -56.74 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.902 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.435 ' HB3' HG21 ' A' ' 15' ' ' ILE . 87.2 m-85 -98.47 -74.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.898 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.93 150.78 7.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 72.42 112.492 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.34 -58.32 11.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.568 0.699 . . . . 74.3 110.908 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.73 -6.65 19.09 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.687 2.258 . . . . 75.42 112.332 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' A' ' 11' ' ' PHE . 48.9 mm -94.58 -22.54 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.31 111.124 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.747 HG21 HG22 ' A' ' 8' ' ' VAL . 19.3 m -94.95 -27.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 73.25 111.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.74 -25.07 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.922 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -80.16 -40.69 26.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 60.33 110.865 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -103.75 26.49 8.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 65.21 110.918 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.56 -35.01 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 72.32 110.953 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -71.86 -9.33 58.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 71.1 110.9 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.37 -51.8 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.951 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.55 HD11 HD11 ' A' ' 40' ' ' ILE . 13.5 mt -56.44 -63.61 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.1 111.151 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ttt -57.17 -26.06 59.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 74.23 110.903 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.51 -18.64 60.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.24 110.871 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -91.9 -50.68 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 64.53 110.868 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.8 pt -51.09 -28.9 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 72.13 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.13 -23.57 32.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 73.23 112.51 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -92.06 -74.88 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 62.13 110.896 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.19 44.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 52.21 112.489 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.62 -179.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.78 0.324 . . . . 75.14 110.946 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -102.07 -169.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 65.2 111.134 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 tt -99.14 -10.03 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.24 111.146 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.463 ' HA ' HD12 ' A' ' 37' ' ' ILE . 10.8 m120 -111.04 -20.28 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.33 110.897 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 5.3 mmtp -61.52 -59.2 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.05 110.921 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.087 HD12 HD21 ' A' ' 7' ' ' LEU . 10.4 pt -50.36 -31.35 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 73.33 111.182 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.752 HD13 ' HE3' ' A' ' 10' ' ' LYS . 74.0 mt -66.82 -60.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 64.45 111.134 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.39 -25.06 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.41 110.852 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -67.21 -57.22 7.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.915 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 7' ' ' LEU . 42.7 mt -62.7 -36.93 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 53.21 111.124 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -61.75 -61.36 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.54 110.924 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -52.7 -29.41 26.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.01 110.897 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -72.07 -68.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 71.04 110.859 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.15 111.129 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.705 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 26.7 mm . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.823 0.344 . . . . 70.12 111.126 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.19 -19.95 56.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.114 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -67.62 -30.54 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.904 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.991 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -84.25 -26.06 28.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.933 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.743 HG22 HG21 ' A' ' 16' ' ' VAL . 83.9 t -61.04 -69.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 63.22 111.13 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -22.16 61.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 62.14 111.079 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' HG2' HG23 ' A' ' 37' ' ' ILE . 23.9 tptt -77.1 -37.48 54.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 72.21 110.909 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.04 -74.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.35 110.894 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.31 149.65 7.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.736 -0.745 . . . . 54.53 112.501 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.02 -58.11 12.55 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.554 0.693 . . . . 73.33 110.927 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.77 -6.41 18.55 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.669 2.246 . . . . 70.12 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mm -93.64 -23.29 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 64.35 111.127 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.743 HG21 HG22 ' A' ' 8' ' ' VAL . 17.0 m -94.37 -28.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 55.12 111.119 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.84 -35.66 81.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.869 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -73.25 -30.73 63.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 70.03 110.872 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.535 ' O ' HD12 ' A' ' 23' ' ' ILE . 59.1 m-85 -103.3 22.13 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 72.51 110.914 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.705 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.42 -26.17 63.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 74.51 110.958 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -75.59 -6.07 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 73.31 110.885 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -112.09 -60.84 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 71.55 110.903 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.6 mt -51.19 -67.98 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.31 111.124 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -26.51 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.853 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -74.64 -23.27 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 73.23 110.885 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -87.36 -51.33 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 71.14 110.843 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -51.29 -29.5 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 60.41 111.118 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.24 -21.03 38.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.742 . . . . 73.01 112.465 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -93.35 -68.99 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 75.51 110.861 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.48 36.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.704 -0.76 . . . . 63.24 112.468 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -56.64 179.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.754 0.311 . . . . 75.33 110.966 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -86.05 -169.32 2.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 71.44 111.09 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -102.13 -21.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 70.03 111.178 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.572 ' HA ' HD13 ' A' ' 37' ' ' ILE . 65.4 m-80 -116.65 22.09 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 70.52 110.877 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 12.1 mmtt -94.63 -54.71 3.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 73.3 110.839 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.991 HD12 HD21 ' A' ' 7' ' ' LEU . 10.3 pt -50.23 -36.04 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 75.51 111.129 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -65.18 -48.89 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.55 111.113 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 -24.01 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 61.45 110.886 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -69.18 -49.94 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 73.44 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.26 -45.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 75.14 111.115 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -57.74 -29.07 64.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 72.13 110.855 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.53 23.48 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 63.22 110.917 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -126.69 -38.84 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.41 110.837 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.12 111.133 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.798 0.332 . . . . 73.43 111.106 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.59 -21.79 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 53.34 111.073 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' A' ' 33' ' ' ILE . 17.2 tppt? -67.62 -29.75 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 64.24 110.912 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.926 HD21 HD12 ' A' ' 36' ' ' ILE . 2.7 mm? -83.75 -27.65 28.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 75.53 110.885 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.749 HG22 HG21 ' A' ' 16' ' ' VAL . 86.1 t -64.68 -69.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.14 111.125 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.71 19.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 53.12 111.142 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HD3' HG23 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -75.43 -74.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 72.42 110.918 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.448 ' HB3' HG21 ' A' ' 15' ' ' ILE . 79.0 m-85 -77.85 -74.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 74.42 110.835 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.07 150.89 7.11 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 50.42 112.462 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.33 11.02 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 75.21 110.928 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.85 19.58 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 51.22 112.324 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 11' ' ' PHE . 46.0 mm -94.37 -23.21 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.04 111.134 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 8' ' ' VAL . 19.8 m -94.12 -27.92 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.43 111.125 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -32.06 70.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 72.42 110.895 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.99 -42.29 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 72.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -99.58 27.72 5.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 75.52 110.95 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.85 -1.25 42.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.159 -0.473 . . . . 65.12 110.904 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 -11.79 22.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.91 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -109.74 -50.65 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 72.53 110.905 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 40' ' ' ILE . 26.4 mt -51.16 -69.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 63.5 111.122 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -24.72 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 54.42 110.885 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -75.65 -23.72 56.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 75.53 110.926 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -87.87 -50.2 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 72.25 110.865 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.4 pt -51.29 -29.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.21 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.52 -21.95 36.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 62.42 112.466 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -92.28 -74.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 65.33 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.0 41.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 52.31 112.491 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -68.43 -179.8 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.786 0.327 . . . . 64.41 110.892 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.638 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -102.42 -169.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 52.43 111.076 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.438 HD11 ' HG2' ' A' ' 6' ' ' LYS . 10.7 tp -96.29 -21.93 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 75.11 111.128 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.671 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.8 t30 -99.7 -20.07 16.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.14 110.875 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.638 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -58.23 -63.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 65.24 110.865 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.926 HD12 HD21 ' A' ' 7' ' ' LEU . 11.5 pt -51.06 -35.26 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 74.5 111.101 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 34' ' ' ASN . 81.9 mt -60.87 -58.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 61.55 111.128 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.96 -25.29 67.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.33 110.861 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -66.88 -55.91 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 71.14 110.938 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.495 HD11 ' CD1' ' A' ' 23' ' ' ILE . 51.3 mt -63.58 -42.45 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 42.24 111.126 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -58.35 -38.49 77.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 62.3 110.909 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -69.07 -46.86 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.897 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -56.95 -61.3 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 75.34 110.86 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 62.12 111.139 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.773 HD11 ' HG3' ' A' ' 24' ' ' MET . 27.3 mm . . . . . 0 N--CA 1.458 -0.063 0 CA-C-O 120.856 0.36 . . . . 72.33 111.125 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.47 -28.95 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 62.13 111.123 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HE2' HD11 ' A' ' 33' ' ' ILE . 20.1 mmmt -54.98 -40.71 70.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 65.44 110.894 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.914 HD21 HD12 ' A' ' 36' ' ' ILE . 2.8 mm? -77.6 -28.43 51.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 73.13 110.91 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG22 HG21 ' A' ' 16' ' ' VAL . 87.7 t -61.35 -58.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 54.03 111.139 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.25 65.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 53.35 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -75.86 -38.98 57.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.934 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.504 ' HB3' HG21 ' A' ' 15' ' ' ILE . 86.5 m-85 -121.74 -74.63 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 63.34 110.913 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.98 151.83 8.55 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 64.23 112.508 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.48 -58.21 11.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 75.45 110.912 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.56 18.91 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.693 2.262 . . . . 54.11 112.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.2 mm -93.93 -23.46 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 70.32 111.134 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.717 HG21 HG22 ' A' ' 8' ' ' VAL . 17.8 m -94.09 -28.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 73.02 111.134 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -60.29 -29.66 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.03 110.902 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -76.17 -43.07 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.885 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.5 ' O ' HD12 ' A' ' 23' ' ' ILE . 60.7 m-85 -98.17 26.46 5.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.31 -1.53 41.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 74.22 110.938 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -98.09 -8.55 27.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 75.35 110.922 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -113.62 -50.95 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 73.44 110.902 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.5 HD12 ' O ' ' A' ' 19' ' ' TYR . 16.0 mt -51.32 -69.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 75.4 111.085 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.773 ' HG3' HD11 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -56.78 -24.57 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 73.3 110.885 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -76.32 -22.93 54.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 70.01 110.932 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -87.72 -49.74 6.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 62.41 110.881 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 pt -51.53 -29.12 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 72.54 111.206 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.96 39.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 61.35 112.545 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 -69.0 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 74.21 110.879 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.33 36.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.69 -0.767 . . . . 33.45 112.446 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -56.89 179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.31 110.891 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -87.25 -169.33 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.32 111.13 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.484 HG23 HD22 ' A' ' 34' ' ' ASN . 8.8 tp -100.97 -21.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 50.42 111.116 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.574 ' HA ' HD13 ' A' ' 37' ' ' ILE . 1.3 m-80 -116.21 22.66 12.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.886 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 2.7 mmtp -95.41 -55.4 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 75.1 110.873 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.914 HD12 HD21 ' A' ' 7' ' ' LEU . 10.1 pt -50.19 -36.22 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 35.32 111.157 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -64.54 -55.96 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 72.34 111.113 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -64.84 -22.26 66.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -72.31 -53.11 13.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 70.15 110.963 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.458 HD12 HD12 ' A' ' 7' ' ' LEU . 48.1 mt -58.55 -59.11 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 71.2 111.159 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -52.16 -34.82 46.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.923 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -65.91 -35.35 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 72.25 110.882 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.36 -61.89 1.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.869 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.24 111.157 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.776 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 27.5 mm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.851 0.358 . . . . 63.22 111.136 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.94 53.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 72.53 111.118 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.53 -35.85 72.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.44 110.875 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.025 HD21 HD12 ' A' ' 36' ' ' ILE . 1.6 mm? -84.67 -22.02 29.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 75.2 110.884 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.715 HG22 HG21 ' A' ' 16' ' ' VAL . 88.8 t -68.19 -69.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.33 111.09 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.22 -29.48 22.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 75.43 111.154 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.432 ' HD2' HG23 ' A' ' 37' ' ' ILE . 2.3 tmtt? -76.5 -65.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 71.2 110.884 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.467 ' HB3' HG21 ' A' ' 15' ' ' ILE . 87.2 m-85 -87.49 -75.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 73.33 110.872 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.77 152.41 7.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 63.23 112.477 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.69 -57.9 14.09 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 74.34 110.927 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.75 -7.12 20.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.684 2.256 . . . . 54.32 112.341 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 11' ' ' PHE . 42.7 mm -94.57 -23.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 72.21 111.154 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.715 HG21 HG22 ' A' ' 8' ' ' VAL . 24.3 m -93.65 -26.6 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 62.42 111.128 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -62.2 -23.38 66.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.14 110.892 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -81.58 -47.5 12.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 71.21 110.861 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.83 24.99 5.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 53.21 110.881 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -65.59 -50.59 64.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 63.23 110.951 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -50.98 -52.89 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 72.35 110.893 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -57.03 -58.83 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 71.01 110.894 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.718 HD11 HD11 ' A' ' 40' ' ' ILE . 35.7 mt -50.75 -59.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 75.54 111.134 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -28.94 61.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 72.21 110.854 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -19.9 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 70.12 110.925 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.13 -48.61 6.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 71.21 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.47 -23.71 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 60.13 111.186 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.0 8.77 71.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 43.22 112.505 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.81 -65.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 55.22 110.849 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.96 48.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 72.24 112.491 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -85.94 -177.85 6.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 73.22 110.893 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -96.27 -168.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 71.24 111.13 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -100.57 -14.67 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.422 . . . . 61.23 111.117 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.618 ' HA ' HD13 ' A' ' 37' ' ' ILE . 88.9 m-20 -119.28 19.6 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.902 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 2.2 mmpt? -95.24 -57.05 2.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.884 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.025 HD12 HD21 ' A' ' 7' ' ' LEU . 6.3 pt -48.01 -33.53 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.14 111.146 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.0 mp -67.12 -49.45 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 62.4 111.105 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.01 -25.81 63.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.32 110.856 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -69.2 -42.9 75.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 73.51 110.904 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.718 HD11 HD11 ' A' ' 23' ' ' ILE . 72.2 mt -73.3 -41.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 75.5 111.097 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -56.94 -47.41 80.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.882 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -62.7 -44.51 96.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 70.13 110.88 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.24 -64.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 72.5 110.823 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.54 111.142 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.5 mm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.786 0.327 . . . . 74.33 111.13 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.71 -26.51 34.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 75.23 111.077 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.94 -34.5 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.04 110.893 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.988 HD21 HD12 ' A' ' 36' ' ' ILE . 2.4 mm? -87.7 -25.1 23.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.33 110.935 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.752 HG22 HG21 ' A' ' 16' ' ' VAL . 85.7 t -64.6 -70.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 51.12 111.131 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.08 -29.83 23.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 63.3 111.098 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -74.24 -71.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.42 110.92 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -81.27 -74.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.01 110.857 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.01 150.13 6.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 75.22 112.444 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.33 -58.3 11.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.523 0.678 . . . . 64.51 110.896 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.72 -6.74 19.29 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 2.264 . . . . 73.24 112.358 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.66 -22.94 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.13 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.752 HG21 HG22 ' A' ' 8' ' ' VAL . 20.0 m -94.28 -28.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 63.04 111.105 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -60.85 -30.61 70.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 72.44 110.877 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -75.73 -38.76 58.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 55.52 110.906 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.2 27.91 6.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 70.11 110.916 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -82.8 -0.82 49.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 71.34 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.87 32.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 75.33 110.902 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -116.01 -47.09 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.912 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 40' ' ' ILE . 35.4 mt -51.78 -67.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 73.44 111.11 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.1 ptm -57.12 -25.67 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.24 110.904 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.02 -19.46 60.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 74.54 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -94.5 -51.56 4.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 62.12 110.861 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.29 -29.49 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 50.12 111.116 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.77 -21.66 37.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 22.11 112.491 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -93.05 -74.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 73.41 110.884 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.79 41.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 53.32 112.476 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -64.77 177.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.737 0.303 . . . . 73.1 110.946 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 35' ' ' LYS . . . -91.74 -171.55 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 73.43 111.122 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -102.73 0.71 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 61.24 111.101 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.652 ' HA ' HD13 ' A' ' 37' ' ' ILE . 16.5 m120 -129.08 5.82 5.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 65.05 110.893 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 25.0 mmtp -86.35 -55.08 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 71.33 110.913 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.988 HD12 HD21 ' A' ' 7' ' ' LEU . 10.3 pt -50.21 -35.94 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.23 111.143 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.652 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.0 mp -66.12 -62.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 61.23 111.171 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -57.79 -24.68 58.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 72.21 110.88 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -67.72 -60.97 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.908 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 23' ' ' ILE . 63.2 mt -51.54 -42.64 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 72.12 111.128 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -42.38 98.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 62.52 110.92 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.06 -26.01 67.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 63.13 110.932 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -80.2 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.42 110.848 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 73.42 111.137 -179.966 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 mm . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.853 0.358 . . . . 63.22 111.14 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.73 -25.09 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 72.54 111.089 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -59.64 -33.2 71.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 64.34 110.841 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -84.85 -25.83 27.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 74.41 110.934 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.742 HG22 HG21 ' A' ' 16' ' ' VAL . 86.8 t -61.38 -64.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 33.33 111.123 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.59 -23.96 44.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 71.1 111.129 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 37' ' ' ILE . 16.3 tptt -77.67 -66.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 75.34 110.901 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.577 ' HB3' HG21 ' A' ' 15' ' ' ILE . 96.6 m-85 -91.91 -75.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.843 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.15 155.19 11.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.699 -0.762 . . . . 73.14 112.47 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.538 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.77 -57.92 14.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.589 0.709 . . . . 74.2 110.889 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.78 -6.7 19.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.695 2.263 . . . . 73.12 112.332 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.577 HG21 ' HB3' ' A' ' 11' ' ' PHE . 42.8 mm -94.75 -23.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 74.25 111.124 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.742 HG21 HG22 ' A' ' 8' ' ' VAL . 21.4 m -93.71 -26.97 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 71.14 111.142 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.76 -20.75 66.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 75.12 110.885 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 -49.71 9.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -94.94 22.09 6.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 74.31 110.915 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -65.79 -40.67 92.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 70.14 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -55.48 34.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 54.43 110.906 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -56.77 -55.6 32.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 54.35 110.908 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 40' ' ' ILE . 40.3 mt -50.52 -62.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 72.3 111.149 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.6 ttt -56.63 -29.78 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 71.11 110.872 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -72.86 -18.84 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 72.13 110.933 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.92 -51.79 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.45 110.886 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -51.31 -29.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 75.13 111.158 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.15 -21.33 38.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 71.41 112.478 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -95.29 -75.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 74.33 110.856 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.07 49.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 32.22 112.522 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -68.49 -179.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 75.0 110.906 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.629 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -86.97 -169.4 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.31 111.109 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.63 -21.26 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 75.31 111.121 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -115.49 17.05 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 75.54 110.88 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.629 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 33.3 mmtt -89.38 -57.74 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 75.34 110.918 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.037 HD12 HD21 ' A' ' 7' ' ' LEU . 8.2 pt -49.58 -32.11 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.02 111.113 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 10' ' ' LYS . 74.9 mt -67.68 -58.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 71.15 111.112 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.78 -32.26 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 70.02 110.857 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.43 -47.63 85.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 74.32 110.929 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 23' ' ' ILE . 64.2 mt -69.06 -42.66 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.158 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.49 -25.89 52.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.13 110.92 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -96.32 31.02 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 54.23 110.884 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -137.72 -49.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 71.41 110.815 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 73.44 111.126 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.5 mm . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.821 0.343 . . . . 72.04 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.31 -26.18 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 54.43 111.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -61.31 -25.59 67.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 64.13 110.918 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.844 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -91.41 -22.97 20.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.24 110.897 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.681 HG22 HG21 ' A' ' 16' ' ' VAL . 93.0 t -65.57 -57.39 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 73.04 111.106 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.48 -24.07 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 65.53 111.084 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -78.37 -46.6 19.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.912 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.479 ' HB3' HG21 ' A' ' 15' ' ' ILE . 82.8 m-85 -111.86 -74.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 75.31 110.896 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.7 151.65 7.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 75.15 112.435 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.14 -58.37 10.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 63.45 110.889 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.74 -6.61 19.01 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.691 2.261 . . . . 65.32 112.354 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 11' ' ' PHE . 45.9 mm -94.8 -22.6 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.42 111.109 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.681 HG21 HG22 ' A' ' 8' ' ' VAL . 19.7 m -94.73 -27.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 65.31 111.119 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -62.63 -29.01 70.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 71.54 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -75.46 -47.21 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 64.31 110.901 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.87 28.42 3.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 62.15 110.953 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -74.33 -30.51 62.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 73.03 110.935 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -70.15 -10.92 60.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 52.13 110.923 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -108.18 -60.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.91 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mt -49.96 -33.7 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -80.24 -49.9 10.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 65.1 110.843 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -20.29 57.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 74.44 110.87 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -83.77 -58.39 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.884 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.0 pt -50.92 -29.58 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 73.04 111.176 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.5 -21.72 35.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 71.43 112.474 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.2 -74.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 74.52 110.879 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.15 46.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.743 . . . . 53.31 112.504 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.87 -179.65 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 62.45 110.962 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.711 ' HB3' ' HG2' ' A' ' 35' ' ' LYS . . . -98.92 -169.27 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 63.11 111.124 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 tt -98.5 -16.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.33 111.097 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.551 ' HA ' HD12 ' A' ' 37' ' ' ILE . 12.3 t-20 -105.32 -20.62 13.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 60.32 110.893 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.711 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 21.5 mmtp -58.68 -65.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 71.53 110.871 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.844 HD12 HD21 ' A' ' 7' ' ' LEU . 6.2 pt -49.01 -32.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 73.4 111.137 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 34' ' ' ASN . 71.5 mt -65.54 -66.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 62.2 111.159 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.3 -19.95 57.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 72.33 110.886 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.4 -50.85 23.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 73.35 110.937 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mt -60.97 -59.77 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 52.42 111.116 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -51.61 -30.19 20.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 63.32 110.892 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -65.98 -41.37 91.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.882 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -69.52 -62.47 1.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 75.32 110.866 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.04 111.139 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.606 HD11 ' HG3' ' A' ' 24' ' ' MET . 27.1 mm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.819 0.343 . . . . 73.31 111.112 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.04 -22.23 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 63.31 111.101 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -38.28 90.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 64.54 110.925 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 36' ' ' ILE . 3.0 mm? -75.18 -22.3 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 65.54 110.914 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.697 HG22 HG21 ' A' ' 16' ' ' VAL . 94.3 t -67.71 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 71.14 111.128 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.09 -24.59 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 34.22 111.071 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.736 ' HD2' HG23 ' A' ' 37' ' ' ILE . 4.5 tmtt? -79.57 -52.63 7.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 63.54 110.928 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HB3' HG21 ' A' ' 15' ' ' ILE . 81.3 m-85 -104.26 -74.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.4 110.898 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.98 151.21 7.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.718 . . . . 42.24 112.535 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.2 -58.18 11.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.624 0.726 . . . . 75.43 110.931 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.72 -6.8 19.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.715 2.276 . . . . 44.4 112.371 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.47 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.8 mm -94.82 -23.09 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.34 111.15 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -93.99 -27.2 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 71.21 111.115 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -61.68 -28.27 69.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.31 110.884 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -77.14 -43.67 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 73.3 110.87 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.484 ' O ' HD12 ' A' ' 23' ' ' ILE . 63.1 m-85 -96.91 27.05 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 71.41 110.946 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.86 -1.09 41.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.43 110.932 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.29 -9.78 24.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 65.24 110.899 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -112.25 -51.16 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 70.23 110.889 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.536 ' CD1' HD11 ' A' ' 40' ' ' ILE . 17.8 mt -51.3 -68.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 64.41 111.167 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.606 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -56.46 -25.66 51.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.13 110.852 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -75.21 -23.88 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 65.34 110.874 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -86.86 -50.85 6.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 75.41 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -51.16 -29.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 64.21 111.12 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.68 -22.01 38.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.77 -0.729 . . . . 44.13 112.501 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -93.65 -74.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 72.23 110.926 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.3 46.81 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.54 112.451 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -66.9 -179.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 74.52 110.916 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -87.22 -169.48 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 74.03 111.107 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tt -101.65 -21.41 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.3 111.161 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HA ' HD12 ' A' ' 37' ' ' ILE . 32.6 m120 -114.84 19.25 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.97 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.548 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 12.6 mmtp -91.46 -58.05 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 73.41 110.9 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 7' ' ' LEU . 10.9 pt -50.7 -31.95 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 64.33 111.121 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.736 HG23 ' HD2' ' A' ' 10' ' ' LYS . 67.6 mt -65.02 -59.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 70.22 111.128 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.83 -26.06 68.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 64.22 110.879 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.01 -53.82 40.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 70.44 110.883 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.607 HD12 HD12 ' A' ' 7' ' ' LEU . 56.0 mt -64.95 -45.3 95.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 74.23 111.127 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -34.29 56.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 74.2 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -93.81 42.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 62.4 110.893 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -148.3 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.1 110.838 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 64.14 111.119 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.89 52.39 1.95 Allowed Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.191 -0.913 . . . . 73.33 112.46 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.45 -54.66 3.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.745 0.307 . . . . 55.41 111.098 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.778 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 36.3 mm -85.22 -34.81 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.462 . . . . 70.4 111.113 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.53 35.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 54.33 111.096 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.6 mmtt -61.7 -26.53 68.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 72.23 110.896 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.976 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -91.22 -24.63 19.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 64.45 110.935 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.733 HG22 HG21 ' A' ' 16' ' ' VAL . 87.3 t -70.39 -64.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 70.24 111.136 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.25 -25.74 35.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 73.5 111.045 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -82.43 -66.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 74.13 110.902 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' HB3' HG21 ' A' ' 15' ' ' ILE . 90.7 m-85 -85.15 -75.02 0.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 71.41 110.844 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.57 153.74 8.45 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.732 -0.747 . . . . 72.02 112.462 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -53.33 -58.11 14.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 72.32 110.918 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.2 Cg_endo -69.73 -6.98 19.88 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.695 2.263 . . . . 73.13 112.343 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.5 mm -94.88 -21.91 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 60.11 111.176 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.733 HG21 HG22 ' A' ' 8' ' ' VAL . 31.0 m -95.49 -25.94 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.34 111.12 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -25.05 66.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.05 110.896 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -79.88 -30.38 40.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 74.15 110.943 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -110.18 25.42 11.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 75.11 110.92 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.778 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -72.51 -25.18 61.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 73.33 110.891 -179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -76.04 -5.72 47.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 52.04 110.919 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -115.92 -56.35 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 64.33 110.888 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 mt -51.18 -69.45 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 61.23 111.115 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -23.94 50.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 52.12 110.858 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -77.12 -21.49 54.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 71.31 110.898 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -89.57 -48.77 7.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.866 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.7 pt -51.5 -29.4 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 74.43 111.097 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -21.26 39.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 65.34 112.488 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -93.08 -74.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 71.14 110.889 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.91 44.39 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.757 -0.735 . . . . 63.42 112.504 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -69.47 -179.96 1.86 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 74.21 110.915 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.6 -175.83 2.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 53.34 111.098 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tt -88.45 -19.85 7.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 60.54 111.142 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -101.84 22.02 13.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 71.14 110.827 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmtt -112.1 -64.38 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 54.14 110.916 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.976 HD12 HD21 ' A' ' 7' ' ' LEU . 11.8 pt -50.87 -35.31 14.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 72.04 111.149 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.3 -64.16 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 75.3 111.154 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.93 -21.96 61.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 71.23 110.853 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.2 t90 -71.51 -56.39 6.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 70.23 110.932 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.434 HD12 HD12 ' A' ' 7' ' ' LEU . 51.9 mt -56.22 -58.38 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 63.1 111.149 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.13 -35.01 47.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 75.21 110.875 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -68.58 -36.31 78.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.877 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -72.47 -62.51 1.42 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 65.24 110.869 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 pt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.0 111.152 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.39 19.93 10.09 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.132 -0.94 . . . . 34.33 112.489 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.21 -28.64 13.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.742 0.306 . . . . 72.42 111.124 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.78 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 37.1 mm -75.47 -33.24 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 73.24 111.141 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.67 -27.54 28.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 44.45 111.085 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mptt -60.45 -32.06 71.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 73.42 110.929 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.085 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -84.38 -24.71 29.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.968 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.747 HG22 HG21 ' A' ' 16' ' ' VAL . 84.1 t -69.6 -59.89 3.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 75.11 111.11 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 35.35 111.09 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.549 ' HG2' HG23 ' A' ' 37' ' ' ILE . 3.3 tppp? -81.11 -46.0 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 64.44 110.893 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.423 ' HB3' HG21 ' A' ' 15' ' ' ILE . 91.8 m-85 -109.29 -74.83 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 75.15 110.862 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.31 150.77 7.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.762 -0.732 . . . . 74.31 112.476 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.527 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.71 -58.05 12.42 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.558 0.694 . . . . 72.12 110.936 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.9 Cg_endo -69.79 -6.75 19.35 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.732 2.288 . . . . 55.21 112.32 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.1 mm -94.49 -22.68 5.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 41.1 111.127 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.747 HG21 HG22 ' A' ' 8' ' ' VAL . 19.5 m -94.72 -27.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 63.13 111.097 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.85 -25.5 67.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.901 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -79.83 -30.67 40.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.54 110.877 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.588 ' O ' HD12 ' A' ' 23' ' ' ILE . 60.6 m-85 -109.8 28.04 8.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 52.33 110.948 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.78 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -77.59 -6.14 52.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.5 . . . . 73.54 110.922 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -91.36 -11.26 38.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.93 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -109.77 -55.94 2.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 61.03 110.89 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 19' ' ' TYR . 7.2 mt -51.62 -68.26 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 73.2 111.11 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.2 tpt -56.64 -24.94 51.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 64.23 110.848 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.76 -23.15 52.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 74.05 110.915 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -86.12 -49.42 7.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 73.22 110.877 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.5 pt -52.07 -28.37 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 71.53 111.091 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.46 -18.5 44.12 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.75 . . . . 62.12 112.532 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -97.7 -74.99 0.56 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 72.5 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.34 49.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.766 -0.73 . . . . 71.45 112.513 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -69.73 -179.76 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.775 0.322 . . . . 73.14 110.922 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -85.75 -169.47 2.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 71.13 111.125 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -101.58 -21.45 5.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.34 111.172 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.589 ' HA ' HD13 ' A' ' 37' ' ' ILE . 17.8 p30 -116.78 23.22 12.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 73.24 110.883 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -95.74 -55.37 3.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 63.51 110.945 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.085 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.76 -35.31 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.14 111.109 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.589 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -65.26 -53.46 40.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 72.53 111.128 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -66.48 -25.13 66.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 61.12 110.884 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -65.41 -57.33 8.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.162 -0.472 . . . . 71.25 110.93 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.506 HD11 ' CD1' ' A' ' 23' ' ' ILE . 35.4 mt -60.32 -46.51 94.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.35 111.14 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -52.28 -32.25 36.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.878 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -75.55 -46.91 29.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.888 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -57.25 -62.91 1.43 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 73.43 110.847 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.9 pt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 64.13 111.177 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.82 51.46 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.177 -0.92 . . . . 72.45 112.448 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.86 -46.92 20.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 73.44 111.111 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.796 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 29.4 mm -102.04 -30.62 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 72.53 111.061 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.99 -24.62 39.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.154 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.28 -35.55 81.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 65.0 110.845 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.882 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -76.08 -26.2 56.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 74.12 110.882 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.669 HG22 HG21 ' A' ' 16' ' ' VAL . 98.0 t -68.44 -58.78 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 61.24 111.16 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.9 -24.96 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 62.44 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -79.9 -44.47 20.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 64.01 110.902 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.434 ' CE1' HD11 ' A' ' 44' ' ' ILE . 77.5 m-85 -111.99 -74.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 71.01 110.914 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.63 150.79 6.98 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 74.3 112.479 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.2 11.47 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.571 0.7 . . . . 61.44 110.905 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.76 -6.77 19.39 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.655 2.237 . . . . 73.2 112.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.4 mm -95.02 -22.9 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 74.45 111.138 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.669 HG21 HG22 ' A' ' 8' ' ' VAL . 21.6 m -94.07 -27.25 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 72.31 111.119 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -66.32 -25.43 66.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.42 110.958 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.9 mtmm -78.89 -28.35 44.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 63.55 110.867 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.425 ' O ' HD12 ' A' ' 23' ' ' ILE . 74.4 m-85 -113.66 25.59 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.245 -0.434 . . . . 70.44 110.908 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.796 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -72.88 -17.39 61.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 75.33 110.914 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -84.5 3.44 36.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 73.53 110.903 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -126.01 -56.34 1.45 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.13 110.938 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.425 HD12 ' O ' ' A' ' 19' ' ' TYR . 8.9 mt -51.2 -68.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 71.31 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.54 ' HG3' HD11 ' A' ' 4' ' ' ILE . 5.8 ttp -57.41 -23.56 50.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 64.32 110.867 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -78.27 -20.68 51.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 73.25 110.867 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.73 -49.23 6.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 54.2 110.893 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -51.17 -29.65 8.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 72.53 111.123 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.42 -22.06 36.56 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 64.32 112.542 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -91.72 -68.83 0.77 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.873 0.368 . . . . 75.4 110.88 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.42 35.51 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.746 -0.74 . . . . 70.33 112.484 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -57.77 -179.85 0.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.804 0.335 . . . . 64.5 110.897 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.517 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -98.15 -169.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 71.21 111.057 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 tt -98.62 -10.01 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 73.02 111.124 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.45 ' HA ' HD12 ' A' ' 37' ' ' ILE . 1.1 p-10 -111.09 -24.77 10.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 73.03 110.865 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER -54.83 -63.24 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 71.12 110.907 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.882 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.51 -35.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.01 111.159 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 34' ' ' ASN . 68.5 mt -64.49 -60.11 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 72.43 111.112 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.69 -17.91 63.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.199 -0.455 . . . . 70.33 110.868 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -76.28 -58.62 3.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 74.02 110.905 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.6 HD12 HD12 ' A' ' 7' ' ' LEU . 40.0 mt -54.09 -55.0 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 75.51 111.167 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.93 -34.53 42.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 61.35 110.931 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -53.2 -46.19 68.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 75.2 110.915 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -73.56 -72.82 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 70.24 110.904 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.434 HD11 ' CE1' ' A' ' 11' ' ' PHE . 33.0 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 71.34 111.157 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.51 92.25 0.22 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.207 -0.906 . . . . 64.55 112.454 178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.81 -53.2 2.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.738 0.304 . . . . 63.41 111.095 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.9 mm -100.76 -32.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 71.05 111.133 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.48 -25.4 36.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 72.22 111.07 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -58.27 -37.91 75.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.11 110.923 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.083 HD21 HD12 ' A' ' 36' ' ' ILE . 2.7 mm? -80.3 -23.11 40.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.451 . . . . 52.44 110.952 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.74 HG22 HG21 ' A' ' 16' ' ' VAL . 84.3 t -66.86 -67.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 73.53 111.148 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.96 -27.22 29.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 71.42 111.108 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -78.5 -70.0 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.895 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.432 ' HB3' HG21 ' A' ' 15' ' ' ILE . 72.9 m-85 -82.61 -74.93 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 74.32 110.837 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.67 150.84 7.01 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.755 -0.736 . . . . 75.21 112.498 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.17 -58.27 11.07 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.587 0.708 . . . . 71.22 110.89 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.4 Cg_endo -69.74 -6.92 19.74 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 63.25 112.325 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG21 ' HB3' ' A' ' 11' ' ' PHE . 43.4 mm -94.87 -22.69 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 75.31 111.086 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.74 HG21 HG22 ' A' ' 8' ' ' VAL . 22.2 m -94.5 -27.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 71.43 111.148 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 mmtm -61.6 -25.44 67.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 74.42 110.914 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -81.36 -42.23 20.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 72.34 110.896 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -100.77 27.32 6.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 62.05 110.894 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -76.13 -34.57 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 62.43 110.905 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -71.9 -9.04 57.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 60.21 110.922 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -103.64 -52.38 3.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 70.51 110.92 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 40' ' ' ILE . 18.0 mt -54.5 -65.46 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 62.44 111.113 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 4.6 ttt -56.74 -25.81 55.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.42 110.884 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -73.71 -20.75 60.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 71.24 110.94 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -90.67 -51.53 5.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 54.12 110.871 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.6 pt -50.85 -29.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 64.44 111.172 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.39 -23.58 34.91 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.72 -0.752 . . . . 74.21 112.49 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -92.35 -75.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.847 0.356 . . . . 62.41 110.875 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.44 48.02 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.76 -0.733 . . . . 61.1 112.512 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.04 -179.59 1.56 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 75.33 110.955 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.478 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -89.54 -169.35 2.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 32.11 111.099 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.5 tt -102.86 -13.31 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 65.51 111.107 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.582 ' HA ' HD13 ' A' ' 37' ' ' ILE . 21.5 m-80 -122.42 20.46 10.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 62.33 110.893 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.8 OUTLIER -95.36 -54.36 3.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 70.14 110.899 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.083 HD12 HD21 ' A' ' 7' ' ' LEU . 10.0 pt -50.11 -35.73 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 73.15 111.169 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -64.82 -56.66 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.01 111.146 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -63.92 -25.53 68.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 70.42 110.867 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -66.44 -48.72 69.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.193 -0.458 . . . . 70.52 110.912 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 23' ' ' ILE . 46.0 mt -68.99 -36.35 73.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.21 111.141 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.45 -38.91 92.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 53.31 110.908 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.4 mmtt -73.87 -26.9 60.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 72.04 110.939 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -75.5 -61.84 1.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 75.21 110.859 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.5 pt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 72.34 111.09 179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.17 32.52 0.95 Allowed Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.171 -0.922 . . . . 71.3 112.459 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -122.02 -39.57 2.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.769 0.318 . . . . 75.43 111.121 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.78 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 31.2 mm -80.67 -29.85 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.45 111.113 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.05 -24.72 41.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 54.13 111.115 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.99 -41.92 84.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 74.33 110.895 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.032 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -76.2 -24.58 54.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 70.33 110.925 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.751 HG22 HG21 ' A' ' 16' ' ' VAL . 87.4 t -65.71 -43.54 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 65.23 111.129 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.1 -24.41 37.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.15 111.11 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.713 ' HG2' HD12 ' A' ' 37' ' ' ILE . 0.3 OUTLIER -81.34 -30.29 33.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.54 110.87 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.7 m-85 -126.29 -75.32 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 53.43 110.872 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.88 151.98 7.69 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 55.44 112.5 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.7 -58.17 11.99 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.53 0.681 . . . . 74.35 110.908 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.76 -6.62 19.03 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.67 2.247 . . . . 65.32 112.335 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.5 mm -95.06 -22.7 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 72.42 111.145 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.751 HG21 HG22 ' A' ' 8' ' ' VAL . 21.3 m -94.3 -27.18 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 72.32 111.119 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -63.48 -29.73 70.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 71.2 110.909 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -75.53 -32.82 60.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 70.15 110.921 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.54 ' O ' HD12 ' A' ' 23' ' ' ILE . 80.0 m-85 -104.87 24.76 11.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 74.3 110.904 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.78 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -76.31 -11.44 59.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.503 . . . . 52.42 110.951 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -90.89 13.55 16.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 54.53 110.931 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -139.3 -51.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 55.54 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.54 HD12 ' O ' ' A' ' 19' ' ' TYR . 9.9 mt -54.68 -65.71 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 61.33 111.136 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.409 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.8 OUTLIER -58.7 -21.33 54.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 71.3 110.908 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -82.11 -21.99 36.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 62.11 110.893 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -86.96 -43.55 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 63.32 110.883 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -55.57 -25.5 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.104 -0.498 . . . . 73.32 111.099 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -73.07 -6.93 69.73 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.783 -0.722 . . . . 61.52 112.505 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.0 -71.48 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.907 0.384 . . . . 62.02 110.908 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.87 49.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 74.32 112.473 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 8.3 m95 -82.52 -178.24 6.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 71.4 110.944 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.57 -175.6 2.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 63.31 111.116 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.545 HG23 ' OD1' ' A' ' 34' ' ' ASN . 10.7 tp -86.38 -21.05 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.31 111.143 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 33' ' ' ILE . 26.6 m-20 -99.28 20.02 14.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.42 110.871 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -110.28 -68.21 0.94 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.51 110.908 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.032 HD12 HD21 ' A' ' 7' ' ' LEU . 9.8 pt -49.84 -31.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 72.44 111.152 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.713 HD12 ' HG2' ' A' ' 10' ' ' LYS . 44.3 mm -61.38 -67.64 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 43.44 111.113 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -61.38 -31.02 70.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.03 110.833 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -55.56 -37.69 68.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 71.25 110.891 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 44' ' ' ILE . 44.9 mt -86.43 -37.63 11.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 75.32 111.081 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -61.02 -28.75 69.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 65.32 110.891 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -89.37 -26.73 20.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.3 110.888 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -77.22 -26.53 52.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 62.11 110.846 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 40' ' ' ILE . 26.4 pt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 63.51 111.107 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.01 -47.32 0.41 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.143 -0.935 . . . . 73.42 112.486 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.84 -41.28 26.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.764 0.316 . . . . 60.21 111.114 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.772 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 27.2 mm -77.01 -33.78 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.23 111.112 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.11 -24.86 43.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 54.43 111.147 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -35.08 70.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 74.32 110.92 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.022 HD21 HD12 ' A' ' 36' ' ' ILE . 1.8 mm? -84.53 -25.57 28.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 70.34 110.95 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.714 HG22 HG21 ' A' ' 16' ' ' VAL . 94.7 t -69.53 -35.31 65.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 64.12 111.15 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.01 17.14 11.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 45.33 111.101 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -130.49 -39.58 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 63.22 110.902 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -112.39 -75.0 0.61 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 74.13 110.931 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 149.09 5.98 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.755 -0.736 . . . . 23.44 112.5 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.529 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -50.79 -58.01 11.59 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.598 0.713 . . . . 74.2 110.922 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.82 -5.29 15.9 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 73.24 112.355 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.21 -22.28 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 75.4 111.139 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.714 HG21 HG22 ' A' ' 8' ' ' VAL . 27.1 m -92.99 -29.12 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.14 111.091 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -26.22 63.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 52.52 110.895 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -73.4 -21.12 60.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 73.0 110.88 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -120.91 21.51 11.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 73.21 110.909 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.772 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -64.86 -28.25 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 75.11 110.897 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.9 -9.35 58.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 63.14 110.936 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.0 mm-40 -109.02 -60.76 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.917 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.442 HD11 HD11 ' A' ' 40' ' ' ILE . 5.5 mt -51.37 -65.47 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 74.02 111.099 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 44.0 ttp -56.42 -28.48 59.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 72.43 110.859 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -75.22 -21.57 58.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 54.13 110.959 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -87.76 -50.35 6.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 61.02 110.908 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.8 pt -51.95 -28.86 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 63.02 111.168 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -18.73 41.83 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 73.44 112.473 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -94.91 -69.18 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 75.23 110.906 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.66 36.61 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.757 . . . . 44.4 112.463 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -57.04 -179.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.793 0.33 . . . . 71.35 110.889 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.504 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -87.19 -169.33 2.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 64.41 111.107 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -101.54 -21.7 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 73.23 111.092 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.51 ' HA ' HD12 ' A' ' 37' ' ' ILE . 70.4 m-80 -114.82 21.04 14.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 61.03 110.901 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -93.5 -58.02 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.879 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.022 HD12 HD21 ' A' ' 7' ' ' LEU . 10.5 pt -50.37 -31.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.429 . . . . 74.55 111.138 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 34' ' ' ASN . 67.8 mt -63.71 -62.89 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 53.02 111.146 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.37 -28.9 69.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 53.41 110.849 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.8 t90 -58.48 -53.79 54.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.226 -0.443 . . . . 72.03 110.951 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.442 HD11 HD11 ' A' ' 23' ' ' ILE . 22.8 mt -69.04 -40.08 80.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.21 111.14 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -52.01 -67.35 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 51.11 110.873 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -28.27 57.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 75.24 110.903 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.74 -68.81 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 72.5 110.83 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 pt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.428 . . . . 75.21 111.132 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.18 72.47 1.28 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.155 -0.929 . . . . 53.54 112.486 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.54 -40.15 6.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.761 0.315 . . . . 52.12 111.121 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.786 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 30.1 mm -79.79 -34.84 15.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.145 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.5 -24.32 45.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 63.43 111.083 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -63.03 -25.03 68.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 74.54 110.883 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.06 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -92.02 -25.35 18.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 64.33 110.918 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 16' ' ' VAL . 91.7 t -67.3 -68.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 73.33 111.125 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.59 -28.73 22.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 74.25 111.138 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' HD2' HG23 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -76.47 -61.43 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 64.32 110.903 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.471 ' HB3' HG21 ' A' ' 15' ' ' ILE . 97.0 m-85 -93.45 -74.91 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 71.34 110.907 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.92 151.64 7.51 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.769 -0.729 . . . . 53.13 112.508 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.528 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.44 -58.2 11.6 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.591 0.71 . . . . 75.14 110.952 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.59 18.97 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.64 2.227 . . . . 63.51 112.364 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.471 HG21 ' HB3' ' A' ' 11' ' ' PHE . 49.4 mm -94.93 -22.44 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 64.44 111.114 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -94.81 -27.16 4.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 54.05 111.157 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -65.96 -25.42 67.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.45 110.872 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.11 -25.74 39.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.434 . . . . 62.51 110.924 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.578 ' O ' HD12 ' A' ' 23' ' ' ILE . 78.4 m-85 -114.49 24.94 11.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 73.23 110.913 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.786 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.18 -27.84 64.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 73.4 110.945 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -7.84 53.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.863 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -109.98 -60.1 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 73.1 110.888 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.578 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.3 mt -52.74 -65.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.03 111.143 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -56.64 -25.79 54.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 71.44 110.881 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -77.68 -22.27 50.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 54.31 110.895 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -85.34 -47.95 9.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 72.42 110.912 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.8 pt -53.32 -27.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 71.12 111.171 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.56 -14.68 55.52 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 75.44 112.454 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -98.54 -69.91 0.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 73.13 110.864 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.88 48.55 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 54.53 112.481 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -72.82 -179.23 3.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.765 0.317 . . . . 75.45 110.92 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -88.92 -169.55 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 64.13 111.058 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tt -101.54 -11.11 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 74.21 111.096 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.61 ' HA ' HD13 ' A' ' 37' ' ' ILE . 5.7 m120 -122.96 4.29 9.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.85 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 6.3 mmtm -78.6 -56.72 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.93 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.06 HD12 HD21 ' A' ' 7' ' ' LEU . 8.5 pt -49.42 -37.48 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 74.21 111.089 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.5 mp -65.37 -44.37 94.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 73.34 111.125 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -74.48 -20.84 59.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 72.42 110.891 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 80.5 t90 -71.24 -53.88 12.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 63.02 110.891 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.554 HD11 ' CD1' ' A' ' 23' ' ' ILE . 36.7 mt -62.4 -47.87 91.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 55.43 111.139 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 -43.39 63.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 73.14 110.912 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -68.23 -39.58 82.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 71.21 110.924 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -64.75 -62.04 1.82 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.86 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 74.44 111.081 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.71 25.0 12.29 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.186 -0.916 . . . . 52.42 112.431 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.81 -52.13 3.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.823 0.344 . . . . 63.45 111.111 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.74 -33.37 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 53.31 111.127 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.01 -21.15 58.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 45.14 111.114 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -64.52 -29.64 70.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 61.5 110.889 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.99 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -87.1 -25.08 24.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 61.3 110.931 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.718 HG22 HG21 ' A' ' 16' ' ' VAL . 87.8 t -68.61 -32.42 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 72.55 111.176 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.88 17.18 10.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 61.54 111.093 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.539 ' HG2' HG23 ' A' ' 37' ' ' ILE . 11.3 tppt? -129.36 -45.53 1.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.909 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.476 ' HB3' HG21 ' A' ' 15' ' ' ILE . 94.4 m-85 -107.77 -75.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 64.11 110.871 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.65 152.8 8.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.801 -0.714 . . . . 50.14 112.537 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.07 -58.14 12.46 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.617 0.722 . . . . 75.43 110.957 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.78 -7.13 20.28 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.718 2.279 . . . . 63.22 112.327 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 11' ' ' PHE . 43.3 mm -95.28 -22.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 61.13 111.166 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.718 HG21 HG22 ' A' ' 8' ' ' VAL . 29.1 m -93.6 -26.22 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 74.24 111.144 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -65.37 -24.57 67.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 71.25 110.912 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -78.16 -47.97 16.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 74.43 110.9 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -97.26 22.22 8.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.931 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.53 -41.07 93.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.135 -0.484 . . . . 75.3 110.936 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -56.9 -56.47 21.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 64.33 110.854 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -56.24 -55.65 30.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.41 110.942 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 40' ' ' ILE . 41.9 mt -50.97 -62.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.111 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -29.15 59.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 60.42 110.871 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -72.77 -23.63 60.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 73.32 110.905 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -86.8 -52.52 5.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 73.43 110.878 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.1 pt -51.31 -29.84 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.059 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.02 -21.5 38.49 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.759 -0.734 . . . . 52.24 112.506 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -94.0 -74.96 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.905 0.383 . . . . 71.15 110.856 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.83 47.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 75.05 112.447 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -67.02 -179.65 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.782 0.325 . . . . 75.51 110.883 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -90.33 -169.45 2.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 61.24 111.091 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.2 tt -103.39 -10.04 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 70.53 111.127 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.639 ' HA ' HD13 ' A' ' 37' ' ' ILE . 21.0 p30 -124.09 19.65 9.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 63.13 110.901 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 10.4 mmtp -96.13 -56.17 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 73.15 110.893 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.99 HD12 HD21 ' A' ' 7' ' ' LEU . 9.4 pt -50.05 -31.29 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 71.23 111.145 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.639 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.1 mp -69.24 -50.74 49.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 55.34 111.126 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -69.53 -26.03 64.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 65.52 110.831 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.7 t90 -68.31 -44.08 76.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.204 -0.453 . . . . 71.45 110.955 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 23' ' ' ILE . 51.3 mt -72.72 -45.2 58.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.439 . . . . 65.3 111.129 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -55.95 -38.65 70.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 64.02 110.935 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -72.95 -26.28 61.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 72.3 110.916 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -77.86 -56.94 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 72.03 110.865 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.3 pt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 72.44 111.082 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.8 33.35 6.57 Favored Glycine 0 N--CA 1.452 -0.291 0 CA-C-N 115.166 -0.924 . . . . 73.2 112.482 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.08 -27.65 10.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 75.31 111.084 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.792 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 33.4 mm -102.66 -32.33 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 61.41 111.107 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.57 67.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 65.33 111.067 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HG3' HD22 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -51.59 -37.62 50.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 72.53 110.907 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.095 HD21 HD12 ' A' ' 36' ' ' ILE . 3.6 mm? -69.27 -34.16 74.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 70.3 110.939 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 16' ' ' VAL . 66.5 t -61.39 -66.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 70.42 111.184 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.3 -24.3 42.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.051 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.4 mmmt -77.29 -41.72 39.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.43 110.852 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -118.84 -75.2 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 75.53 110.882 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.1 149.11 6.85 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 53.02 112.496 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.67 -58.22 11.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.519 0.676 . . . . 64.44 110.918 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.1 Cg_endo -69.67 -6.94 19.76 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.671 2.248 . . . . 73.14 112.393 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.9 mm -94.31 -23.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.52 111.132 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.661 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -93.63 -27.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 74.33 111.161 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.6 mmtt -66.23 -28.2 68.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 73.34 110.902 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -76.45 -24.57 53.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 71.53 110.898 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.515 ' O ' HD12 ' A' ' 23' ' ' ILE . 78.4 m-85 -117.59 25.4 10.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.792 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.07 -24.6 63.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 65.51 110.918 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -77.91 -3.82 43.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 62.42 110.914 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -114.27 -58.83 2.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 75.05 110.841 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.7 mt -51.4 -69.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 72.44 111.113 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -23.79 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 71.41 110.868 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -77.01 -21.82 54.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.916 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -89.65 -48.43 7.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.875 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.7 pt -51.95 -28.79 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 55.34 111.132 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.39 -18.41 43.29 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.761 -0.733 . . . . 74.25 112.478 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -97.7 -75.03 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.878 0.37 . . . . 64.15 110.874 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.85 48.23 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.72 -0.753 . . . . 61.5 112.48 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -68.05 -179.67 1.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.838 0.352 . . . . 73.14 110.885 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.21 -169.34 2.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 62.43 111.078 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 tt -103.33 -7.94 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 75.4 111.18 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -118.63 14.63 13.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -95.81 -61.01 1.52 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.937 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.095 HD12 HD21 ' A' ' 7' ' ' LEU . 10.4 pt -50.04 -30.82 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.446 . . . . 72.51 111.169 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 81.6 mt -67.26 -72.48 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 71.44 111.144 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.25 -35.06 59.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 65.15 110.878 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -52.68 -45.9 67.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.51 110.912 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 7' ' ' LEU . 42.9 mt -77.37 -47.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 72.15 111.09 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -52.81 -32.54 44.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 73.23 110.89 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -79.41 -43.59 23.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 64.52 110.865 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.25 -63.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.864 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 64.21 111.148 179.981 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.81 46.53 17.3 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.183 -0.917 . . . . 75.02 112.454 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.05 -45.41 4.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.71 0.291 . . . . 53.3 111.058 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.77 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 30.9 mm -77.34 -34.19 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 75.23 111.118 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.46 47.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.03 111.071 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -61.3 -33.47 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 74.34 110.921 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.015 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -83.94 -21.23 31.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.449 . . . . 64.23 110.923 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.722 HG22 HG21 ' A' ' 16' ' ' VAL . 89.2 t -68.28 -64.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 73.51 111.122 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.71 -24.95 59.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 61.31 111.086 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HD2' HG23 ' A' ' 37' ' ' ILE . 3.5 tmtm? -79.81 -58.29 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 54.51 110.891 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.505 ' HB3' HG21 ' A' ' 15' ' ' ILE . 93.3 m-85 -96.95 -75.11 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 70.11 110.892 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.85 151.78 7.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 32.3 112.479 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.53 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.58 -58.09 12.16 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.599 0.714 . . . . 72.25 110.933 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.83 19.54 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.692 2.262 . . . . 63.24 112.333 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.505 HG21 ' HB3' ' A' ' 11' ' ' PHE . 41.8 mm -94.6 -23.23 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 74.05 111.085 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.722 HG21 HG22 ' A' ' 8' ' ' VAL . 20.8 m -93.81 -27.36 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 44.15 111.124 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -62.61 -29.21 70.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.22 110.904 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -75.62 -36.36 60.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 74.35 110.913 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -100.07 26.21 6.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 73.24 110.933 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.77 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -79.45 -6.76 57.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 62.0 110.93 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -94.97 16.58 15.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 73.12 110.886 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -145.01 -50.17 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 62.04 110.943 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' A' ' 40' ' ' ILE . 37.7 mt -51.56 -67.16 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 71.44 111.133 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -57.51 -23.64 51.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 72.05 110.892 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -79.12 -19.55 50.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 71.12 110.905 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.35 -46.19 8.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 75.04 110.888 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.1 pp -56.42 -23.46 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 65.34 111.14 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.28 9.46 70.04 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.779 -0.724 . . . . 72.33 112.454 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.37 -63.58 1.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.906 0.384 . . . . 42.23 110.931 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.06 46.25 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 54.43 112.481 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -85.0 -178.66 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.778 0.323 . . . . 75.24 110.945 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.33 -169.38 1.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 64.3 111.107 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.427 HG23 ' OD1' ' A' ' 34' ' ' ASN . 14.6 tt -101.19 -10.56 8.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 75.54 111.12 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HA ' HD12 ' A' ' 37' ' ' ILE . 4.0 m-20 -121.72 19.5 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 75.24 110.872 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -95.36 -58.34 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 73.33 110.888 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.015 HD12 HD21 ' A' ' 7' ' ' LEU . 9.0 pt -49.48 -33.77 7.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.453 . . . . 73.33 111.117 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 34' ' ' ASN . 75.7 mt -60.58 -60.97 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 73.44 111.15 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.09 -26.48 68.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 53.05 110.85 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -65.46 -30.03 70.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 75.51 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.405 HD11 ' CD1' ' A' ' 23' ' ' ILE . 55.3 mt -93.26 -30.98 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 72.3 111.084 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -38.78 78.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 72.14 110.909 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -70.21 -41.42 73.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 64.11 110.93 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -58.69 -64.9 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 73.4 110.859 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 73.51 111.134 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.73 56.9 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.135 -0.939 . . . . 64.44 112.488 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.02 -46.44 3.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.778 0.323 . . . . 72.31 111.117 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.794 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 34.1 mm -75.65 -32.1 24.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 71.43 111.127 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -25.31 36.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 65.13 111.143 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HD2' HD11 ' A' ' 33' ' ' ILE . 7.5 mmpt? -62.69 -32.67 73.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.889 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.022 HD21 HD12 ' A' ' 36' ' ' ILE . 2.3 mm? -82.67 -23.93 33.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.269 -0.423 . . . . 71.31 110.947 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.72 HG22 HG21 ' A' ' 16' ' ' VAL . 89.2 t -69.98 -56.82 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 53.4 111.153 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.8 -26.17 66.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 72.14 111.094 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -79.97 -45.12 19.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 72.11 110.894 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.441 ' HB3' HG21 ' A' ' 15' ' ' ILE . 89.7 m-85 -109.43 -74.79 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 73.41 110.87 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 168.32 150.9 6.82 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.716 -0.754 . . . . 60.4 112.492 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.26 11.27 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.572 0.701 . . . . 74.41 110.908 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.74 -6.59 18.94 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 63.23 112.36 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.441 HG21 ' HB3' ' A' ' 11' ' ' PHE . 48.8 mm -95.13 -22.55 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 71.23 111.138 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.72 HG21 HG22 ' A' ' 8' ' ' VAL . 20.8 m -94.5 -27.26 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 75.45 111.113 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -64.44 -25.32 67.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 65.24 110.901 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -80.06 -32.48 39.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 74.11 110.884 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.552 ' O ' HD12 ' A' ' 23' ' ' ILE . 85.0 m-85 -106.52 24.44 12.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 50.34 110.902 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.794 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -75.82 -11.72 60.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 73.41 110.898 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -89.29 10.26 22.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 75.25 110.931 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -135.95 -54.48 0.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 73.33 110.897 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.552 HD12 ' O ' ' A' ' 19' ' ' TYR . 8.6 mt -51.51 -68.39 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 73.11 111.108 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.417 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -57.47 -23.78 51.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 75.24 110.859 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -78.18 -20.37 52.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 53.14 110.915 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -89.7 -47.5 7.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.897 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.2 -27.69 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 75.02 111.135 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.32 -21.97 35.5 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.735 -0.745 . . . . 62.11 112.502 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -93.45 -74.93 0.51 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 73.52 110.892 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.65 43.86 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.767 -0.73 . . . . 74.34 112.5 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -71.17 161.07 31.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.801 0.334 . . . . 74.14 110.924 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.573 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -84.86 -169.05 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 72.33 111.113 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.406 HD11 ' HD2' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -101.04 -0.07 10.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.437 . . . . 54.23 111.136 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -115.84 -25.88 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 53.32 110.893 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 10.7 mttm -57.48 -62.8 1.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 72.04 110.913 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.022 HD12 HD21 ' A' ' 7' ' ' LEU . 11.5 pt -50.38 -35.37 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 64.34 111.111 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.88 -50.11 76.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 73.25 111.176 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -78.19 -3.79 44.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.135 -0.484 . . . . 73.55 110.868 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -90.43 -42.0 11.14 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 74.34 110.943 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.498 HD12 HD12 ' A' ' 7' ' ' LEU . 28.3 mt -72.29 -52.62 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 63.45 111.146 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -52.74 -30.59 33.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 52.53 110.87 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -67.25 -41.25 85.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 63.43 110.894 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -70.38 -63.29 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 73.31 110.868 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.4 pt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 73.34 111.105 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.1 38.16 40.96 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.183 -0.917 . . . . 40.33 112.458 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.77 -54.17 49.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.312 . . . . 61.52 111.076 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.4 mm -90.67 -32.42 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 72.55 111.141 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.25 -20.95 58.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 60.44 111.059 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.651 ' NZ ' HD11 ' A' ' 37' ' ' ILE . 21.1 tptm -68.25 -34.88 77.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 72.33 110.883 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.087 HD21 HD12 ' A' ' 36' ' ' ILE . 2.8 mm? -77.93 -22.73 49.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 74.3 110.903 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.747 HG22 HG21 ' A' ' 16' ' ' VAL . 88.6 t -68.59 -66.58 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 71.2 111.154 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.1 48.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 54.2 111.093 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.752 ' HE3' HD13 ' A' ' 37' ' ' ILE . 3.8 mttm -80.36 -56.74 3.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.902 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.435 ' HB3' HG21 ' A' ' 15' ' ' ILE . 87.2 m-85 -98.47 -74.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.898 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.93 150.78 7.2 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 72.42 112.492 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.34 -58.32 11.08 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.568 0.699 . . . . 74.3 110.908 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.73 -6.65 19.09 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.687 2.258 . . . . 75.42 112.332 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.435 HG21 ' HB3' ' A' ' 11' ' ' PHE . 48.9 mm -94.58 -22.54 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.31 111.124 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.747 HG21 HG22 ' A' ' 8' ' ' VAL . 19.3 m -94.95 -27.44 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 73.25 111.102 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.74 -25.07 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.922 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -80.16 -40.69 26.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 60.33 110.865 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -103.75 26.49 8.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 65.21 110.918 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -72.56 -35.01 67.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.135 -0.484 . . . . 72.32 110.953 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -71.86 -9.33 58.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 71.1 110.9 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -102.37 -51.8 3.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.951 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.55 HD11 HD11 ' A' ' 40' ' ' ILE . 13.5 mt -56.44 -63.61 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.1 111.151 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 13.3 ttt -57.17 -26.06 59.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 74.23 110.903 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -74.51 -18.64 60.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 72.24 110.871 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -91.9 -50.68 5.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 64.53 110.868 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.8 pt -51.09 -28.9 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 72.13 111.127 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.13 -23.57 32.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 73.23 112.51 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -92.06 -74.88 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 62.13 110.896 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.19 44.72 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.79 -0.719 . . . . 52.21 112.489 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -69.62 -179.83 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.78 0.324 . . . . 75.14 110.946 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.535 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -102.07 -169.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 65.2 111.134 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 tt -99.14 -10.03 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.24 111.146 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.463 ' HA ' HD12 ' A' ' 37' ' ' ILE . 10.8 m120 -111.04 -20.28 12.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 75.33 110.897 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 5.3 mmtp -61.52 -59.2 5.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.05 110.921 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.087 HD12 HD21 ' A' ' 7' ' ' LEU . 10.4 pt -50.36 -31.35 8.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 73.33 111.182 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.752 HD13 ' HE3' ' A' ' 10' ' ' LYS . 74.0 mt -66.82 -60.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 64.45 111.134 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -60.39 -25.06 65.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 73.41 110.852 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.6 t90 -67.21 -57.22 7.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.915 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.568 HD12 HD12 ' A' ' 7' ' ' LEU . 42.7 mt -62.7 -36.93 77.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 53.21 111.124 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -61.75 -61.36 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.54 110.924 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -52.7 -29.41 26.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.01 110.897 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -72.07 -68.29 0.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 71.04 110.859 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.15 111.129 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -147.73 58.39 0.48 Allowed Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.131 -0.941 . . . . 43.14 112.453 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.41 -64.1 0.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.786 0.327 . . . . 73.41 111.097 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.705 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 26.7 mm -75.22 -32.16 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 70.12 111.126 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.19 -19.95 56.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.114 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -67.62 -30.54 70.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.904 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.991 HD21 HD12 ' A' ' 36' ' ' ILE . 1.9 mm? -84.25 -26.06 28.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.933 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.743 HG22 HG21 ' A' ' 16' ' ' VAL . 83.9 t -61.04 -69.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 63.22 111.13 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.72 -22.16 61.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 62.14 111.079 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' HG2' HG23 ' A' ' 37' ' ' ILE . 23.9 tptt -77.1 -37.48 54.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 72.21 110.909 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.04 -74.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 73.35 110.894 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 177.31 149.65 7.95 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.736 -0.745 . . . . 54.53 112.501 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.02 -58.11 12.55 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.554 0.693 . . . . 73.33 110.927 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.77 -6.41 18.55 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.669 2.246 . . . . 70.12 112.309 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.9 mm -93.64 -23.29 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 64.35 111.127 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.743 HG21 HG22 ' A' ' 8' ' ' VAL . 17.0 m -94.37 -28.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 55.12 111.119 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 39.7 mttm -64.84 -35.66 81.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.43 110.869 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -73.25 -30.73 63.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 70.03 110.872 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.535 ' O ' HD12 ' A' ' 23' ' ' ILE . 59.1 m-85 -103.3 22.13 14.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 72.51 110.914 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.705 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -70.42 -26.17 63.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 74.51 110.958 -179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -75.59 -6.07 48.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.086 -0.506 . . . . 73.31 110.885 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -112.09 -60.84 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 71.55 110.903 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.535 HD12 ' O ' ' A' ' 19' ' ' TYR . 5.6 mt -51.19 -67.98 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 73.31 111.124 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -26.51 53.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.853 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -74.64 -23.27 58.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 73.23 110.885 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -87.36 -51.33 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 71.14 110.843 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.0 pt -51.29 -29.5 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 60.41 111.118 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.24 -21.03 38.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.742 . . . . 73.01 112.465 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -93.35 -68.99 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.849 0.357 . . . . 75.51 110.861 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 165.48 36.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.704 -0.76 . . . . 63.24 112.468 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -56.64 179.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.754 0.311 . . . . 75.33 110.966 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.509 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -86.05 -169.32 2.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 71.44 111.09 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -102.13 -21.63 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 70.03 111.178 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.572 ' HA ' HD13 ' A' ' 37' ' ' ILE . 65.4 m-80 -116.65 22.09 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.487 . . . . 70.52 110.877 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 12.1 mmtt -94.63 -54.71 3.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 73.3 110.839 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.991 HD12 HD21 ' A' ' 7' ' ' LEU . 10.3 pt -50.23 -36.04 12.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 75.51 111.129 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.572 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -65.18 -48.89 81.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.55 111.113 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -70.62 -24.01 62.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 61.45 110.886 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 86.7 t90 -69.18 -49.94 52.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 73.44 110.915 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.8 mt -67.26 -45.05 87.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 75.14 111.115 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -57.74 -29.07 64.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 72.13 110.855 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.53 23.48 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 63.22 110.917 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -126.69 -38.84 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.41 110.837 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.5 pt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 74.12 111.133 179.997 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.96 72.98 0.76 Allowed Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.198 -0.91 . . . . 64.21 112.511 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.26 -75.24 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.752 0.31 . . . . 72.0 111.133 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.0 mm -82.61 -34.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 73.43 111.106 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.59 -21.79 54.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 53.34 111.073 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.438 ' HG2' HD11 ' A' ' 33' ' ' ILE . 17.2 tppt? -67.62 -29.75 69.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 64.24 110.912 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.926 HD21 HD12 ' A' ' 36' ' ' ILE . 2.7 mm? -83.75 -27.65 28.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 75.53 110.885 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.749 HG22 HG21 ' A' ' 16' ' ' VAL . 86.1 t -64.68 -69.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 73.14 111.125 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.66 -29.71 19.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 53.12 111.142 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.651 ' HD3' HG23 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -75.43 -74.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 72.42 110.918 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.448 ' HB3' HG21 ' A' ' 15' ' ' ILE . 79.0 m-85 -77.85 -74.89 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 74.42 110.835 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.07 150.89 7.11 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.749 . . . . 50.42 112.462 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.31 -58.33 11.02 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.604 0.716 . . . . 75.21 110.928 -179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.5 Cg_endo -69.76 -6.85 19.58 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.696 2.264 . . . . 51.22 112.324 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.448 HG21 ' HB3' ' A' ' 11' ' ' PHE . 46.0 mm -94.37 -23.21 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.04 111.134 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.749 HG21 HG22 ' A' ' 8' ' ' VAL . 19.8 m -94.12 -27.92 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.43 111.125 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.15 -32.06 70.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 72.42 110.895 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.99 -42.29 60.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 72.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -99.58 27.72 5.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 75.52 110.95 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.85 -1.25 42.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.159 -0.473 . . . . 65.12 110.904 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 -11.79 22.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.91 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -109.74 -50.65 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 72.53 110.905 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.495 ' CD1' HD11 ' A' ' 40' ' ' ILE . 26.4 mt -51.16 -69.89 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 63.5 111.122 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.51 -24.72 48.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 54.42 110.885 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -75.65 -23.72 56.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 75.53 110.926 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -87.87 -50.2 6.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 72.25 110.865 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.4 pt -51.29 -29.55 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 73.21 111.107 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.52 -21.95 36.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 62.42 112.466 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -92.28 -74.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.892 0.377 . . . . 65.33 110.871 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.0 41.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 52.31 112.491 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -68.43 -179.8 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.786 0.327 . . . . 64.41 110.892 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.638 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -102.42 -169.41 1.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 52.43 111.076 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.438 HD11 ' HG2' ' A' ' 6' ' ' LYS . 10.7 tp -96.29 -21.93 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 75.11 111.128 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.671 ' HA ' HD12 ' A' ' 37' ' ' ILE . 5.8 t30 -99.7 -20.07 16.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.14 110.875 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.638 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 0.6 OUTLIER -58.23 -63.04 1.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 65.24 110.865 179.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.926 HD12 HD21 ' A' ' 7' ' ' LEU . 11.5 pt -51.06 -35.26 14.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 74.5 111.101 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 34' ' ' ASN . 81.9 mt -60.87 -58.03 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 61.55 111.128 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.96 -25.29 67.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 72.33 110.861 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -66.88 -55.91 12.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 71.14 110.938 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.495 HD11 ' CD1' ' A' ' 23' ' ' ILE . 51.3 mt -63.58 -42.45 96.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 42.24 111.126 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -58.35 -38.49 77.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 62.3 110.909 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -69.07 -46.86 66.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 73.1 110.897 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -56.95 -61.3 2.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 75.34 110.86 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 62.12 111.139 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.49 74.89 1.26 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.148 -0.933 . . . . 70.55 112.472 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.07 -58.83 1.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 54.35 111.093 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.773 HD11 ' HG3' ' A' ' 24' ' ' MET . 27.3 mm -90.6 -25.79 5.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 72.33 111.125 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.47 -28.95 22.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 62.13 111.123 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' HE2' HD11 ' A' ' 33' ' ' ILE . 20.1 mmmt -54.98 -40.71 70.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 65.44 110.894 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.914 HD21 HD12 ' A' ' 36' ' ' ILE . 2.8 mm? -77.6 -28.43 51.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 73.13 110.91 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG22 HG21 ' A' ' 16' ' ' VAL . 87.7 t -61.35 -58.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 54.03 111.139 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.84 -24.25 65.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 53.35 111.082 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -75.86 -38.98 57.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 73.32 110.934 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.504 ' HB3' HG21 ' A' ' 15' ' ' ILE . 86.5 m-85 -121.74 -74.63 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.458 . . . . 63.34 110.913 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 173.98 151.83 8.55 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.712 -0.756 . . . . 64.23 112.508 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.48 -58.21 11.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.568 0.699 . . . . 75.45 110.912 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.78 -6.56 18.91 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.693 2.262 . . . . 54.11 112.314 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.504 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.2 mm -93.93 -23.46 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 70.32 111.134 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.717 HG21 HG22 ' A' ' 8' ' ' VAL . 17.8 m -94.09 -28.3 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 73.02 111.134 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -60.29 -29.66 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.03 110.902 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -76.17 -43.07 44.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.885 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.5 ' O ' HD12 ' A' ' 23' ' ' ILE . 60.7 m-85 -98.17 26.46 5.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.897 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.31 -1.53 41.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 74.22 110.938 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 ttmm -98.09 -8.55 27.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 75.35 110.922 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -113.62 -50.95 2.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 73.44 110.902 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.5 HD12 ' O ' ' A' ' 19' ' ' TYR . 16.0 mt -51.32 -69.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 75.4 111.085 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.773 ' HG3' HD11 ' A' ' 4' ' ' ILE . 1.0 OUTLIER -56.78 -24.57 51.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 73.3 110.885 179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -76.32 -22.93 54.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 70.01 110.932 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -87.72 -49.74 6.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 62.41 110.881 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 pt -51.53 -29.12 9.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 72.54 111.206 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.99 -19.96 39.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 61.35 112.545 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -94.1 -69.0 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 74.21 110.879 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.33 36.38 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.69 -0.767 . . . . 33.45 112.446 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -56.89 179.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 73.31 110.891 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.52 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -87.25 -169.33 2.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 72.32 111.13 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.484 HG23 HD22 ' A' ' 34' ' ' ASN . 8.8 tp -100.97 -21.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 50.42 111.116 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.574 ' HA ' HD13 ' A' ' 37' ' ' ILE . 1.3 m-80 -116.21 22.66 12.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 74.03 110.886 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 2.7 mmtp -95.41 -55.4 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 75.1 110.873 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.914 HD12 HD21 ' A' ' 7' ' ' LEU . 10.1 pt -50.19 -36.22 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 35.32 111.157 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.574 HD13 ' HA ' ' A' ' 34' ' ' ASN . 4.9 mp -64.54 -55.96 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 72.34 111.113 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -64.84 -22.26 66.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.194 -0.457 . . . . 74.21 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -72.31 -53.11 13.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 70.15 110.963 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.458 HD12 HD12 ' A' ' 7' ' ' LEU . 48.1 mt -58.55 -59.11 4.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.429 . . . . 71.2 111.159 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -52.16 -34.82 46.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 75.25 110.923 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -65.91 -35.35 80.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 72.25 110.882 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -73.36 -61.89 1.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.869 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 pt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 75.24 111.157 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.48 38.93 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.188 -0.915 . . . . 44.25 112.505 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.77 -41.11 5.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.765 0.317 . . . . 70.23 111.058 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.776 HG21 ' CZ ' ' A' ' 20' ' ' TYR . 27.5 mm -73.77 -27.44 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 63.22 111.136 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.51 -21.94 53.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 72.53 111.118 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -58.53 -35.85 72.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 73.44 110.875 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.025 HD21 HD12 ' A' ' 36' ' ' ILE . 1.6 mm? -84.67 -22.02 29.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 75.2 110.884 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.715 HG22 HG21 ' A' ' 16' ' ' VAL . 88.8 t -68.19 -69.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 75.33 111.09 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.22 -29.48 22.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 75.43 111.154 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.432 ' HD2' HG23 ' A' ' 37' ' ' ILE . 2.3 tmtt? -76.5 -65.6 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 71.2 110.884 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.467 ' HB3' HG21 ' A' ' 15' ' ' ILE . 87.2 m-85 -87.49 -75.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 73.33 110.872 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.77 152.41 7.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 63.23 112.477 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.532 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.69 -57.9 14.09 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.571 0.701 . . . . 74.34 110.927 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.6 Cg_endo -69.75 -7.12 20.24 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.684 2.256 . . . . 54.32 112.341 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.467 HG21 ' HB3' ' A' ' 11' ' ' PHE . 42.7 mm -94.57 -23.19 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 72.21 111.154 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.715 HG21 HG22 ' A' ' 8' ' ' VAL . 24.3 m -93.65 -26.6 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 62.42 111.128 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.1 mmmt -62.2 -23.38 66.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.471 . . . . 74.14 110.892 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -81.58 -47.5 12.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 71.21 110.861 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.83 24.99 5.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.234 -0.439 . . . . 53.21 110.881 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.776 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -65.59 -50.59 64.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.139 -0.482 . . . . 63.23 110.951 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -50.98 -52.89 38.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 72.35 110.893 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -57.03 -58.83 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 71.01 110.894 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.718 HD11 HD11 ' A' ' 40' ' ' ILE . 35.7 mt -50.75 -59.66 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.428 . . . . 75.54 111.134 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.49 -28.94 61.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 72.21 110.854 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -19.9 58.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 70.12 110.925 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -91.13 -48.61 6.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 71.21 110.866 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.8 pp -56.47 -23.71 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 60.13 111.186 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.0 8.77 71.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.782 -0.723 . . . . 43.22 112.505 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.81 -65.29 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 55.22 110.849 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.96 48.47 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 72.24 112.491 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -85.94 -177.85 6.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.816 0.341 . . . . 73.22 110.893 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.526 ' HB3' ' HG3' ' A' ' 35' ' ' LYS . . . -96.27 -168.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 71.24 111.13 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -100.57 -14.67 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.422 . . . . 61.23 111.117 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.618 ' HA ' HD13 ' A' ' 37' ' ' ILE . 88.9 m-20 -119.28 19.6 12.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.902 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HG3' ' HB3' ' A' ' 32' ' ' ALA . 2.2 mmpt? -95.24 -57.05 2.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 72.24 110.884 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.025 HD12 HD21 ' A' ' 7' ' ' LEU . 6.3 pt -48.01 -33.53 3.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 75.14 111.146 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.0 mp -67.12 -49.45 73.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 62.4 111.105 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.01 -25.81 63.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 71.32 110.856 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -69.2 -42.9 75.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.465 . . . . 73.51 110.904 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.718 HD11 HD11 ' A' ' 23' ' ' ILE . 72.2 mt -73.3 -41.86 57.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 75.5 111.097 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.0 mtmt -56.94 -47.41 80.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 73.21 110.882 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -62.7 -44.51 96.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 70.13 110.88 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -57.24 -64.69 0.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 72.5 110.823 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.54 111.142 -179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.41 -49.86 0.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.189 -0.914 . . . . 72.14 112.451 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -104.56 -35.78 7.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.732 0.301 . . . . 71.42 111.055 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 26.5 mm -80.37 -28.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 74.33 111.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.71 -26.51 34.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 75.23 111.077 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -54.94 -34.5 63.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 73.04 110.893 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.988 HD21 HD12 ' A' ' 36' ' ' ILE . 2.4 mm? -87.7 -25.1 23.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.33 110.935 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.752 HG22 HG21 ' A' ' 16' ' ' VAL . 85.7 t -64.6 -70.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 51.12 111.131 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.08 -29.83 23.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.483 . . . . 63.3 111.098 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -74.24 -71.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 65.42 110.92 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -81.27 -74.84 0.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.01 110.857 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.01 150.13 6.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.679 -0.772 . . . . 75.22 112.444 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.33 -58.3 11.16 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.523 0.678 . . . . 64.51 110.896 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.72 -6.74 19.29 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 2.264 . . . . 73.24 112.358 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.66 -22.94 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 75.13 111.156 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.752 HG21 HG22 ' A' ' 8' ' ' VAL . 20.0 m -94.28 -28.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 63.04 111.105 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? -60.85 -30.61 70.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 72.44 110.877 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -75.73 -38.76 58.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 55.52 110.906 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -103.2 27.91 6.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 70.11 110.916 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -82.8 -0.82 49.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.085 -0.507 . . . . 71.34 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.3 -5.87 32.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 75.33 110.902 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -116.01 -47.09 2.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 74.14 110.912 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 40' ' ' ILE . 35.4 mt -51.78 -67.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 73.44 111.11 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 9.1 ptm -57.12 -25.67 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.24 110.904 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -74.02 -19.46 60.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 74.54 110.898 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -94.5 -51.56 4.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 62.12 110.861 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.29 -29.49 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 50.12 111.116 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.77 -21.66 37.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.745 -0.741 . . . . 22.11 112.491 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -93.05 -74.68 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.9 0.381 . . . . 73.41 110.884 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.79 41.77 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.71 -0.757 . . . . 53.32 112.476 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.1 m95 -64.77 177.7 0.9 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.737 0.303 . . . . 73.1 110.946 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 35' ' ' LYS . . . -91.74 -171.55 2.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 73.43 111.122 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.6 tt -102.73 0.71 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.236 -0.438 . . . . 61.24 111.101 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.652 ' HA ' HD13 ' A' ' 37' ' ' ILE . 16.5 m120 -129.08 5.82 5.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 65.05 110.893 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.482 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 25.0 mmtp -86.35 -55.08 4.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 71.33 110.913 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.988 HD12 HD21 ' A' ' 7' ' ' LEU . 10.3 pt -50.21 -35.94 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 74.23 111.143 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.652 HD13 ' HA ' ' A' ' 34' ' ' ASN . 5.0 mp -66.12 -62.96 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 61.23 111.171 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -57.79 -24.68 58.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 72.21 110.88 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -67.72 -60.97 2.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.908 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 23' ' ' ILE . 63.2 mt -51.54 -42.64 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 72.12 111.128 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.2 -42.38 98.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.473 . . . . 62.52 110.92 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.06 -26.01 67.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 63.13 110.932 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -80.2 -62.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.42 110.848 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 pt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 73.42 111.137 -179.966 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.79 49.92 0.71 Allowed Glycine 0 N--CA 1.451 -0.302 0 CA-C-N 115.131 -0.94 . . . . 65.15 112.459 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.09 -56.99 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 75.11 111.128 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 24.5 mm -104.34 -30.6 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 63.22 111.14 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.73 -25.09 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 72.54 111.089 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 mmmt -59.64 -33.2 71.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 64.34 110.841 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.037 HD21 HD12 ' A' ' 36' ' ' ILE . 2.1 mm? -84.85 -25.83 27.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.418 . . . . 74.41 110.934 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.742 HG22 HG21 ' A' ' 16' ' ' VAL . 86.8 t -61.38 -64.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 33.33 111.123 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.59 -23.96 44.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 71.1 111.129 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.666 ' HG2' HG23 ' A' ' 37' ' ' ILE . 16.3 tptt -77.67 -66.32 0.85 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 75.34 110.901 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.577 ' HB3' HG21 ' A' ' 15' ' ' ILE . 96.6 m-85 -91.91 -75.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.843 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.15 155.19 11.68 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.699 -0.762 . . . . 73.14 112.47 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.538 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -52.77 -57.92 14.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.589 0.709 . . . . 74.2 110.889 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.8 Cg_endo -69.78 -6.7 19.23 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.695 2.263 . . . . 73.12 112.332 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.577 HG21 ' HB3' ' A' ' 11' ' ' PHE . 42.8 mm -94.75 -23.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 74.25 111.124 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.742 HG21 HG22 ' A' ' 8' ' ' VAL . 21.4 m -93.71 -26.97 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 71.14 111.142 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -63.76 -20.75 66.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 75.12 110.885 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 -49.71 9.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 74.22 110.873 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -94.94 22.09 6.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.431 . . . . 74.31 110.915 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -65.79 -40.67 92.17 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 70.14 110.913 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.49 -55.48 34.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 54.43 110.906 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -56.77 -55.6 32.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.251 -0.431 . . . . 54.35 110.908 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 40' ' ' ILE . 40.3 mt -50.52 -62.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 72.3 111.149 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.6 ttt -56.63 -29.78 62.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 71.11 110.872 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -72.86 -18.84 61.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 72.13 110.933 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -91.92 -51.79 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 75.45 110.886 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 pt -51.31 -29.36 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.483 . . . . 75.13 111.158 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.15 -21.33 38.81 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.7 -0.762 . . . . 71.41 112.478 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 26.4 tp10 -95.29 -75.04 0.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.852 0.358 . . . . 74.33 110.856 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.07 49.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 32.22 112.522 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -68.49 -179.54 1.38 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.771 0.32 . . . . 75.0 110.906 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.629 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -86.97 -169.4 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.31 111.109 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.8 tp -100.63 -21.26 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 75.31 111.121 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -115.49 17.05 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 75.54 110.88 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.629 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 33.3 mmtt -89.38 -57.74 2.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 75.34 110.918 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.037 HD12 HD21 ' A' ' 7' ' ' LEU . 8.2 pt -49.58 -32.11 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.02 111.113 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.666 HG23 ' HG2' ' A' ' 10' ' ' LYS . 74.9 mt -67.68 -58.57 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 71.15 111.112 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.78 -32.26 72.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 70.02 110.857 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.43 -47.63 85.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 74.32 110.929 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 23' ' ' ILE . 64.2 mt -69.06 -42.66 82.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 75.5 111.158 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -56.49 -25.89 52.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 73.13 110.92 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -96.32 31.02 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 54.23 110.884 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -137.72 -49.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 71.41 110.815 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 73.44 111.126 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.25 -88.96 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.166 -0.924 . . . . 74.04 112.465 178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.74 -28.94 12.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.769 0.318 . . . . 51.03 111.088 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.5 mm -75.93 -33.59 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 72.04 111.139 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.31 -26.18 38.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 54.43 111.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -61.31 -25.59 67.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 64.13 110.918 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.844 HD21 HD12 ' A' ' 36' ' ' ILE . 2.9 mm? -91.41 -22.97 20.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.24 110.897 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.681 HG22 HG21 ' A' ' 16' ' ' VAL . 93.0 t -65.57 -57.39 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 73.04 111.106 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.48 -24.07 66.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 65.53 111.084 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -78.37 -46.6 19.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 74.44 110.912 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.479 ' HB3' HG21 ' A' ' 15' ' ' ILE . 82.8 m-85 -111.86 -74.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 75.31 110.896 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.7 151.65 7.89 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.704 -0.76 . . . . 75.15 112.435 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.531 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.14 -58.37 10.73 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 63.45 110.889 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 54.0 Cg_endo -69.74 -6.61 19.01 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.691 2.261 . . . . 65.32 112.354 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 11' ' ' PHE . 45.9 mm -94.8 -22.6 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.42 111.109 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.681 HG21 HG22 ' A' ' 8' ' ' VAL . 19.7 m -94.73 -27.66 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 65.31 111.119 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -62.63 -29.01 70.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 71.54 110.917 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -75.46 -47.21 28.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 64.31 110.901 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -96.87 28.42 3.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 62.15 110.953 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -74.33 -30.51 62.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 73.03 110.935 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -70.15 -10.92 60.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 52.13 110.923 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -108.18 -60.1 1.77 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 72.21 110.91 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mt -49.96 -33.7 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.0 111.14 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.7 tmm? -80.24 -49.9 10.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 65.1 110.843 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.02 -20.29 57.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 74.44 110.87 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -83.77 -58.39 2.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 71.43 110.884 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.0 pt -50.92 -29.58 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 73.04 111.176 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.5 -21.72 35.75 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 71.43 112.474 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.2 -74.91 0.52 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 74.52 110.879 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.15 46.11 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.743 . . . . 53.31 112.504 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -68.87 -179.65 1.53 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.733 0.301 . . . . 62.45 110.962 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.711 ' HB3' ' HG2' ' A' ' 35' ' ' LYS . . . -98.92 -169.27 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 63.11 111.124 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.4 tt -98.5 -16.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 75.33 111.097 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.551 ' HA ' HD12 ' A' ' 37' ' ' ILE . 12.3 t-20 -105.32 -20.62 13.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 60.32 110.893 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.711 ' HG2' ' HB3' ' A' ' 32' ' ' ALA . 21.5 mmtp -58.68 -65.4 0.67 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 71.53 110.871 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.844 HD12 HD21 ' A' ' 7' ' ' LEU . 6.2 pt -49.01 -32.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 73.4 111.137 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 34' ' ' ASN . 71.5 mt -65.54 -66.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 62.2 111.159 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -60.3 -19.95 57.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 72.33 110.886 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -72.4 -50.85 23.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 73.35 110.937 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 29.0 mt -60.97 -59.77 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 52.42 111.116 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -51.61 -30.19 20.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 63.32 110.892 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -65.98 -41.37 91.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.882 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -69.52 -62.47 1.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.239 -0.437 . . . . 75.32 110.866 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 pt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 75.04 111.139 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' FME . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.61 36.96 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.186 -0.915 . . . . 52.53 112.536 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.04 -64.85 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 72.43 111.092 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.606 HD11 ' HG3' ' A' ' 24' ' ' MET . 27.1 mm -71.93 -33.58 48.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 73.31 111.112 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.04 -22.23 49.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.481 . . . . 63.31 111.101 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -38.28 90.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 64.54 110.925 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.0 HD21 HD12 ' A' ' 36' ' ' ILE . 3.0 mm? -75.18 -22.3 58.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 65.54 110.914 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.697 HG22 HG21 ' A' ' 16' ' ' VAL . 94.3 t -67.71 -63.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 71.14 111.128 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.09 -24.59 63.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 34.22 111.071 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.736 ' HD2' HG23 ' A' ' 37' ' ' ILE . 4.5 tmtt? -79.57 -52.63 7.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 63.54 110.928 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HB3' HG21 ' A' ' 15' ' ' ILE . 81.3 m-85 -104.26 -74.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.4 110.898 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.98 151.21 7.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.718 . . . . 42.24 112.535 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -51.2 -58.18 11.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.624 0.726 . . . . 75.43 110.931 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 13' ' ' TRP . 53.7 Cg_endo -69.72 -6.8 19.45 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.715 2.276 . . . . 44.4 112.371 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.47 HG21 ' HB3' ' A' ' 11' ' ' PHE . 44.8 mm -94.82 -23.09 5.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 72.34 111.15 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.697 HG21 HG22 ' A' ' 8' ' ' VAL . 20.4 m -93.99 -27.2 4.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 71.21 111.115 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.2 mmtt -61.68 -28.27 69.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 75.31 110.884 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -77.14 -43.67 33.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 73.3 110.87 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.484 ' O ' HD12 ' A' ' 23' ' ' ILE . 63.1 m-85 -96.91 27.05 4.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 71.41 110.946 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -80.86 -1.09 41.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 74.43 110.932 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.29 -9.78 24.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 65.24 110.899 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -112.25 -51.16 2.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 70.23 110.889 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.536 ' CD1' HD11 ' A' ' 40' ' ' ILE . 17.8 mt -51.3 -68.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 64.41 111.167 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.606 ' HG3' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -56.46 -25.66 51.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 74.13 110.852 179.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -75.21 -23.88 57.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 65.34 110.874 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -86.86 -50.85 6.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 75.41 110.896 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.2 pt -51.16 -29.87 8.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 64.21 111.12 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.68 -22.01 38.2 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.77 -0.729 . . . . 44.13 112.501 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -93.65 -74.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 72.23 110.926 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.3 46.81 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.54 112.451 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -66.9 -179.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.822 0.344 . . . . 74.52 110.916 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.548 ' HB3' ' CG ' ' A' ' 35' ' ' LYS . . . -87.22 -169.48 2.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 74.03 111.107 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.0 tt -101.65 -21.41 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 74.3 111.161 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HA ' HD12 ' A' ' 37' ' ' ILE . 32.6 m120 -114.84 19.25 16.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.97 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.548 ' CG ' ' HB3' ' A' ' 32' ' ' ALA . 12.6 mmtp -91.46 -58.05 2.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 73.41 110.9 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.0 HD12 HD21 ' A' ' 7' ' ' LEU . 10.9 pt -50.7 -31.95 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 64.33 111.121 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.736 HG23 ' HD2' ' A' ' 10' ' ' LYS . 67.6 mt -65.02 -59.19 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 70.22 111.128 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -64.83 -26.06 68.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 64.22 110.879 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.01 -53.82 40.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.458 . . . . 70.44 110.883 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.607 HD12 HD12 ' A' ' 7' ' ' LEU . 56.0 mt -64.95 -45.3 95.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 74.23 111.127 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.23 -34.29 56.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 74.2 110.877 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.8 tttp -93.81 42.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 62.4 110.893 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -148.3 -48.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 64.1 110.838 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 64.14 111.119 179.996 . . . . . . . . 1 1 . 1 stop_ save_